Processing 00000000.tx.1: Does the Glucose-Dependent Insulin Secretion Mechanism Itself Cause Oxidative Stress in Pancreatic -Cells? 

Phrase: "Does"

Phrase: "the Glucose-Dependent Insulin Secretion Mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0441712:Mechanism [Functional Concept]
   804   C1706376:Mechanism [Manufactured Object]

Phrase: "Itself"

Phrase: "Cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Oxidative Stress in Pancreatic -Cells?"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   760   C0038435:Stress [Finding]
   760   C0311404:Oxidative [Functional Concept]
Processing 00000000.tx.2: Leonid E. 

Phrase: "Leonid E."
Processing 00000000.tx.3: Fridlyand, and Louis H. 

Phrase: "Fridlyand,"

Phrase: "and"

Phrase: "Louis H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.4: Philipson From the Department of Medicine, University of Chicago, Chicago, Illinois  ABSTRACT TOP ABSTRACT GDIS and adenine nucleotide... 

Phrase: "Philipson From the Department of Medicine,"

Phrase: "University of Chicago,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0008044:Chicago [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "Illinois  ABSTRACT TOP ABSTRACT GDIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   822   C1719133:Glucose/Insulin [Quantitative Concept]
   812   C1256369:insulin secretion [Cell Function]
   793   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C0036536:secretion [Biologic Function]
   793   C0036537:Secretion [Body Substance]
   793   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C1579433:Insulin [Pharmacologic Substance]
   737 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   710 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "adenine nucleotide..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.5: Dependence of ROS production... 

Phrase: "Dependence of ROS production..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011546:Dependence [Mental Process]
   753   C0439857:Dependence [Mental or Behavioral Dysfunction]
   753   C2698668:DEPENDENCE [Regulation or Law]
Processing 00000000.tx.6: Manifestations of oxidative... 

Phrase: "Manifestations of oxidative..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   866   C1280464:Manifestation of [Qualitative Concept]
           manifestations
   790   C0205319:manifestations [Functional Concept]
Processing 00000000.tx.7: Dual role of the... 

Phrase: "Dual role of the..."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.8: Dual role of -cell... 

Phrase: "Dual role of -cell..."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.9: Intracellular inhibition of ROS... 

Phrase: "Intracellular inhibition of ROS..."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0034750:Reactive Inhibition [Individual Behavior]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
Processing 00000000.tx.10: Preservation of -cell... 

Phrase: "Preservation of -cell..."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.11: CONCLUSIONS REFERENCES  Glucose-dependent insulin secretion (GDIS), reactive oxygen species (ROS) production, and oxidative stress in pancreatic -cells may be tightly linked processes. 

Phrase: "CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusions [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Glucose-dependent insulin secretion (GDIS),"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "reactive oxygen species (ROS) production,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033268:production [Occupational Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "and"

Phrase: "oxidative stress in pancreatic -cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   760   C0038435:Stress [Finding]
   760   C0311404:Oxidative [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "tightly linked processes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1184743:Process [Body Part, Organ, or Organ Component]
   793   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.12: Here we suggest that the same pathways used in the activation of GDIS (increased glycolytic flux, ATP-to-ADP ratio, and intracellular Ca2+ concentration) can dramatically enhance ROS production and manifestations of oxidative stress and, possibly, apoptosis. 

Phrase: "Here"

Phrase: "we"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the same pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "used in the activation of GDIS"
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   807   C2245392:activation of insulin secretion [Cell Function]
   784   C2259154:activation of secretion [Cell Function]
   764   C1256369:insulin secretion [Cell Function]
   762   C0240016:Insulin used [Finding]
   762   C1719133:Glucose/Insulin [Quantitative Concept]
   745   C1524063:Use of [Functional Concept]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C0851827:Dependent [Qualitative Concept]
   742   C1273517:used [Finding]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1701901:Dependent [Qualitative Concept]
   742   C1879547:Activation [Activity]
   742   C3244310:dependent [Functional Concept]
   708 E C0042153:use [Functional Concept]
   708 E C0457083:Use [Functional Concept]
   708 E C1947944:Use [Intellectual Product]

Phrase: "(increased glycolytic flux,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2348693:Flux [Natural Phenomenon or Process]

Phrase: "ATP-to-ADP ratio,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "intracellular Ca2+ concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ")"

Phrase: "can"

Phrase: "dramatically"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "ROS production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033268:production [Occupational Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "and"

Phrase: "manifestations of oxidative stress"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   816   C1280464:Manifestation of [Qualitative Concept]
           manifestations
   770   C0205319:manifestations [Functional Concept]

Phrase: "and"

Phrase: ","

Phrase: "possibly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.13: The increase in ROS production and oxidative stress produced by GDIS activation itself suggests a dual role for metabolic insulin secretagogues, as an initial sharp increase in insulin secretion rate can be accompanied by progressive -cell injury. 

Phrase: "The increase in ROS production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "produced by GDIS activation"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C1256369:insulin secretion [Cell Function]
   774   C1719133:Glucose/Insulin [Quantitative Concept]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1701901:Dependent [Qualitative Concept]
   748   C1879547:Activation [Activity]
   748   C3244310:dependent [Functional Concept]

Phrase: "itself"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a dual role for metabolic insulin secretagogues,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "as"

Phrase: "an initial sharp increase in insulin secretion rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0020459:INSULIN INCREASE [Disease or Syndrome]
   744   C0442805:Increase [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "accompanied by progressive -cell injury."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0599732:cell injury [Cell or Molecular Dysfunction]
   760   C0007634:Cell [Cell]
   760   C0205329:Progressive [Functional Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3263722:Injury [Injury or Poisoning]
   760   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.14: We propose that therapeutic strategies targeting enhancement of GDIS should be carefully considered in light of possible loss of -cell function and mass. 

Phrase: "We"

Phrase: "propose"

Phrase: "that therapeutic strategies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategies [Mental Process]

Phrase: "targeting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeting [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "enhancement of GDIS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   753   C2349975:Enhancement [Activity]

Phrase: "should"

Phrase: "be"

Phrase: "carefully"

Phrase: "considered in light of possible loss of -cell function"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   764   C0007613:Cell Function [Cell Function]
   762   C1517881:Light Cell [Cell]
   742   C0007634:Cell [Cell]
   742   C0023693:Light [Natural Phenomenon or Process]
   742   C0031843:function [Physiologic Function]
   742   C0332149:Possible [Qualitative Concept]
   742   C0542341:Function [Functional Concept]
   742   C0700205:FUNCTION [Classification]
   742   C0750591:considered [Idea or Concept]
   742   C1269647:Cell [Cell]
   742   C1306462:Light [Functional Concept]
   742   C1517945:Loss [Quantitative Concept]
   742   C1704653:Cell [Medical Device]
   742   C1705273:Function [Intellectual Product]
   742   C1705910:Possible [Qualitative Concept]
   742   C1881376:Light [Qualitative Concept]
   742   C1948049:Cell [Spatial Concept]
   742   C2362652:Possible [Qualitative Concept]

Phrase: "and"

Phrase: "mass."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0577559:Mass [Finding]
  1000   C1306372:*Mass [Quantitative Concept]
  1000   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.15: Insulin-secreting -cells are subject to injury from oxidative stress. 

Phrase: "Insulin-secreting -cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0030281:Insulin-Secreting Cells [Cell]
           Insulin Cell
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "are subject to injury"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0681850:Subject [Group]
   770   C1550501:{Subject} [Idea or Concept]
   770   C1551058:Are [Quantitative Concept]
   770   C1706203:Subject [Idea or Concept]
   770   C2349001:Subject [Human]
   770   C2697811:Subject [Functional Concept]
   770   C3263722:Injury [Injury or Poisoning]
   770   C3263723:Injury [Injury or Poisoning]

Phrase: "from oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.16: Formation of reactive oxygen species (ROS) such as superoxide anion (O2), hydrogen peroxide, hydroxyl radicals, and the concomitant generation of nitric oxide have been implicated in -cell dysfunction or cell death caused by autoimmune attack and actions of cytokines in type 1 diabetes. 

Phrase: "Formation of reactive oxygen species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "(ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: ")"

Phrase: "such as superoxide anion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038836:Superoxide Anion [Element, Ion, or Isotope]
           Superoxide
   861   C0003075:Anion [Element, Ion, or Isotope]

Phrase: "(O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "hydrogen peroxide,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "hydroxyl radicals,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C0063146:Hydroxyl Radical [Inorganic Chemical]
           Hydroxyl
   861   C0302912:radicals [Chemical Viewed Structurally]
   861   C0700307:Hydroxyl [Inorganic Chemical]
   827 E C0439807:Radical [Qualitative Concept]

Phrase: "and"

Phrase: "the concomitant generation of nitric oxide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]

Phrase: "have"

Phrase: "been"

Phrase: "implicated"

Phrase: "in -cell dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0031847:dysfunction [Functional Concept]
   827   C0277785:Dysfunction, NOS [Qualitative Concept]
   771 E C0231174:Malfunction [Functional Concept]
   771 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "or"

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "caused by autoimmune attack"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0277793:Attack, NOS [Temporal Concept]
   770   C0443146:Autoimmune [Pathologic Function]
   770   C1261512:attack [Social Behavior]
   770   C1304680:Attack [Finding]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "and"

Phrase: "actions of cytokines"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0441472:actions [Functional Concept]
   756 E C3266814:Action [Activity]

Phrase: "in type 1 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.17: ROS have also been associated with the impairment of -cell function in type 2 diabetes (14). 

Phrase: "ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "associated with the impairment of -cell function"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   778   C0007613:Cell Function [Cell Function]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C0699040:cell associated [Cell Component]
   774   C1292719:Associated function [Functional Concept]
   748   C0007634:Cell [Cell]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0684336:Impairment [Pathologic Function]
   748   C0700205:FUNCTION [Classification]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1705273:Function [Intellectual Product]
   748   C1948049:Cell [Spatial Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.18: Compared with many other cell types, the -cell may be uniquely at high risk of oxidative damage and has an increased sensitivity for apoptosis (2,3,5). 

Phrase: "Compared with many"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "other cell types,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "the -cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "uniquely at high risk of oxidative damage"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0332167:High risk of [Qualitative Concept]
           High Risk
   778   C3272283:High Risk [Finding]
   748   C0010957:Damage [Injury or Poisoning]
   748   C0035647:Risk [Qualitative Concept]
   748   C0205250:High [Qualitative Concept]
   748   C0311404:Oxidative [Functional Concept]
   748   C1299351:High [Qualitative Concept]
   748   C1883709:Damage [Functional Concept]
   748   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "has"

Phrase: "an increased sensitivity for apoptosis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C1881189:INCREASED SENSITIVITY [Phenomenon or Process]
   806   C2346484:INCREASED SENSITIVITY [Phenomenon or Process]
           SENSITIVITY
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C2349185:Sensitivity [Qualitative Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.19: Investigations (13,6) implicating ROS in -cell death or damage have, for the most part, relied on the protective effects of antioxidants, scavengers, and overexpression of antioxidant enzymes in islets or transgenic mice to reduce the destructive influence of some oxyradicals. 

Phrase: "Investigations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1261322:Investigations [Health Care Activity]
   966 E C1552578:investigation [Idea or Concept]
   916 E C1517586:Investigational [Qualitative Concept]
   916 E C3245491:investigational [Intellectual Product]

Phrase: "(13,"

Phrase: "6"

Phrase: ")"

Phrase: "implicating"

Phrase: "ROS in -cell death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0007587:Cell Death [Cell Function]
   799   C0011065:Death [Organism Function]
   799   C1306577:Death, NOS [Finding]

Phrase: "or"

Phrase: "damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010957:Damage [Injury or Poisoning]
  1000   C1883709:Damage [Functional Concept]

Phrase: "have"

Phrase: ","

Phrase: "for the most part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449719:Part [Spatial Concept]
   861   C1709471:Part [Quantitative Concept]

Phrase: "relied on the protective effects of antioxidants,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   757   C3179302:Antioxidant Effects [Physiologic Function]
   748   C0003402:Antioxidants [Pharmacologic Substance]
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "scavengers,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017108:scavengers [Medical Device]
  1000   C1003377:scavengers [Fish]

Phrase: "and"

Phrase: "overexpression of antioxidant enzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "in islets"

Phrase: "or"

Phrase: "transgenic mice to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "reduce"

Phrase: "the destructive influence of some oxyradicals."
Processing 00000000.tx.20: However, elevated glucose concentrations are thought to alter metabolism, create oxidative stress, and induce apoptosis in many cell types in addition to glucose-responsive -cells (2,5). 

Phrase: "However,"

Phrase: "elevated glucose concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   884   C0427743:Glucose concentration [Laboratory Procedure]
   884   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "are"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "metabolism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis in many cell types"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162638:Apoptosis [Cell Function]

Phrase: "in addition to glucose-responsive -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.21: Why should ROS generation in -cells be more dangerous than in other cell types? 

Phrase: "Why"

Phrase: "should"

Phrase: "ROS generation in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "be"

Phrase: "more dangerous than"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0010968:Dangerousness [Idea or Concept]

Phrase: "in other cell types?"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.22: We have analyzed the existing data on mechanisms of glucose-dependent insulin secretion (GDIS) in -cells, ROS production, oxidative stress, and apoptosis and propose that the same pathways can dramatically influence oxidative stress, apoptosis, and insulin production.  

Phrase: "We"

Phrase: "have"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the existing data on mechanisms of glucose-dependent insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1511726:Data [Idea or Concept]
   739   C3245479:data [Medical Device]

Phrase: "(GDIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "in -cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "ROS production,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033268:production [Occupational Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "propose"

Phrase: "that"

Phrase: "the same pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "can"

Phrase: "dramatically"

Phrase: "influence"

Phrase: "oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "insulin production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]
Processing 00000000.tx.23: GDIS and adenine nucleotide regulation. 

Phrase: "GDIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "adenine nucleotide regulation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]
   734   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
Processing 00000000.tx.24: TOP ABSTRACT GDIS and adenine nucleotide... 

Phrase: "TOP ABSTRACT GDIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   839   C1719133:Glucose/Insulin [Quantitative Concept]
   827   C1256369:insulin secretion [Cell Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "adenine nucleotide..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.25: Dependence of ROS production... 

Phrase: "Dependence of ROS production..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011546:Dependence [Mental Process]
   753   C0439857:Dependence [Mental or Behavioral Dysfunction]
   753   C2698668:DEPENDENCE [Regulation or Law]
Processing 00000000.tx.26: Manifestations of oxidative... 

Phrase: "Manifestations of oxidative..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   866   C1280464:Manifestation of [Qualitative Concept]
           manifestations
   790   C0205319:manifestations [Functional Concept]
Processing 00000000.tx.27: Dual role of the... 

Phrase: "Dual role of the..."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.28: Dual role of -cell... 

Phrase: "Dual role of -cell..."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.29: Intracellular inhibition of ROS... 

Phrase: "Intracellular inhibition of ROS..."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0034750:Reactive Inhibition [Individual Behavior]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
Processing 00000000.tx.30: Preservation of -cell... 

Phrase: "Preservation of -cell..."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.31: CONCLUSIONS REFERENCES  According to the most widely accepted hypothesis, glucose induces insulin release as follows (2,79) (Fig. 1): glucose rapidly equilibrates across the plasma membrane and is phosphorylated by glucokinase, which determines metabolic flux through glycolysis. 

Phrase: "CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusions [Idea or Concept]

Phrase: "REFERENCES  According to the most widely accepted hypothesis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0680240:according [Social Behavior]
   744   C1272684:Accepted [Qualitative Concept]
   744   C1512571:Hypothesis [Idea or Concept]
   744   C1514811:Reference [Idea or Concept]
   744   C1548435:Accepted [Idea or Concept]
   744   C1706462:Reference [Conceptual Entity]

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "79"

Phrase: ")"

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ":"

Phrase: "glucose rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "equilibrates across the plasma membrane"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0596901:Membrane [Cell Component]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "and"

Phrase: "is"

Phrase: "phosphorylated by glucokinase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1415014:GLUCOKINASE [Gene or Genome]

Phrase: "which"

Phrase: "determines"

Phrase: "metabolic flux through glycolysis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348693:Flux [Natural Phenomenon or Process]
Processing 00000000.tx.32: Because the Km of glucokinase for glucose is 8 mmol/l, this flux climbs steeply as glucose concentration increases, underlying the dependence of the -cell insulin secretory response to glucose in the physiological range. 

Phrase: "Because"

Phrase: "the Km of glucokinase"

Phrase: "for glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "is"

Phrase: "8 mmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1532563:mmol/L [Quantitative Concept]

Phrase: "this flux climbs steeply as glucose concentration increases,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0561942:Climbs [Finding]
   711 E C2584300:Climb [Daily or Recreational Activity]

Phrase: "underlying"

Phrase: "the dependence of the -cell insulin secretory response"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0011546:Dependence [Mental Process]
   744   C0439857:Dependence [Mental or Behavioral Dysfunction]
   744   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "in the physiological range."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]
Processing 00000000.tx.33: View larger version (47K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(47K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.34: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.35: The various components discussed in the text are illustrated in the cartoon of a -cell and a mitochondrion within it. 

Phrase: "The various components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "discussed in the text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1527021:Text [Intellectual Product]
   770   C1554111:Text [Idea or Concept]
   770   C1705606:Text [Intellectual Product]
   770   C3541382:Text [Intellectual Product]

Phrase: "are"

Phrase: "illustrated in the cartoon of a -cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0007306:cartoon [Intellectual Product]
   748   C0007634:Cell [Cell]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "a mitochondrion within it."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0026237:Mitochondrion [Cell Component]
Processing 00000000.tx.36: Glucose and fatty acid metabolism leads to an increase in NADH and Ca2+ and to a decrease in ADP. 

Phrase: "Glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "fatty acid metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0596563:Fatty Acid Metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   734   C0015684:Fatty acid [Lipid]

Phrase: "leads to an increase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C0442805:Increase [Functional Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in NADH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027289:NADH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "and"

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and to a decrease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "in ADP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]
Processing 00000000.tx.37: In turn, decreased ADP leads to increased mitochondrial membrane potential () and a corresponding increase in ROS production. 

Phrase: "In turn,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "decreased ADP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0523452:ADP [Laboratory Procedure]

Phrase: "leads to increased mitochondrial membrane potential"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   833   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   790   C0025251:Membrane Potential [Cell Function]
   790   C0596952:Mitochondrial membrane [Cell Component]
   783   C0861064:increased lead [Finding]
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0025255:Membrane [Tissue]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0181586:leads [Medical Device]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C1706182:Membrane [Manufactured Object]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3245505:Potential [Qualitative Concept]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "a corresponding increase in ROS production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]
Processing 00000000.tx.38: Increased glycolytic flux, decreased ADP concentration, and increased intracellular Ca2+ concentration could all contribute to both increased GDIS and ROS generation in the ETC. 

Phrase: "Increased glycolytic flux,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2348693:Flux [Natural Phenomenon or Process]

Phrase: "decreased ADP concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "increased intracellular Ca2+ concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "could"

Phrase: "all"

Phrase: "contribute to both increased GDIS"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   793   C1372360:Increased Insulin Secretion [Organ or Tissue Function]
   770   C0860803:increased glucose [Finding]
   770   C1256369:insulin secretion [Cell Function]
   767   C0020459:increased insulin [Disease or Syndrome]
   767   C1719133:Glucose/Insulin [Quantitative Concept]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]
   744   C0205217:Increased [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1701901:Dependent [Qualitative Concept]
   744   C1880177:Contribute [Activity]
   744   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "ROS generation in the ETC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0079411:Generation [Temporal Concept]
   742   C3146294:Generation [Activity]
Processing 00000000.tx.39: Solid lines indicate flux of substrates, and dashed lines indicate regulating effects, where (+) represents activation and () represents repression.  

Phrase: "Solid lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "indicate"

Phrase: "flux of substrates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348693:Flux [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "dashed lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "indicate"

Phrase: "regulating"

Phrase: "effects,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "where"

Phrase: "(+"

Phrase: ")"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "and ()"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "repression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035143:Repression [Mental Process]
Processing 00000000.tx.40: Reducing equivalents are recovered by the tricarboxylic acid cycle from carbohydrates and from fats (after prior -oxidation). 

Phrase: "Reducing equivalents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439185:Equivalents [Quantitative Concept]
   827 E C0205163:Equivalent [Qualitative Concept]

Phrase: "are"

Phrase: "recovered by the tricarboxylic acid cycle"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0008858:Tricarboxylic Acid Cycle [Molecular Function]
   790   C0040887:tricarboxylic acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0521108:recovered [Qualitative Concept]
   753   C1511572:Cycle [Temporal Concept]
   719 E C2004454:recover [Organism Function]

Phrase: "from carbohydrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007004:Carbohydrates [Carbohydrate]

Phrase: "and from fats"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0015677:Fats [Lipid,Pharmacologic Substance]
   790   C1428607:FATS [Gene or Genome]
   790   C1515981:And [Idea or Concept]
   756 E C0424612:FAT [Organism Attribute]

Phrase: "("

Phrase: "after prior -oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: ")."
Processing 00000000.tx.41: Synthesized reducing equivalents [NAD(P)H and flavins] are transferred to the electron transport chain (ETC). 

Phrase: "Synthesized reducing equivalents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439185:Equivalents [Quantitative Concept]
   793 E C0205163:Equivalent [Qualitative Concept]

Phrase: "[NAD(P)H"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0027289:NAD(H) [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "flavins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016213:Flavins [Organic Chemical]
   966 E C0062166:flavin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "]"

Phrase: "are"

Phrase: "transferred to the electron transport chain (ETC)."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   833   C2244392:electron transport chain [Molecular Function]
   790   C0013846:Electron Transport [Molecular Function]
           Electron transfer
   783   C1550030:Transport To [Idea or Concept]
   767   C2244393:electron transfer [Molecular Function]
   753   C0005528:Transport, NOS [Cell Function]
   753   C0013852:Electron [Quantitative Concept]
   753   C0337112:Chain [Manufactured Object]
   753   C0348011:transferred [Functional Concept]
   753   C1317949:Transport [Manufactured Object]
   753   C1524075:Chain [Idea or Concept]
   753   C3463986:Electron [Bird]
   753   C3495449:transport [Medical Device]
   719 E C0040671:Transfer [Mental Process]
   719 E C1705822:Transfer [Activity]
Processing 00000000.tx.42: The energy released by the ETC is used to pump protons out of the mitochondrial inner membrane, creating the transmembrane electrochemical gradient. 

Phrase: "The energy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0424589:Energy [Finding]
  1000   C0542479:Energy [Natural Phenomenon or Process]
  1000   C1442080:Energy [Quantitative Concept]

Phrase: "released by the ETC"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   833   C2244392:electron transport chain [Molecular Function]
   790   C0013846:Electron Transport [Molecular Function]
   753   C0005528:Transport, NOS [Cell Function]
   753   C0013852:Electron [Quantitative Concept]
   753   C0337112:Chain [Manufactured Object]
   753   C0391871:Released [Functional Concept]
   753   C1283071:Released [Functional Concept]
   753   C1317949:Transport [Manufactured Object]
   753   C1524075:Chain [Idea or Concept]
   753   C3463986:Electron [Bird]
   753   C3495449:transport [Medical Device]
   719 E C0030685:Release [Health Care Activity]
   719 E C0439180:% release [Quantitative Concept]
   719 E C0680255:release [Health Care Activity]
   719 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "pump"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0182537:Pump [Medical Device]
  1000   C1706421:Pump [Manufactured Object]

Phrase: "protons out of the mitochondrial inner membrane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033727:Protons [Element, Ion, or Isotope]

Phrase: "creating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1706214:Create [Activity]
   966   C3244320:create [Functional Concept]

Phrase: "the transmembrane electrochemical gradient."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439182:% gradient [Quantitative Concept]
   827   C0812409:Gradient [Quantitative Concept]
Processing 00000000.tx.43: This gradient is used to make ATP from ADP and Pi, driven by proton movement back through the ATP synthase complex. 

Phrase: "This gradient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439182:% gradient [Quantitative Concept]
  1000   C0812409:Gradient [Quantitative Concept]

Phrase: "is"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "ATP from ADP"

Phrase: "and"

Phrase: "Pi,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0429863:PI [Clinical Attribute]
  1000   C3537219:PI [Gene or Genome]
  1000   C3539772:PI [Intellectual Product]

Phrase: "driven by proton movement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0026649:Movement [Organism Function]
   770   C0033727:Proton [Element, Ion, or Isotope]
   737   C0013126:Drive [Mental Process]

Phrase: "back through the ATP synthase complex."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004600:Back [Body Location or Region]
   753   C0205095:Back [Spatial Concept]
   753   C0460009:Back [Body Location or Region]
   753   C1995000:Back [Body Location or Region]
Processing 00000000.tx.44: The exchange of ATP and ADP across the inner membrane is catalyzed by the adenine nucleotide translocator. 

Phrase: "The exchange of ATP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0678640:exchange [Social Behavior]

Phrase: "and"

Phrase: "ADP across the inner membrane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0523452:ADP [Laboratory Procedure]

Phrase: "is"

Phrase: "catalyzed by the adenine nucleotide translocator."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   753   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.45: These events result in increased ATP production in mitochondria and in an enhanced ratio of ATP to ADP in the cytoplasm. 

Phrase: "These events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441471:Events [Event]
  1000   C3541888:Events [Classification]

Phrase: "result in increased ATP production"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0033268:production [Occupational Activity]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "in mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "and in an enhanced ratio of ATP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0456603:Ratio [Quantitative Concept]
   748   C1515981:And [Idea or Concept]
   748   C1547037:Ratio [Intellectual Product]
   748   C2349975:Enhanced [Activity]

Phrase: "to ADP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]

Phrase: "in the cytoplasm."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]
Processing 00000000.tx.46: In the presence of glucose, the increase in intracellular ATP-to-ADP ratio closes the ATP-sensitive K+ (KATP) channels, which in turn results in depolarization of the plasma membrane, influx of extracellular Ca2+, and activation of exocytosis. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "the increase in intracellular ATP-to-ADP ratio"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "closes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0587267:Close [Functional Concept]

Phrase: "the ATP-sensitive K+ (KATP) channels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   771   C0439799:Channel [Spatial Concept]
   771   C1706095:Channel [Conceptual Entity]

Phrase: "which in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "results in depolarization of the plasma membrane,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0007603:Plasma membrane [Cell Component]
   774   C1816453:membrane depolarization [Cell Function]
   748   C0025255:Membrane [Tissue]
   748   C0032105:Plasma [Body Substance]
   748   C0596901:Membrane [Cell Component]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C1706182:Membrane [Manufactured Object]
   748   C2825142:Result [Finding]

Phrase: "influx of extracellular Ca2+,"

Phrase: "and"

Phrase: "activation of exocytosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2249811:activation of exocytosis [Cell Function]
   790   C1879547:Activation [Activity]
Processing 00000000.tx.47: We have recently developed (10) a computer model of regulation Ca2+ and ATP concentrations in pancreatic -cells. 

Phrase: "We"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "developed"

Phrase: "(10"

Phrase: ")"

Phrase: "a computer model of regulation Ca2+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0009609:computer model [Machine Activity]
   783   C0814675:model regulation [Regulation or Law]
   753   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "ATP concentrations in pancreatic -cells."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.48: However, our modeling studies suggest that the current understanding of adenine nucleotide regulation in -cells is incomplete (L.E.F., L.H.P., unpublished observations). 

Phrase: "However,"

Phrase: "our modeling studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the current understanding of adenine nucleotide regulation in -cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0162340:Understanding [Mental Process]

Phrase: "is"

Phrase: "incomplete"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205257:Incomplete [Quantitative Concept]
  1000   C0728938:incomplete [Quantitative Concept]
  1000   C1548386:incomplete [Idea or Concept]

Phrase: "(L.E.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "L.H.P.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C2346686:L/h [Quantitative Concept]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "unpublished observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: ")."
Processing 00000000.tx.49: In particular, the effect of substrates that markedly enhance insulin secretion, including glucose, on ATP concentration is small, but the ratio of total ATP to total ADP increases considerably in most studies (1113). 

Phrase: "In particular,"

Phrase: "the effect of substrates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "that markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "insulin secretion,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "on ATP concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "is"

Phrase: "small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "but"

Phrase: "the ratio of total ATP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "to total ADP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0523452:ADP [Laboratory Procedure]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "considerably in most studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "(1113"

Phrase: ")."
Processing 00000000.tx.50: In contrast to ATP, only a small fraction of total cellular ADP is free (11,14). 

Phrase: "In contrast to ATP,"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a small fraction of total cellular ADP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C0439160:Fraction of total [Quantitative Concept]
   778   C1264633:Fraction of [Quantitative Concept]
           Fraction
   748   C1554103:Fraction [Idea or Concept]

Phrase: "is"

Phrase: "free"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332296:free [Functional Concept]
  1000   C1880497:Free [Qualitative Concept]
  1000   C1996904:Free [Qualitative Concept]

Phrase: "(11,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.51: Several measurements of free ADP have been performed in -cells. 

Phrase: "Several measurements of free ADP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0242485:measurements [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.52: Ghosh et al. 

Phrase: "Ghosh et al."
Processing 00000000.tx.53: (15) found in -cellrich rat pancreatic islet cores that an increase of glucose from 4 to 8 mmol/l led to a decrease of free ADP from 44 to 31 mol/l (pooled data from Table 5 in Ghosh et al. [15]). 

Phrase: "(15"

Phrase: ")"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "in -cellrich rat pancreatic islet cores"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   766   C0444669:Core [Spatial Concept]
   766   C1167518:core [Cell Component]
   766   C1706352:Core [Medical Device]
   766   C1882467:Core [Manufactured Object]
   766   C3274653:Core [Body Substance]

Phrase: "that"

Phrase: "an increase of glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "from 4"

Phrase: "to 8 mmol/l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1532563:mmol/L [Quantitative Concept]

Phrase: "led to a decrease of free ADP"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   748   C0332296:free [Functional Concept]
   748   C0392756:Decrease [Qualitative Concept]
   748   C0523452:ADP [Laboratory Procedure]
   748   C0547047:Decrease [Quantitative Concept]
   748   C1708698:LED [Manufactured Object]
   748   C1880497:Free [Qualitative Concept]
   748   C1996904:Free [Qualitative Concept]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C1522538:Lead [Functional Concept]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "from 44"

Phrase: "to 31 mol/l (pooled data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1511726:Data [Idea or Concept]
   804   C3245479:data [Medical Device]

Phrase: "from Table 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "in Ghosh et al."

Phrase: "[15"

Phrase: "]"

Phrase: ")."
Processing 00000000.tx.54: ATP concentration increased only insignificantly following glucose challenge in these experiments. 

Phrase: "ATP concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "only insignificantly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "glucose challenge in these experiments."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0798503:Challenge [Clinical Attribute]
   760   C0805586:Challenge [Health Care Activity]
   760   C3274764:Challenge [Conceptual Entity]
Processing 00000000.tx.55: Ronner et al. 

Phrase: "Ronner et al."
Processing 00000000.tx.56: (12) found (in clonal HC9 insulin-secreting cells) that increased glucose concentration was associated with an exponential decline in the concentration of free ADP from 50 mol/l at 0 mmol/l glucose to 5 mol/l at 30 mmol/l glucose, whereas the concentration of ATP remained nearly constant. 

Phrase: "(12"

Phrase: ")"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "("

Phrase: "in clonal HC9 insulin-secreting cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   884   C0030281:Insulin-Secreting Cells [Cell]
           Insulin Cell
   862   C0009013:Clone Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "that increased glucose concentration"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0427743:Glucose concentration [Laboratory Procedure]
   901   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0860803:increased glucose [Finding]

Phrase: "was"

Phrase: "associated with an exponential decline"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C1552645:exponential [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of free ADP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0523452:ADP [Laboratory Procedure]

Phrase: "from 50 mol/l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0347982:mol/L [Quantitative Concept]

Phrase: "at 0 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "to 5 mol/l"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C2348935:.5 L [Quantitative Concept]
   901   C0347982:mol/L [Quantitative Concept]

Phrase: "at 30 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "whereas"

Phrase: "the concentration of ATP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "remained"

Phrase: "nearly constant."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1547014:*Constant [Quantitative Concept]
   861   C1948059:Constant [Qualitative Concept]
Processing 00000000.tx.57: These data suggest that a sharp decrease of free ADP with only a relatively small change in ATP concentrations is the characteristic feature of the response of -cells to glucose stimulation. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a sharp decrease of free ADP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "with only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a relatively small change in ATP concentrations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C0700321:Small [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]

Phrase: "is"

Phrase: "the characteristic feature of the response of -cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   750   C1562749:Cell feature [Organism Attribute]
   744   C1521970:Feature [Qualitative Concept]
   744   C1706388:Feature [Conceptual Entity]
   744   C2346469:Feature [Qualitative Concept]
   744   C2348519:Feature [Qualitative Concept]

Phrase: "to glucose stimulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.58: The functional necessity of this change in the ATP-to-ADP ratio can be understood from a consideration of KATP regulation (for details, see the review in ref. 9). 

Phrase: "The functional necessity of this change"

Phrase: "in the ATP-to-ADP ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "can"

Phrase: "be"

Phrase: "understood from a consideration of KATP regulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0518609:consideration [Finding]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]
   714   C0162340:Understand [Mental Process]

Phrase: "("

Phrase: "for details,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522508:Details [Qualitative Concept]
   966 E C1561567:detail [Functional Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "the review in ref. 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0282443:Review [Intellectual Product]
   760   C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.59: The activity of KATP channels decreases when pancreatic -cells are exposed to increasing concentrations of glucose. 

Phrase: "The activity of KATP channels"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C1153410:channel activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "when"

Phrase: "pancreatic -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "exposed to increasing concentrations of glucose."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   783   C0427743:concentrations glucose [Laboratory Procedure]
   783   C1287281:concentrations glucose [Laboratory or Test Result]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0086045:Concentrations [Mental Process]
   753   C0442808:Increasing [Functional Concept]
   719 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.60: However, as discussed above, only small changes in ATP concentrations were found following exposure to increased glucose concentrations. 

Phrase: "However,"

Phrase: "as"

Phrase: "discussed above,"

Phrase: "only small changes in ATP concentrations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   753   C0700321:Small [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "exposure to increased glucose concentrations."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332157:Exposure to [Clinical Attribute]
           Exposure
   760   C0274281:Exposure, NOS [Injury or Poisoning]
Processing 00000000.tx.61: This cannot by itself induce sufficient closure of KATP channels. 

Phrase: "This"

Phrase: "cannot by itself"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "sufficient closure of KATP channels."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0185003:Closure [Therapeutic or Preventive Procedure]
   760   C1521802:Closure [Research Activity]
   704 E C0447303:Occlusal [Body Location or Region]
   704 E C0591895:occlusal [Organic Chemical,Pharmacologic Substance]
   704 E C1947917:Occlusal [Functional Concept]
Processing 00000000.tx.62: However, decreased free ADP concentrations in the physiological range can close KATP channels at constant ATP concentration (7,16,17). 

Phrase: "However,"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "free ADP concentrations in the physiological range"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0086045:Concentrations [Mental Process]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "can"

Phrase: "close"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0587267:Close [Functional Concept]

Phrase: "KATP channels at constant ATP concentration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   719   C0439799:Channel [Spatial Concept]
   719   C1706095:Channel [Conceptual Entity]

Phrase: "(7,"

Phrase: "16,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.63: This means that a considerable increase in glycolytic flux and a sharp decrease in free ADP levels could be the necessary conditions leading to closure of KATP channels following glucose challenge and to insulin secretion.  

Phrase: "This means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "that"

Phrase: "a considerable increase in glycolytic flux"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "a sharp decrease in free ADP levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "the necessary conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "leading to closure of KATP channels"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   790   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   753   C0185003:Closure [Therapeutic or Preventive Procedure]
   753   C0332152:Leading [Temporal Concept]
   753   C1521802:Closure [Research Activity]
   753   C1522538:Leading [Functional Concept]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719   C0439799:Channel [Spatial Concept]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719   C1706095:Channel [Conceptual Entity]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "glucose challenge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0798503:Challenge [Clinical Attribute]
   861   C0805586:Challenge [Health Care Activity]
   861   C3274764:Challenge [Conceptual Entity]

Phrase: "and to insulin secretion."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C1256369:insulin secretion [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C1515981:And [Idea or Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.64: Dependence of ROS production in -cells on the GDIS mechanism. 

Phrase: "Dependence of ROS production in -cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0011546:Dependence [Mental Process]
   744   C0439857:Dependence [Mental or Behavioral Dysfunction]
   744   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "on the GDIS mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0441712:Mechanism [Functional Concept]
   804   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.65: TOP ABSTRACT GDIS and adenine nucleotide... 

Phrase: "TOP ABSTRACT GDIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   839   C1719133:Glucose/Insulin [Quantitative Concept]
   827   C1256369:insulin secretion [Cell Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "adenine nucleotide..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.66: Dependence of ROS production... 

Phrase: "Dependence of ROS production..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011546:Dependence [Mental Process]
   753   C0439857:Dependence [Mental or Behavioral Dysfunction]
   753   C2698668:DEPENDENCE [Regulation or Law]
Processing 00000000.tx.67: Manifestations of oxidative... 

Phrase: "Manifestations of oxidative..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   866   C1280464:Manifestation of [Qualitative Concept]
           manifestations
   790   C0205319:manifestations [Functional Concept]
Processing 00000000.tx.68: Dual role of the... 

Phrase: "Dual role of the..."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.69: Dual role of -cell... 

Phrase: "Dual role of -cell..."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.70: Intracellular inhibition of ROS... 

Phrase: "Intracellular inhibition of ROS..."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0034750:Reactive Inhibition [Individual Behavior]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
Processing 00000000.tx.71: Preservation of -cell... 

Phrase: "Preservation of -cell..."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.72: CONCLUSIONS REFERENCES  Recently we reported (18) that real-time estimations of superoxide production indicated that O2 generation is coupled to mitochondrial metabolism in pancreatic -cells. 

Phrase: "CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusions [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "we"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(18"

Phrase: ")"

Phrase: "that real-time estimations of superoxide production"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0680844:estimations [Mental Process]
   714 E C0681916:Estimation [Quantitative Concept]
   714 E C0750572:Estimation [Quantitative Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that O2 generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]

Phrase: "is"

Phrase: "coupled to mitochondrial metabolism"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]
   770   C0026237:Mitochondrial [Cell Component]
   770   C0521451:Mitochondrial [Functional Concept]
   770   C1948027:Coupled [Functional Concept]
   737 E C0010222:couple [Family Group]

Phrase: "in pancreatic -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.73: A similar conclusion was reached by Sakai et al. 

Phrase: "A similar conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707478:Conclusion [Idea or Concept]

Phrase: "was"

Phrase: "reached by Sakai et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C2584321:Reach [Organism Function]
Processing 00000000.tx.74: (19). 

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.75: The principal source of ROS in most mammalian tissues is the ETC itself (2022). 

Phrase: "The principal source of ROS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449416:Source [Finding]
   748   C1705919:Source [Idea or Concept]

Phrase: "in most mammalian tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "is"

Phrase: "the ETC"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   923   C2244392:electron transport chain [Molecular Function]
   861   C0013846:Electron Transport [Molecular Function]
   812   C0005528:Transport, NOS [Cell Function]
   812   C0013852:Electron [Quantitative Concept]
   812   C0337112:Chain [Manufactured Object]
   812   C1317949:Transport [Manufactured Object]
   812   C1524075:Chain [Idea or Concept]
   812   C3463986:Electron [Bird]
   812   C3495449:transport [Medical Device]
   741 E C0013850:Electronic [Manufactured Object]
   741 E C1547561:Electronic [Idea or Concept]

Phrase: "itself"

Phrase: "(2022"

Phrase: ")."
Processing 00000000.tx.76: Superoxide anions are generated by single-electron reduction of molecular oxygen in complexes of the mitochondrial ETC. 

Phrase: "Superoxide anions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0038836:Superoxide Anion [Element, Ion, or Isotope]
           Superoxide
   861   C0003075:Anions [Element, Ion, or Isotope]

Phrase: "are"

Phrase: "generated by single-electron reduction of molecular oxygen"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   770   C0302920:Molecular oxygen [Element, Ion, or Isotope]
   744   C0013852:Electron [Quantitative Concept]
   744   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0037179:Single [Population Group]
   744   C0087136:single [Finding]
   744   C0205171:Single [Quantitative Concept]
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]
   744   C1521991:Molecular [Qualitative Concept]
   744   C3146294:Generated [Activity]
   744   C3463986:Electron [Bird]
   731   C0872367:single molecule [Substance]

Phrase: "in complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704241:Complexes [Chemical Viewed Structurally]
   966 E C0439855:Complex [Qualitative Concept]

Phrase: "of the mitochondrial ETC."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1325653:Mitochondrial electron transport chain [Cell Component]
   923   C2244392:electron transport chain [Molecular Function]
   812   C0337112:Chain [Manufactured Object]
   812   C1524075:Chain [Idea or Concept]
   756   C1752477:mitochondrial electron transport [Molecular Function]
   708   C0678851:mitochondrial transport [Cell Function]
Processing 00000000.tx.77: ROS production depends on the concentration of the intermediate metabolites of these complexes because the ETC carriers in a more reduced state have the property of donating electrons to oxygen (2022). 

Phrase: "ROS production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033268:production [Occupational Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "depends on the concentration of the intermediate metabolites of these complexes"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   738   C0086045:Concentration [Mental Process]
   738   C0205103:Intermediate [Spatial Concept]
   738   C0725813:depend [Medical Device]
   738   C0870883:Metabolites [Biologically Active Substance]
   738   C1446561:Concentration [Quantitative Concept]
   738   C1550465:intermediate [Idea or Concept]
   738   C1704241:Complexes [Chemical Viewed Structurally]
   738   C2698672:METABOLITES [Regulation or Law]
   738   C2827755:INTERMEDIATE [Laboratory or Test Result]
   704 E C0439855:Complex [Qualitative Concept]

Phrase: "because"

Phrase: "the ETC carriers in a more reduced state"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   741   C0560175:Carrier State [Finding]
       E   Carrier
   739   C0007294:carriers [Finding]
   706 E C1706209:Carrier [Medical Device]
   706 E C3273162:Carrier [Intellectual Product]

Phrase: "have"

Phrase: "the property of donating electrons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0871161:Property [Qualitative Concept]
   760   C1882134:Property [Conceptual Entity]
   760   C2347695:Property [Entity]

Phrase: "to oxygen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(2022"

Phrase: ")."
Processing 00000000.tx.78: The reduced state of the ETC carriers can be achieved by increased production of reducing equivalents in mitochondria or by decreased electron transfer capability on (or after) these carriers (2022). 

Phrase: "The reduced state of the ETC carriers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   745   C0560175:Carrier State [Finding]
   742   C1301808:State [Geographic Area]
   742   C1442792:State [Functional Concept]
   742   C3148680:State [Geographic Area]

Phrase: "can"

Phrase: "be"

Phrase: "achieved by increased production of reducing equivalents"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0033268:production [Occupational Activity]
   748   C0205217:Increased [Quantitative Concept]
   748   C0392756:Reducing [Qualitative Concept]
   748   C0439185:Equivalents [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   714 E C0205163:Equivalent [Qualitative Concept]

Phrase: "in mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "or by decreased electron transfer capability"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C0013846:Electron transfer [Molecular Function]
   790   C2244393:electron transfer [Molecular Function]
   753   C0013852:Electron [Quantitative Concept]
   753   C0040671:Transfer [Mental Process]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   753   C1705822:Transfer [Activity]
   753   C2698977:Capability [Qualitative Concept]
   753   C3463986:Electron [Bird]
   719 E C0547047:Decrease [Quantitative Concept]

Phrase: "on ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720176:On [Functional Concept]
  1000   C1720294:On [Intellectual Product]

Phrase: "or"

Phrase: "after"

Phrase: ")"

Phrase: "these carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0007294:carriers [Finding]
   966 E C0560175:Carrier [Finding]
   966 E C1706209:Carrier [Medical Device]
   966 E C3273162:Carrier [Intellectual Product]

Phrase: "(2022"

Phrase: ")."
Processing 00000000.tx.79: -Cells have a sensitive system, starting with glucokinase, for initiating the response to physiological changes in glucose concentration. 

Phrase: "-Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "a sensitive system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "starting with glucokinase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1415014:GLUCOKINASE [Gene or Genome]
   756   C0439659:Start [Temporal Concept]

Phrase: "for initiating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]

Phrase: "the response to physiological changes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "in glucose concentration."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427743:Glucose concentration [Laboratory Procedure]
  1000   C1287281:Glucose concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.80: Therefore, in contrast to most other mammalian cell types, increased glucose concentration stimulates a steeply increased glycolytic flux in -cells, followed by a sharp stimulation in the production of reducing equivalents (7,23). 

Phrase: "Therefore,"

Phrase: "in contrast to most"

Phrase: "other mammalian cell types,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0449475:Cell types [Intellectual Product]
   901   C1512977:Mammalian Cell [Cell]
   867 E C0007634:Cell Type [Cell]
           Cell
   827   C0332307:Types [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1547052:*Type [Quantitative Concept]

Phrase: "increased glucose concentration"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0427743:Glucose concentration [Laboratory Procedure]
   901   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0860803:increased glucose [Finding]

Phrase: "stimulates"

Phrase: "a steeply"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "glycolytic flux in -cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "followed by a sharp stimulation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1444775:Sharp [Finding]
   760   C1539835:SHARP [Gene or Genome]
   760   C1948023:Stimulation [Natural Phenomenon or Process]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "in the production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "of reducing equivalents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439185:Equivalents [Quantitative Concept]
   827 E C0205163:Equivalent [Qualitative Concept]

Phrase: "(7,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.81: This means that this part of the GDIS mechanism could lead itself to an enhancement of ROS production in pancreatic -cells following glucose challenge. 

Phrase: "This means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "that"

Phrase: "this part of the GDIS mechanism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1292711:Part of [Spatial Concept]
   742   C0449719:Part [Spatial Concept]
   742   C1709471:Part [Quantitative Concept]

Phrase: "could"

Phrase: "lead"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "itself to an enhancement of ROS production"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   742   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0033268:production [Occupational Activity]
   742   C0205332:Reactive [Qualitative Concept]
   742   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   742   C1705920:Species [Conceptual Entity]
   742   C2349975:Enhancement [Activity]

Phrase: "in pancreatic -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "glucose challenge."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0798503:Challenge [Clinical Attribute]
   861   C0805586:Challenge [Health Care Activity]
   861   C3274764:Challenge [Conceptual Entity]
Processing 00000000.tx.82: Increased fatty acid oxidation and the addition of some intermediate metabolites could also lead to additional production of reducing equivalents. 

Phrase: "Increased fatty acid oxidation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1158366:fatty acid oxidation [Molecular Function]
   861   C0015684:Fatty acid [Lipid]
   812   C0001128:Acid [Chemical]
   812   C0030011:Oxidation [Molecular Function]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "the addition of some intermediate metabolites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883712:Addition [Functional Concept]

Phrase: "could"

Phrase: "also"

Phrase: "lead to additional production of reducing equivalents."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0033268:production [Occupational Activity]
   748   C0392756:Reducing [Qualitative Concept]
   748   C0439185:Equivalents [Quantitative Concept]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C1524062:Additional [Functional Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]
   714 E C0205163:Equivalent [Qualitative Concept]
Processing 00000000.tx.83: However, decreased electron transfer capability in the ETC can also be an important mechanism affecting ROS production. 

Phrase: "However,"

Phrase: "decreased electron transfer capability in the ETC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2698977:Capability [Qualitative Concept]

Phrase: "can"

Phrase: "also"

Phrase: "be"

Phrase: "an important mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "ROS production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033268:production [Occupational Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
Processing 00000000.tx.84: Because ETC is coupled to ATP synthesis through membrane potential (), the electron transport rate and, consequently, the rate of superoxide production will also depend on . The increased decreases electron transport capability in ETC, leading to a reduced state of the carriers and increased ROS production (2022). 

Phrase: "Because"

Phrase: "ETC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2244392:electron transport chain [Molecular Function]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   734   C0013846:Electron Transport [Molecular Function]

Phrase: "is"

Phrase: "coupled to ATP synthesis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1157223:ATP synthesis [Molecular Function]
   833   C1510700:ATP Synthesis [Functional Concept]
   770   C0220781:synthesis [Biologic Function]
   770   C1883254:Synthesis [Activity]
   770   C1948027:Coupled [Functional Concept]
   737 E C0010222:couple [Family Group]

Phrase: "through membrane potential"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0025251:Membrane Potential [Cell Function]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   861   C3245505:Potential [Qualitative Concept]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "the electron transport rate"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0013846:Electron Transport [Molecular Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C0871208:Rate [Activity]
   827   C1317949:Transport [Manufactured Object]
   827   C1521828:Rate [Quantitative Concept]
   827   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: ","

Phrase: "consequently,"

Phrase: "the rate of superoxide production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "will"

Phrase: "also"

Phrase: "depend on ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0725813:depend [Medical Device]

Phrase: "The increased decreases electron transport capability in ETC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2698977:Capability [Qualitative Concept]

Phrase: "leading to a reduced state of the carriers"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   750   C0560175:Carrier State [Finding]
       E   Carrier
   744   C0007294:carriers [Finding]
   744   C0332152:Leading [Temporal Concept]
   744   C0392756:Reduced [Qualitative Concept]
   744   C1301808:State [Geographic Area]
   744   C1442792:State [Functional Concept]
   744   C1522538:Leading [Functional Concept]
   744   C3148680:State [Geographic Area]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C1706209:Carrier [Medical Device]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3273162:Carrier [Intellectual Product]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "increased ROS production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0033268:production [Occupational Activity]
   717   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "(2022"

Phrase: ")."
Processing 00000000.tx.85: It was shown experimentally (2426) and confirmed by simulation with the corresponding mathematical model (27) that the rate of superoxide production increases dramatically with increased >140 mV, when the rate of electron transport is restricted by increased . Since is used to make ATP from ADP and Pi, driven by proton movement back through the ATP synthase complex, its value also depends on the ATP production rate and, in particular, on free ADP concentration. 

Phrase: "It"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "experimentally"

Phrase: "(2426"

Phrase: ")"

Phrase: "and"

Phrase: "confirmed by simulation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0679083:Simulation [Research Activity]
   790   C0750484:Confirmed [Idea or Concept]
   756 E C1456348:Confirm [Qualitative Concept]
   718 E C0284447:simulated [Biomedical or Dental Material]

Phrase: "with the corresponding mathematical model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0876936:Mathematical Model [Intellectual Product]
   827   C0024934:Mathematical [Occupation or Discipline]
   827   C3161035:Model [Intellectual Product]

Phrase: "(27"

Phrase: ")"

Phrase: "that"

Phrase: "the rate of superoxide production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "dramatically with increased"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]

Phrase: ">140 mV,"

Phrase: "when"

Phrase: "the rate of electron transport"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "is"

Phrase: "restricted by increased ."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C0443288:Restricted [Functional Concept]

Phrase: "Since"

Phrase: "is"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "ATP from ADP"

Phrase: "and"

Phrase: "Pi,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0429863:PI [Clinical Attribute]
  1000   C3537219:PI [Gene or Genome]
  1000   C3539772:PI [Intellectual Product]

Phrase: "driven by proton movement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0026649:Movement [Organism Function]
   770   C0033727:Proton [Element, Ion, or Isotope]
   737   C0013126:Drive [Mental Process]

Phrase: "back through the ATP synthase complex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004600:Back [Body Location or Region]
   753   C0205095:Back [Spatial Concept]
   753   C0460009:Back [Body Location or Region]
   753   C1995000:Back [Body Location or Region]

Phrase: "its value also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522609:Value [Quantitative Concept]

Phrase: "depends on the ATP production rate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0033268:production [Occupational Activity]
   753   C0725813:depend [Medical Device]
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: ","

Phrase: "in particular,"

Phrase: "on free ADP concentration."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.86: The mitochondrial oxidative phosphorylation rate increases with increased free ADP concentration, with an apparent half-saturated concentration of 2045 mol/l (2830). 

Phrase: "The mitochondrial oxidative phosphorylation rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0871208:Rate [Activity]
   812   C1521828:Rate [Quantitative Concept]

Phrase: "increases with increased free ADP concentration,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0086045:Concentration [Mental Process]
   753   C0332296:free [Functional Concept]
   753   C0442805:Increase [Functional Concept]
   753   C0523452:ADP [Laboratory Procedure]
   753   C1446561:Concentration [Quantitative Concept]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]

Phrase: "with an apparent half-saturated concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 2045 mol/l (2830"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0347982:mol/L [Quantitative Concept]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ")."
Processing 00000000.tx.87: Therefore, a decrease in free ADP concentration leads to decreased ATP production, which in turn increases and, correspondingly, ROS production. 

Phrase: "Therefore,"

Phrase: "a decrease in free ADP concentration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "leads to decreased ATP production,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0033268:production [Occupational Activity]
   760   C0181586:leads [Medical Device]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "which in turn increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: ","

Phrase: "correspondingly,"

Phrase: "ROS production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033268:production [Occupational Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
Processing 00000000.tx.88: Results of mathematical modeling of coupled mitochondria show that can increase from 120 to 200 mV as ADP decreases from 40 to 15 mol/l (Fig. 3A from Demin, Westerhoff, and Kholodenko [27]). 

Phrase: "Results of mathematical modeling of coupled mitochondria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "can"

Phrase: "increase from 120"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
   790   C0442805:Increase [Functional Concept]
   734 E C1517378:Gain [Quantitative Concept]
   706 E C0205217:Increased [Quantitative Concept]
   706 E C0439661:Acquired [Temporal Concept]
   706 E C0442808:Increasing [Functional Concept]
   706 E C1301820:Obtain [Functional Concept]
   706 E C1706701:Acquire [Activity]
   706 E C3245488:acquired [Intellectual Product]

Phrase: "to 200 mV"

Phrase: "as ADP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]

Phrase: "decreases from 40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0392756:Decrease [Qualitative Concept]
   790   C0439509:/40 [Temporal Concept]
   790   C0547047:Decrease [Quantitative Concept]

Phrase: "to 15 mol/l (Fig. 3A"

Phrase: "from Demin,"

Phrase: "Westerhoff,"

Phrase: "and"

Phrase: "Kholodenko"

Phrase: "[27"

Phrase: "]"

Phrase: ")."
Processing 00000000.tx.89: This explains the sharp increase in ROS production with decreased ADP concentration (Fig. 2). 

Phrase: "This"

Phrase: "explains"

Phrase: "the sharp increase in ROS production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "with decreased ADP concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.90: Modeling data were supported by the finding that a decrease in steady-state level and a corresponding fall in H2O2 generation rate were both obtained after the addition of progressively increasing amounts of uncoupler (SF6847) or ADP into a mitochondrial suspension (25). 

Phrase: "Modeling data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "supported by the finding"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0037088:Finding [Sign or Symptom]
   770   C0243095:Finding [Finding]
   770   C1521721:Supported [Conceptual Entity]
   770   C2825141:Finding [Finding]
   737 E C0183683:Support [Medical Device]

Phrase: "that"

Phrase: "a decrease in steady-state level"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "a corresponding fall in H2O2 generation rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0085639:Fall [Finding]
   748   C0238715:Fall [Temporal Concept]

Phrase: "were"

Phrase: "both"

Phrase: "obtained after the addition of progressively increasing amounts of uncoupler"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   739   C1265611:amounts [Quantitative Concept]
   739   C1301820:Obtained [Functional Concept]
   739   C1883712:Addition [Functional Concept]
   706 E C1706701:Obtain [Activity]

Phrase: "(SF6847"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0074431:SF6847 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "or"

Phrase: "ADP into a mitochondrial suspension"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0523452:ADP [Laboratory Procedure]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.91: These data lead to the conclusion that decreased ADP concentration can cause a considerable increase in ROS production (20,27). 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "lead to the conclusion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1707478:Conclusion [Idea or Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that decreased ADP concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "can"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a considerable increase in ROS production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "(20,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.92: This idea was recently confirmed for -cells by the demonstration that ADP inhibited ROS generation in permeabilized MIN6 cells (31). 

Phrase: "This idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "confirmed for -cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0007634:Cells [Cell]
   790   C0521093:confirmed [Qualitative Concept]
   790   C0750484:Confirmed [Idea or Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1456348:Confirm [Qualitative Concept]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "by the demonstration"

Phrase: "that ADP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "ROS generation in permeabilized MIN6 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0079411:Generation [Temporal Concept]
   744   C3146294:Generation [Activity]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.93: View larger version (23K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.94: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.95: Proposed causative link between elevated mitochondrial ROS generation, increased cytoplasmic Ca2+, oxidative stress, -cell dysfunction, and apoptosis (explanations are in the text).  

Phrase: "Proposed causative link between elevated mitochondrial ROS generation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1517892:Link [Intellectual Product]
   739   C1704666:Link [Intellectual Product]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "cytoplasmic Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "oxidative stress, -"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "cell dysfunction,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(explanations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681841:Explanations [Intellectual Product]

Phrase: "are in the text"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1527021:Text [Intellectual Product]
   770   C1551058:Are [Quantitative Concept]
   770   C1554111:Text [Idea or Concept]
   770   C1705606:Text [Intellectual Product]
   770   C3541382:Text [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.96: View larger version (11K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(11K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.97: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.98: Results of mathematical modeling of coupled mitochondria for relative rate of superoxide production as a function of extramitochondrial-free ADP concentration. 

Phrase: "Results of mathematical modeling of coupled mitochondria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "for relative rate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "of superoxide production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "as a function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "of extramitochondrial-free ADP concentration."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.99: Recalculated from Fig. 

Phrase: "Recalculated from Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.100: 3A and D in the model of Demin, Westerhoff, and Kholodenko (27).  

Phrase: "3A"

Phrase: "and"

Phrase: "D in the model of Demin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Westerhoff,"

Phrase: "and"

Phrase: "Kholodenko"

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.101: After the addition of glucose there is a decrease in free [ADP] in -cells (see GDIS AND ADENINE NUCLEOTIDE REGULATION). 

Phrase: "After the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of glucose there"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "is"

Phrase: "a decrease in free"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "[ADP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]

Phrase: "] in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "GDIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "AND"

Phrase: "ADENINE NUCLEOTIDE REGULATION"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]
   734   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.102: Hence, the specific stage in the GDIS mechanism leading to a decrease in free [ADP] can also be directly responsible for an overproduction of ROS. 

Phrase: "Hence,"

Phrase: "the specific stage in the GDIS mechanism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0205390:Stage [Temporal Concept]
   739   C1300072:Stage [Clinical Attribute]
   739   C1306673:Stage [Qualitative Concept]

Phrase: "leading to a decrease"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0332152:Leading [Temporal Concept]
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in free"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332296:free [Functional Concept]
  1000   C1880497:Free [Qualitative Concept]
  1000   C1996904:Free [Qualitative Concept]

Phrase: "[ADP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]

Phrase: "]"

Phrase: "can"

Phrase: "also"

Phrase: "be"

Phrase: "directly responsible for an overproduction of ROS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1273518:Responsible [Finding]
Processing 00000000.tx.103: This decrease in ADP concentration is a specific property of -cell stimulus-secretion coupling, possibly shared with other cell types that have a fuel-sensing function. 

Phrase: "This decrease in ADP concentration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "is"

Phrase: "a specific property of -cell stimulus-secretion coupling,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1948027:Coupling [Functional Concept]

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "shared with other cell types"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0449475:Cell types [Intellectual Product]
   773 E C0007634:Cell Type [Cell]
           Cell
   760   C0237876:shared [Social Behavior]
   760   C0332307:Types [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1522138:Shared [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1547052:*Type [Quantitative Concept]

Phrase: "that"

Phrase: "have"

Phrase: "a fuel-sensing function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.104: In contrast, muscle work during aerobic exercise leads to increased ADP concentrations (30). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "muscle work during aerobic exercise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0043227:Work [Occupational Activity]

Phrase: "leads to increased ADP concentrations"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   797   C0861064:increased lead [Finding]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0086045:Concentrations [Mental Process]
   760   C0181586:leads [Medical Device]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0523452:ADP [Laboratory Procedure]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.105: To make matters worse, -cells have relatively low levels of free radicaldetoxifying and redox-regulating enzymes such as superoxide dismutase, glutathione peroxidase, catalase (2,3,32), and thioredoxin (1). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "matters worse, -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "relatively low levels of free radicaldetoxifying"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "redox-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030012:Redox [Molecular Function]

Phrase: "regulating"

Phrase: "enzymes such as superoxide dismutase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014442:Enzymes [Enzyme,Organic Chemical]
   760   C0014445:enzymes [Functional Concept]

Phrase: "glutathione peroxidase,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0017822:GLUTATHIONE PEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415275:GLUTATHIONE PEROXIDASE [Gene or Genome]
   861   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "catalase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "32"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "thioredoxin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.106: The reasons for this are unclear. 

Phrase: "The reasons for this"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392360:reasons [Idea or Concept]

Phrase: "are"

Phrase: "unclear."
Processing 00000000.tx.107: Because ROS are involved in different physiological processes as mediators in signal transduction pathways (33), it was hypothesized that ROS are involved in some signaling pathways that take part in the insulin-secretion mechanism (18). 

Phrase: "Because"

Phrase: "ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "are"

Phrase: "involved in different physiological processes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0031845:Physiological Processes [Physiologic Function]
   760   C0205463:Physiological [Functional Concept]
   760   C1314939:Involved [Functional Concept]
   760   C1705242:Different [Qualitative Concept]
   726   C1184743:Process [Body Part, Organ, or Organ Component]
   726   C1522240:Process [Phenomenon or Process]

Phrase: "as mediators"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   966 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in signal transduction pathways"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0086982:Signal Transduction Pathways [Molecular Function]
   913   C0037080:Signal Pathways [Molecular Function]
   901   C0037083:Signal Transduction [Cell Function]
   827   C1160185:transduction [Organism Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "(33"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "was"

Phrase: "hypothesized"

Phrase: "that ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "are"

Phrase: "involved in some signaling pathways"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   797   C0037080:pathways signaling [Molecular Function]
   790 E C0037083:signaling pathway [Cell Function]
           Signaling
   790 E C0086982:Signaling Pathway [Molecular Function]
   760   C1314939:Involved [Functional Concept]
   760   C1704259:Pathways [Molecular Function]
   760   C1705987:Pathways [Conceptual Entity]
   760   C3537152:signaling [Biologic Function]
   726 E C1710082:Signal [Phenomenon or Process]

Phrase: "that"

Phrase: "take"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "part in the insulin-secretion mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.108: In any case, the limited scavenging systems suggest that enhanced ROS concentrations in -cells may occur due to both decreased scavenging systems and ROS overproduction. 

Phrase: "In any case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "the limited scavenging systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that enhanced ROS concentrations in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "occur due to both decreased scavenging systems"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0205216:Decreased [Quantitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C1709305:Occur [Activity]
   748   C2745955:OCCUR [Temporal Concept]
   748   C3146286:Due [Idea or Concept]
   714   C0449913:System [Functional Concept]
   714 E C0547047:Decrease [Quantitative Concept]
   714   C1553451:System [Manufactured Object]
   714   C1704459:System [Medical Device]

Phrase: "and"

Phrase: "ROS overproduction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
Processing 00000000.tx.109: In support of this hypothesis we recently reported an estimation of ROS using an optical method. 

Phrase: "In support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "of this hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "we recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "an estimation of ROS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0680844:estimation [Mental Process]
   753   C0681916:Estimation [Quantitative Concept]
   753   C0750572:Estimation [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an optical method."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.110: We found that stimulation with 10 mmol/l glucose (from an initial 2 mmol/l) increased nearly twofold the O2 production rate in pancreatic -cells from Zucker lean rats, confirming the possibility of abrupt increases in O2 production with increased glucose (18). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that stimulation with 10 mmol/l glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "("

Phrase: "from an initial 2 mmol/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439190:MMOLE [Quantitative Concept]

Phrase: "l)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "nearly twofold"

Phrase: "the O2 production rate in pancreatic -cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0033268:production [Occupational Activity]
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "from Zucker lean rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the possibility of abrupt increases"

Phrase: "in O2 production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "with increased glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:increased glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.111: A similar increased ROS production rate was obtained by Sakai et al. 

Phrase: "A similar increased ROS production rate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0033268:production [Occupational Activity]
   795   C0871208:Rate [Activity]
   795   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "obtained by Sakai et al."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.112: (19) at increased glucose concentrations in a pancreatic -cell line (MIN6) and in human islets. 

Phrase: "(19"

Phrase: ")"

Phrase: "at increased glucose concentrations"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   884   C0427743:Glucose concentration [Laboratory Procedure]
   884   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0860803:increased glucose [Finding]

Phrase: "in a pancreatic -cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0007600:Cell Line [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "(MIN6"

Phrase: ")"

Phrase: "and in human islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086418:Human [Human]
   770   C1515981:And [Idea or Concept]
Processing 00000000.tx.113: These studies are the first to measure the production of ROS in response to glucose in the -cell.  

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "the first to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205435:First [Quantitative Concept]
   861   C1279901:First [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "the production of ROS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "in the -cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.114: Manifestations of oxidative stress and apoptosis. 

Phrase: "Manifestations of oxidative stress"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   816   C1280464:Manifestation of [Qualitative Concept]
           manifestations
   770   C0205319:manifestations [Functional Concept]

Phrase: "and"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.115: TOP ABSTRACT GDIS and adenine nucleotide... 

Phrase: "TOP ABSTRACT GDIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   839   C1719133:Glucose/Insulin [Quantitative Concept]
   827   C1256369:insulin secretion [Cell Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "adenine nucleotide..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.116: Dependence of ROS production... 

Phrase: "Dependence of ROS production..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011546:Dependence [Mental Process]
   753   C0439857:Dependence [Mental or Behavioral Dysfunction]
   753   C2698668:DEPENDENCE [Regulation or Law]
Processing 00000000.tx.117: Manifestations of oxidative... 

Phrase: "Manifestations of oxidative..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   866   C1280464:Manifestation of [Qualitative Concept]
           manifestations
   790   C0205319:manifestations [Functional Concept]
Processing 00000000.tx.118: Dual role of the... 

Phrase: "Dual role of the..."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.119: Dual role of -cell... 

Phrase: "Dual role of -cell..."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.120: Intracellular inhibition of ROS... 

Phrase: "Intracellular inhibition of ROS..."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0034750:Reactive Inhibition [Individual Behavior]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
Processing 00000000.tx.121: Preservation of -cell... 

Phrase: "Preservation of -cell..."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.122: CONCLUSIONS REFERENCES  Protective effects of antioxidants, scavengers, and overexpression of antioxidant enzymes in transgenic mouse islets suggest that ROS overproduction can lead to manifestations of oxidative stress and apoptosis in -cells (13,6). 

Phrase: "CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusions [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Protective effects of antioxidants,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C3179302:Antioxidant Effects [Physiologic Function]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "scavengers,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017108:scavengers [Medical Device]
  1000   C1003377:scavengers [Fish]

Phrase: "and"

Phrase: "overexpression of antioxidant enzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "in transgenic mouse islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1522528:Mouse Islets [Tissue]
   734   C0025936:Mouse, Transgenic [Mammal]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that ROS overproduction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "can"

Phrase: "lead to manifestations of oxidative stress"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   773   C1280464:Manifestation of [Qualitative Concept]
           manifestations
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0038435:Stress [Finding]
   753   C0205319:manifestations [Functional Concept]
   753   C0311404:Oxidative [Functional Concept]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "apoptosis in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(13,"

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.123: Several reviews (2,3,5,33,34) have recently considered how increased ROS production (or decreased ROS consumption) can lead to oxidative stress and apoptosis in different cell types, including -cells. 

Phrase: "Several reviews"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0282443:reviews [Intellectual Product]
   827 E C1552617:Review [Idea or Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "33,"

Phrase: "34"

Phrase: ")"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "how increased ROS production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0033268:production [Occupational Activity]

Phrase: "("

Phrase: "or"

Phrase: "decreased ROS consumption"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C0030055:Oxygen Consumption [Clinical Attribute]
   853   C1305742:oxygen consumption [Diagnostic Procedure]
   804   C0009830:Consumption [Activity]
   804   C1947907:Consumption [Physiologic Function]
   717   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: ")"

Phrase: "can"

Phrase: "lead to oxidative stress"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "apoptosis in different cell types,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162638:Apoptosis [Cell Function]

Phrase: "including -"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.124: We present in Fig. 

Phrase: "We"

Phrase: "present in Fig."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0150312:Present [Quantitative Concept]
   790   C0349966:Fig [Food]
   790   C0449450:Present [Idea or Concept]
   790   C1337208:FIG [Food]
Processing 00000000.tx.125: 3 the most common steps for this connection. 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "the most common steps for this connection."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C1261552:steps [Conceptual Entity]
   714 E C1704379:Step [Functional Concept]
   714 E C1705117:Step [Quantitative Concept]
   714 E C2825408:Step [Manufactured Object]
Processing 00000000.tx.126: Free radicals in cells (including the -cell) may directly damage proteins, lipids, and nucleic acids, leading to mitochondria and cell dysfunction and death (22,3335). 

Phrase: "Free radicals in cells"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   802   C1183428:Free cell [Cell]
   770   C0302912:radicals [Chemical Viewed Structurally]
   770   C0332296:free [Functional Concept]
   770   C1880497:Free [Qualitative Concept]
   770   C1996904:Free [Qualitative Concept]
   737 E C0439807:Radical [Qualitative Concept]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the -cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "may"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010957:Damage [Injury or Poisoning]
  1000   C1883709:Damage [Functional Concept]

Phrase: "proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "lipids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipids [Lipid]

Phrase: "and"

Phrase: "nucleic acids,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0001128:Acids [Chemical]
   861   C0007610:Nucleic [Cell Component]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "leading to mitochondria"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0026237:Mitochondria [Cell Component]
   790   C0332152:Leading [Temporal Concept]
   790   C1522538:Leading [Functional Concept]
   756 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   756 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   756 E C2348269:Lead [Element, Ion, or Isotope]
   756 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "cell dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "(22,"

Phrase: "3335"

Phrase: ")."
Processing 00000000.tx.127: In our experiments, the mitochondria were generally short and swollen in islets with the highest ROS production from the Zucker diabetic fatty (ZDF) rat, in contrast to Zucker lean control (ZLC) rat islets (18). 

Phrase: "In our experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "the mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "were"

Phrase: "generally short"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1282927:short [Qualitative Concept]
   861   C1806781:Short [Quantitative Concept]
   861   C2350002:Short [Quantitative Concept]

Phrase: "and"

Phrase: "swollen in islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0038999:Swollen [Finding]

Phrase: "with the highest ROS production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0033268:production [Occupational Activity]
   717   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "from the Zucker diabetic fatty (ZDF) rat,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Zucker rat [Mammal]
   812   C0034693:Rat, NOS [Mammal]
   812   C0034721:Rat [Mammal]

Phrase: "in contrast to Zucker lean control (ZLC) rat islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0034719:Zucker rat [Mammal]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.128: In addition to their ability to directly damage cellular macromolecules, ROS may also activate intracellular signaling pathways that lead to cell dysfunction and apoptosis (4,5,33,34,36). 

Phrase: "In addition to their ability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085732:Ability [Organism Attribute]
   928 E C1299581:Able [Finding]

Phrase: "to directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010957:Damage [Injury or Poisoning]
  1000   C1883709:Damage [Functional Concept]

Phrase: "cellular macromolecules,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178735:macromolecules [Chemical Viewed Structurally]

Phrase: "ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "may"

Phrase: "also"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "intracellular signaling pathways"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   988   C2755994:intracellular signaling pathway [Cell Function]
   884   C0037080:Signal Pathways [Molecular Function]
   884   C0037083:signaling pathway [Cell Function]
   884   C0086982:Signaling Pathway [Molecular Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "that"

Phrase: "lead to cell dysfunction"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   770   C0007634:Cell [Cell]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0031847:dysfunction [Functional Concept]
   770   C0277785:Dysfunction, NOS [Qualitative Concept]
   770   C1269647:Cell [Cell]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
   715 E C0231174:Malfunction [Functional Concept]
   715 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "33,"

Phrase: "34,"

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.129: Two principal apoptotic pathways exist in -cells: the "intrinsic" pathway initiated by the mitochondria and the "extrinsic" pathway initiated by cell-surface receptors. 

Phrase: "Two principal apoptotic pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]
   808   C0162638:Apoptosis Pathway [Cell Function]

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "the ""intrinsic"" pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205102:Intrinsic [Spatial Concept]
   861   C0439674:Intrinsic [Functional Concept]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "initiated by the mitochondria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0026237:Mitochondria [Cell Component]
   737   C1548602:Initiate [Idea or Concept]
   737   C1704686:Initiate [Functional Concept]

Phrase: "and"

Phrase: "the ""extrinsic"" pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205101:Extrinsic [Spatial Concept]
   861   C0595947:Extrinsic [Functional Concept]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "initiated by cell-surface receptors."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0034800:Receptors, Cell Surface [Amino Acid, Peptide, or Protein,Receptor]
   806   C0699040:Cell surface [Cell Component]
   781   C1514760:Receptor Cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726   C1548602:Initiate [Idea or Concept]
   726   C1704686:Initiate [Functional Concept]
Processing 00000000.tx.130: The "intrinsic" pathway includes the activation of nuclear factor (NF)-B and additional stress-sensitive targets (5,34). 

Phrase: "The ""intrinsic"" pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205102:Intrinsic [Spatial Concept]
   861   C0439674:Intrinsic [Functional Concept]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the activation of nuclear factor (NF)-B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "additional stress-sensitive targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1521840:Target [Functional Concept]
   779   C2986546:TARGET [Diagnostic Procedure]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.131: There is some evidence that activation of NF-B is mostly a proapoptotic event in -cells (36). 

Phrase: "There"

Phrase: "is"

Phrase: "some evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that activation of NF-B is mostly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1879547:Activation [Activity]

Phrase: "a proapoptotic event in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.132: However, in vascular endothelial cells, normalizing mitochondrial superoxide production blocks several major pathways leading to hyperglycemic damage (including NF-B activation), and it was suggested that ROS production in mitochondria is a causal link between elevated glucose and the main pathways responsible for hyperglycemic damage (37). 

Phrase: "However,"

Phrase: "in vascular endothelial cells,"
Meta Candidates (Total=22; Excluded=12; Pruned=0; Remaining=10)
  1000   C1257792:Vascular Endothelial Cells [Cell]
   901   C0225336:Endothelial Cells [Cell]
   865   C0014261:Endothelium, Vascular [Tissue]
   863   C0005773:Blood Cells [Cell]
   855 E C2328697:Hemal cell [Cell]
   837 E C1706972:Blood Vessel Endothelium [Tissue]
   827   C0005847:vascular [Body Part, Organ, or Organ Component]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C1558950:VASCULAR [Finding]
   827   C1801960:Vascular [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   771 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   771 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C0005767:Blood [Tissue]
   727 E C0005768:blood [Body Substance]
   727 E C0229664:Blood [Body Substance]
   727 E C0392895:Bloods [Population Group]
   711 E C0333275:Bloody [Qualitative Concept]

Phrase: "normalizing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882115:Normalize [Research Activity]

Phrase: "mitochondrial superoxide production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033268:production [Occupational Activity]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "several major pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "leading to hyperglycemic damage"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0010957:Damage [Injury or Poisoning]
   770   C0332152:Leading [Temporal Concept]
   770   C1522538:Leading [Functional Concept]
   770   C1883709:Damage [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "NF-B activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "it"

Phrase: "was"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that ROS production in mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "a causal link between elevated glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1517892:Link [Intellectual Product]
   753   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "the main pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "responsible for hyperglycemic damage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.133: It would appear reasonable that these pathways are also activated by ROS in the -cell (2), but this has not been directly confirmed. 

Phrase: "It"

Phrase: "would"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "reasonable"

Phrase: "that"

Phrase: "these pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "are"

Phrase: "also"

Phrase: "activated by ROS"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   862   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   760   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0205332:Reactive [Qualitative Concept]
   760   C1705920:Species [Conceptual Entity]
   760   C1879547:Activated [Activity]
   726 E C1515877:Activate [Functional Concept]

Phrase: "in the -cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "this"

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "confirmed."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.134: The "extrinsic" pathway includes cytokine signaling and is considered in detail in a recent review by Donath et al. 

Phrase: "The ""extrinsic"" pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205101:Extrinsic [Spatial Concept]
   861   C0595947:Extrinsic [Functional Concept]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "cytokine signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1511617:Cytokine Signaling [Molecular Function]
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "and"

Phrase: "is"

Phrase: "considered in detail"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0750591:considered [Idea or Concept]
   790   C1522508:Detail [Qualitative Concept]
   790   C1561567:detail [Functional Concept]

Phrase: "in a recent review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282443:Review [Intellectual Product]
   861   C1552617:Review [Idea or Concept]

Phrase: "by Donath et al."
Processing 00000000.tx.135: (4). 

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.136: However, the question "What makes the -cell so sensitive to proinflammatory cytokines?" remains open (4). 

Phrase: "However,"

Phrase: "the question """
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "What"

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "the -cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "so"

Phrase: "sensitive to proinflammatory cytokines?"" remains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332324:Sensitive to [Functional Concept]
           Sensitive
   760   C1550474:sensitive [Idea or Concept]

Phrase: "open"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175566:Open [Spatial Concept]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.137: It has been suggested that glucose-induced -cell apoptosis involves the induction of both free oxygen radicals and the synthesis of proinflammatory cytokines, especially interleukin-1, activating proapoptotic pathways (5). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that glucose-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "induced -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "cell apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "involves"

Phrase: "the induction of both free oxygen radicals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205263:Induction [Functional Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the synthesis of proinflammatory cytokines,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1155099:cytokine synthesis [Molecular Function]
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]

Phrase: "especially interleukin-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:activating [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "proapoptotic pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.138: Apoptosis may also be induced by a combination of macromolecular and mitochondrial damage, mainly due to ROS action (35). 

Phrase: "Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "induced by a combination of macromolecular"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205195:Combination [Qualitative Concept]
   753   C0205263:Induced [Functional Concept]
   753   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "mitochondrial damage,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1096176:Mitochondrial Damage [Pathologic Function]
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "mainly due to ROS action"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   778   C0678226:Due to [Functional Concept]
           due
   748   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0205332:Reactive [Qualitative Concept]
   748   C0441472:Action [Functional Concept]
   748   C1705920:Species [Conceptual Entity]
   748   C3146286:Due [Idea or Concept]
   748   C3266814:Action [Activity]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.139: Altered mitochondria function plays a prominent role in the induction of apoptosis in several cellular models (33,35) as well as in the -cell line Ins-1 (38). 

Phrase: "Altered mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026237:Mitochondria [Cell Component]

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a prominent role in the induction of apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in several cellular models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Models [Intellectual Product]

Phrase: "(33,"

Phrase: "35"

Phrase: ")"

Phrase: "as well as in the -cell line"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0007600:Cell Line [Cell]
   748   C0007634:Cell [Cell]
   748   C0205132:Line [Spatial Concept]
   748   C0205170:Well [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1550648:Line [Substance]
   748   C1552960:Line [Quantitative Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3146287:Well [Manufactured Object]

Phrase: "Ins-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.140: If this is the case in the -cell, then the specific -cell sensitivity to proinflammatory cytokines may be explained by the combination of ROS overproduction and insufficient scavenging systems. 

Phrase: "If"

Phrase: "this"

Phrase: "is"

Phrase: "the case in the -cell,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0868928:Case [Functional Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the specific -cell sensitivity to proinflammatory cytokines"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]
   743   C0332324:Sensitive to [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "explained by the combination of ROS overproduction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   742   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0205195:Combination [Qualitative Concept]
   742   C0205332:Reactive [Qualitative Concept]
   742   C1705920:Species [Conceptual Entity]
   742   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "insufficient scavenging systems."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.141: Interestingly, transfection of a glucagon-producing rat cell line with the pancreatic duodenal homeobox transcription factor leading to an insulin-producing -cell phenotype resulted in a higher sensitivity to cytokine toxicity (39). 

Phrase: "Interestingly,"

Phrase: "transfection of a glucagon-producing rat cell line"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "with the pancreatic duodenal homeobox transcription factor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0040649:Transcription [Genetic Function]
   804   C0242303:Homeo Box [Gene or Genome]
   804   C0598306:Homeo Box [Spatial Concept]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]

Phrase: "leading to an insulin-producing -cell phenotype"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   778   C0427385:Cell phenotype [Laboratory Procedure]
   778   C1318444:Cell phenotype [Organism Attribute]
   774   C0030281:Insulin Cell [Cell]
   748   C0007634:Cell [Cell]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0031437:Phenotype [Organism Attribute]
   748   C0332152:Leading [Temporal Concept]
   748   C1269647:Cell [Cell]
   748   C1285572:Phenotype [Laboratory Procedure]
   748   C1522538:Leading [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "resulted in a higher sensitivity"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C1441604:High sensitivity [Laboratory Procedure]
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2349185:Sensitivity [Qualitative Concept]
   726   C0205250:High [Qualitative Concept]
   726   C1274040:Result [Functional Concept]
   726   C1299351:High [Qualitative Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2700149:HIGH [Intellectual Product]
   726   C2825142:Result [Finding]

Phrase: "to cytokine toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.142: In this case, the development of insulin-secretion mechanisms led to enhanced in vitro sensitivity to cytokines. 

Phrase: "In this case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "the development of insulin-secretion mechanisms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]

Phrase: "led to enhanced in vitro sensitivity"
Meta Candidates (Total=19; Excluded=5; Pruned=0; Remaining=14)
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C1708698:LED [Manufactured Object]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]
   753   C2349975:Enhanced [Activity]
   748   C0332324:Sensitive to [Functional Concept]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C1522538:Lead [Functional Concept]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to cytokines."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.143: An elevation of intracellular Ca2+ through voltage-gated Ca2+ channels is an integral part of the GDIS mechanism (see GDIS AND ADENINE NUCLEOTIDE REGULATION) (Fig. 1). 

Phrase: "An elevation of intracellular Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439775:Elevation [Therapeutic or Preventive Procedure]
   760   C0702240:Elevation [Spatial Concept]

Phrase: "through voltage-gated Ca2+ channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   906   C0597675:voltage gated channel [Physiologic Function]
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]

Phrase: "is"

Phrase: "an integral part of the GDIS mechanism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1292711:Part of [Spatial Concept]
   739   C0449719:Part [Spatial Concept]
   739   C1709471:Part [Quantitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "GDIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "AND"

Phrase: "ADENINE NUCLEOTIDE REGULATION"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]
   734   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ")"

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.144: However, increased intracellular Ca2+ is also believed to stimulate mitochondrial generation of ROS (26). 

Phrase: "However,"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "intracellular Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "is"

Phrase: "also"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stimulate"

Phrase: "mitochondrial generation of ROS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.145: Voltage-gated Ca2+ channels are also likely to play an activating role in -cell apoptosis, although the molecular mechanisms remain to be described (4). 

Phrase: "Voltage-gated Ca2+ channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   906   C0597675:voltage gated channel [Physiologic Function]
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]

Phrase: "are"

Phrase: "also likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an activating role in -cell apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0162638:Apoptosis [Cell Function]
   733 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "although"

Phrase: "the molecular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.146: Hence, an increase in cytoplasmic Ca2+ concentration and an activation of voltage-gated Ca2+ channels are additional specific stages in GDIS, which may share responsibility for an increase of oxidative stress and/or for a mediation of apoptosis. 

Phrase: "Hence,"

Phrase: "an increase in cytoplasmic Ca2+ concentration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "an activation of voltage-gated Ca2+ channels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1879547:Activation [Activity]

Phrase: "are"

Phrase: "additional specific stages in GDIS,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C1306673:Stages [Qualitative Concept]
   711 E C0205390:Stage [Temporal Concept]
   711 E C1300072:Stage [Clinical Attribute]

Phrase: "which"

Phrase: "may"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "responsibility for an increase of oxidative stress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0678341:Responsibility [Individual Behavior]

Phrase: "and/or for a mediation of apoptosis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1706528:And/Or [Conceptual Entity]
   748   C0162638:Apoptosis [Cell Function]
   748   C0680727:Mediation [Social Behavior]
   748   C1515981:And [Idea or Concept]
Processing 00000000.tx.147: We can conclude that at least three stages of the GDIS mechanism (increased glycolytic flux, decreased ADP concentration, and increased intracellular Ca2+concentration) could lead to a dramatic increase in the development of oxidative stress and apoptosis in pancreatic -cells. 

Phrase: "We"

Phrase: "can"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that at least three stages of the GDIS mechanism"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   753   C1256369:insulin secretion [Cell Function]
   751   C1719133:Glucose/Insulin [Quantitative Concept]
   736   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   736   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   736   C0036536:secretion [Biologic Function]
   736   C0036537:Secretion [Body Substance]
   736   C0205449:Three [Quantitative Concept]
   736   C0441712:Mechanism [Functional Concept]
   736   C0851827:Dependent [Qualitative Concept]
   736   C1306673:Stages [Qualitative Concept]
   736   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   736   C1579433:Insulin [Pharmacologic Substance]
   736   C1701901:Dependent [Qualitative Concept]
   736   C1706376:Mechanism [Manufactured Object]
   736   C3244310:dependent [Functional Concept]
   703 E C0205390:Stage [Temporal Concept]
   703 E C1300072:Stage [Clinical Attribute]

Phrase: "(increased glycolytic flux,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2348693:Flux [Natural Phenomenon or Process]

Phrase: "decreased ADP concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "increased intracellular Ca2+concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ")"

Phrase: "could"

Phrase: "lead to a dramatic increase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0442805:Increase [Functional Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "apoptosis in pancreatic -cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.148: We can name this connection the GDISROS hypothesis. 

Phrase: "We"

Phrase: "can"

Phrase: "name"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027365:Name [Intellectual Product]
  1000   C1547383:Name [Intellectual Product]

Phrase: "this connection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449379:Connection [Intellectual Product]

Phrase: "the GDISROS hypothesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512571:Hypothesis [Idea or Concept]
Processing 00000000.tx.149: This GDISROS hypothesis provides a testable framework to explain how -cells may be uniquely at high risk for oxidative damage and apoptosis.  

Phrase: "This GDISROS hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512571:Hypothesis [Idea or Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a testable framework to"

Phrase: "explain"

Phrase: "how -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "uniquely at high risk"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0332167:High Risk [Qualitative Concept]
   833   C3272283:High Risk [Finding]
   770   C0035647:Risk [Qualitative Concept]
   770   C0205250:High [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "for oxidative damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.150: Dual role of the GDIS mechanism. 

Phrase: "Dual role of the GDIS mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.151: TOP ABSTRACT GDIS and adenine nucleotide... 

Phrase: "TOP ABSTRACT GDIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   839   C1719133:Glucose/Insulin [Quantitative Concept]
   827   C1256369:insulin secretion [Cell Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "adenine nucleotide..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.152: Dependence of ROS production... 

Phrase: "Dependence of ROS production..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011546:Dependence [Mental Process]
   753   C0439857:Dependence [Mental or Behavioral Dysfunction]
   753   C2698668:DEPENDENCE [Regulation or Law]
Processing 00000000.tx.153: Manifestations of oxidative... 

Phrase: "Manifestations of oxidative..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   866   C1280464:Manifestation of [Qualitative Concept]
           manifestations
   790   C0205319:manifestations [Functional Concept]
Processing 00000000.tx.154: Dual role of the... 

Phrase: "Dual role of the..."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.155: Dual role of -cell... 

Phrase: "Dual role of -cell..."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.156: Intracellular inhibition of ROS... 

Phrase: "Intracellular inhibition of ROS..."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0034750:Reactive Inhibition [Individual Behavior]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
Processing 00000000.tx.157: Preservation of -cell... 

Phrase: "Preservation of -cell..."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.158: CONCLUSIONS REFERENCES  The consequences of the GDISROS hypothesis should be evaluated in light of the existing experimental data. 

Phrase: "CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusions [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The consequences of the GDISROS hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "should"

Phrase: "be"

Phrase: "evaluated in light of the existing experimental data."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0023693:Light [Natural Phenomenon or Process]
   744   C0220825:Evaluated [Functional Concept]
   744   C1306462:Light [Functional Concept]
   744   C1511726:Data [Idea or Concept]
   744   C1517586:Experimental [Qualitative Concept]
   744   C1881376:Light [Qualitative Concept]
   744   C3245479:data [Medical Device]
Processing 00000000.tx.159: According to this hypothesis, GDIS activation plays a dual role: the metabolic secretagogues causing increased insulin secretion can also lead to increased oxidative stress as a result of elevated ROS production. 

Phrase: "According to this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "GDIS activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1879547:Activation [Activity]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a dual role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: ":"

Phrase: "the metabolic secretagogues"

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "increased insulin secretion"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C1372360:Increased Insulin Secretion [Organ or Tissue Function]
   901   C0020459:increased insulin [Disease or Syndrome]
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "can"

Phrase: "also"

Phrase: "lead to increased oxidative stress"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   797   C0231298:Increased stress [Functional Concept]
   797   C0861064:increased lead [Finding]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0038435:Stress [Finding]
   760   C0205217:Increased [Quantitative Concept]
   760   C0311404:Oxidative [Functional Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "as a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of elevated ROS production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0033268:production [Occupational Activity]
   717   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
Processing 00000000.tx.160: This dual role of the GDIS mechanism might hinder investigations since an initial increase in the insulin secretion rate can at first mask eventual detrimental effects of oxidative stress on insulin production. 

Phrase: "This dual role of the GDIS mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "might"

Phrase: "hinder"

Phrase: "investigations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1261322:Investigations [Health Care Activity]
   966 E C1552578:investigation [Idea or Concept]
   916 E C1517586:Investigational [Qualitative Concept]
   916 E C3245491:investigational [Intellectual Product]

Phrase: "since"

Phrase: "an initial increase in the insulin secretion rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0020459:INSULIN INCREASE [Disease or Syndrome]
   744   C0442805:Increase [Functional Concept]

Phrase: "can at first"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205435:First [Quantitative Concept]
   790   C1279901:First [Qualitative Concept]
   790   C1704712:Can [Manufactured Object]

Phrase: "mask"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024861:Mask [Medical Device]
  1000   C1538279:MASK [Gene or Genome]
  1000   C1845191:MASK [Gene or Genome]

Phrase: "eventual detrimental effects of oxidative stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on insulin production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]
Processing 00000000.tx.161: However, there is an essential difference in the temporal development of these processes. 

Phrase: "However,"

Phrase: "there"

Phrase: "is"

Phrase: "an essential difference in the temporal development of these processes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1705241:*Difference [Quantitative Concept]
   739   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.162: Insulin secretion changes relatively quickly and oxidative stress seems to develop more gradually and may be revealed only after several days of exposure to metabolic secretagogues (2,40). 

Phrase: "Insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "changes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "relatively quickly"

Phrase: "and"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "develop"

Phrase: "more gradually"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "and"

Phrase: "may"

Phrase: "be"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "only after several days of exposure"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0205171:Only [Quantitative Concept]
   753   C0274281:Exposure, NOS [Injury or Poisoning]
   753   C0332157:Exposure [Clinical Attribute]
   753   C0439228:days [Temporal Concept]
   753   C1720467:Only [Intellectual Product]
   719 E C0332173:/day [Temporal Concept]
   719 E C0439505:/day [Temporal Concept]

Phrase: "to metabolic secretagogues"

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.163: Therefore, progressive injury of -cell function by the same effectors that increase GDIS quickly could be considered a characteristic feature of oxidative stress activated by the GDIS mechanism itself. 

Phrase: "Therefore,"

Phrase: "progressive injury of -cell function by the same effectors"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0007613:Cell Function [Cell Function]
   762   C0599732:cell injury [Cell or Molecular Dysfunction]
   745   C0312740:Effector Cell [Cell]
   742   C0007634:Cell [Cell]
   742   C0031843:function [Physiologic Function]
   742   C0542341:Function [Functional Concept]
   742   C0700205:FUNCTION [Classification]
   742   C1269647:Cell [Cell]
   742   C1704653:Cell [Medical Device]
   742   C1705273:Function [Intellectual Product]
   742   C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "GDIS quickly"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   853   C1719133:Glucose/Insulin [Quantitative Concept]
   840   C1256369:insulin secretion [Cell Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "could"

Phrase: "be"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "a characteristic feature of oxidative stress"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1521970:Feature [Qualitative Concept]
   753   C1706388:Feature [Conceptual Entity]
   753   C2346469:Feature [Qualitative Concept]
   753   C2348519:Feature [Qualitative Concept]

Phrase: "activated by the GDIS mechanism"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   770   C1256369:insulin secretion [Cell Function]
   767   C1719133:Glucose/Insulin [Quantitative Concept]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]
   744   C0441712:Mechanism [Functional Concept]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1701901:Dependent [Qualitative Concept]
   744   C1706376:Mechanism [Manufactured Object]
   744   C1879547:Activated [Activity]
   744   C3244310:dependent [Functional Concept]
   711 E C1515877:Activate [Functional Concept]

Phrase: "itself."
Processing 00000000.tx.164: For example, chronic exposure to elevated glucose concentrations may cause damage to -cells through mechanisms involving oxidative stress (2,3,34,40). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "chronic exposure to elevated glucose concentrations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332157:Exposure to [Clinical Attribute]
           Exposure
   753   C0205191:chronic [Temporal Concept]
   753   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "may"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "damage to -cells through mechanisms"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   797   C0599732:cells damage [Cell or Molecular Dysfunction]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "34,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.165: This reinforces the idea that glucose initially activating insulin secretion can also injure -cell function with time. 

Phrase: "This"

Phrase: "reinforces"

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that glucose initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:activating [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "can"

Phrase: "also"

Phrase: "injure -"

Phrase: "cell function with time."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0007613:Cell Function [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1705273:Function [Intellectual Product]
   770   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.166: However, the idea that glucose-induced ROS generation is responsible for -cell glucose toxicity remains a testable speculation because glucose-induced ROS generation does occur with a brief exposure to physiologically relevant elevated glucose concentration (18), whereas glucose toxicity does not. 

Phrase: "However,"

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that glucose-induced ROS generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   799   C0079411:Generation [Temporal Concept]
   799   C3146294:Generation [Activity]
   706 E C1414672:Genesis [Gene or Genome]
   706 E C2984892:Genesis [Gene or Genome]

Phrase: "is"

Phrase: "responsible for -cell glucose toxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "remains"

Phrase: "a testable speculation"

Phrase: "because"

Phrase: "glucose-induced ROS generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   799   C0079411:Generation [Temporal Concept]
   799   C3146294:Generation [Activity]
   706 E C1414672:Genesis [Gene or Genome]
   706 E C2984892:Genesis [Gene or Genome]

Phrase: "does"

Phrase: "occur with a brief exposure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0274281:Exposure, NOS [Injury or Poisoning]
   760   C0332157:Exposure [Clinical Attribute]
   760   C1282927:brief [Qualitative Concept]
   760   C1709305:Occur [Activity]
   760   C1879313:Brief [Temporal Concept]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "to physiologically relevant elevated glucose concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   840   C0427743:Glucose concentration [Laboratory Procedure]
   840   C1287281:Glucose concentration [Laboratory or Test Result]
   804   C0086045:Concentration [Mental Process]
   804   C1446561:Concentration [Quantitative Concept]
   733 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(18"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "glucose toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "does"

Phrase: "not."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]
Processing 00000000.tx.167: Lipotoxicity can also develop in -cells in a similar fashion to oxidative stress at elevated glucose. 

Phrase: "Lipotoxicity"

Phrase: "can"

Phrase: "also"

Phrase: "develop"

Phrase: "in -cells in a similar fashion"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "to oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "at elevated glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.168: On a short-term basis (<24 h), fatty acids stimulate GDIS in part by causing an increase in the production of reducing equivalents due to -oxidation and additional acyl-CoA mitochondrial oxidation (7). 

Phrase: "On a short-term basis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1527178:Basis [Functional Concept]
   827   C1874451:Basis [Pharmacologic Substance]
   734   C0443303:Short-term [Temporal Concept]

Phrase: "("

Phrase: "<24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "stimulate"

Phrase: "GDIS in part"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1256369:insulin secretion [Cell Function]
   783   C1719133:Glucose/Insulin [Quantitative Concept]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "by causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "an increase in the production of reducing equivalents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "due to -oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: "and"

Phrase: "additional acyl-CoA mitochondrial oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030011:Oxidation [Molecular Function]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.169: Fatty acids may also increase Ca2+ mobilization from the endoplasmic reticulum (41). 

Phrase: "Fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "may"

Phrase: "also"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "Ca2+ mobilization from the endoplasmic reticulum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   753   C0300926:mobilization [Functional Concept]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.170: This can lead to decreased ADP levels, increased cytoplasmic Ca2+, and increased insulin production. 

Phrase: "This"

Phrase: "can"

Phrase: "lead to decreased ADP levels,"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   797   C0428255:lead levels [Laboratory or Test Result]
   781 E C0524167:Lead level [Laboratory Procedure]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C0523452:ADP [Laboratory Procedure]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
   726 E C0456079:Level [Classification]
   726 E C0547047:Decrease [Quantitative Concept]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "cytoplasmic Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "increased insulin production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033268:production [Occupational Activity]
   734   C0020459:increased insulin [Disease or Syndrome]
Processing 00000000.tx.171: In contrast, chronic exposure (>24 h) of -cells to fatty acids leads to a reduction in GDIS (2,40). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "chronic exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205191:chronic [Temporal Concept]
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]

Phrase: "("

Phrase: ">24 h) of -cells to fatty acids"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "leads to a reduction"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in GDIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.172: Current explanations (2,42) of this lipid-induced toxicity in -cells certainly involve the effects of oxidative stress. 

Phrase: "Current explanations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0681841:Explanations [Intellectual Product]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "42"

Phrase: ")"

Phrase: "of this lipid-induced toxicity in -cells certainly"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "involve"

Phrase: "the effects of oxidative stress."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.173: Hence, lipotoxicity appears to be at least partly a manifestation of supplementary ROS production induced by additional production of reducing equivalents in mitochondria pari pasu with fatty acid metabolism. 

Phrase: "Hence,"

Phrase: "lipotoxicity"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be at least partly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2987476:Be [Conceptual Entity]

Phrase: "a manifestation of supplementary ROS production"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1280464:Manifestation of [Qualitative Concept]
           manifestation
   744   C0205319:manifestation [Functional Concept]

Phrase: "induced by additional production of reducing equivalents"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0033268:production [Occupational Activity]
   748   C0205263:Induced [Functional Concept]
   748   C0392756:Reducing [Qualitative Concept]
   748   C0439185:Equivalents [Quantitative Concept]
   748   C1524062:Additional [Functional Concept]
   714 E C0205163:Equivalent [Qualitative Concept]

Phrase: "in mitochondria pari pasu"

Phrase: "with fatty acid metabolism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0596563:Fatty Acid Metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   734   C0015684:Fatty acid [Lipid]
Processing 00000000.tx.174: Direct data on mitochondrial O2 production rates obtained in our laboratory also confirms the possibility that -cells are subject to oxidative stress at increased concentrations of fatty acids. 

Phrase: "Direct data on mitochondrial O2 production rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "obtained in our laboratory also"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C1301820:Obtained [Functional Concept]
   760   C3244292:laboratory [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the possibility"

Phrase: "that -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "are subject to oxidative stress"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   760   C0038435:Stress [Finding]
   760   C0311404:Oxidative [Functional Concept]
   760   C0681850:Subject [Group]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1551058:Are [Quantitative Concept]
   760   C1706203:Subject [Idea or Concept]
   760   C2349001:Subject [Human]
   760   C2697811:Subject [Functional Concept]

Phrase: "at increased concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of fatty acids."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.175: Superoxide production in ZDF rat islets was significantly higher than in ZLC rat islets under resting conditions (with 2 mmol/l glucose), and the overproduction of superoxide was associated with perturbed mitochondrial morphology in ZDF rat islets (18). 

Phrase: "Superoxide production in ZDF rat islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "significantly higher than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "in ZLC rat islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0034719:Zucker rat [Mammal]

Phrase: "under resting conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "("

Phrase: "with 2 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the overproduction of superoxide"

Phrase: "was"

Phrase: "associated with perturbed mitochondrial morphology"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C0332437:Associated morphology [Qualitative Concept]
           Morphology
   760   C0026237:Mitochondrial [Cell Component]
   760   C0521451:Mitochondrial [Functional Concept]
   760   C0543482:morphology [Spatial Concept]
   760   C0700329:Morphology, NOS [Finding]
   760   C0700619:Morphology [Biomedical Occupation or Discipline]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in ZDF rat islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0034719:Zucker rat [Mammal]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.176: Abnormal mitochondrial morphology in ZDF rat islets and its reversal by systemic treatment with troglitazone were also observed by Higa et al. 

Phrase: "Abnormal mitochondrial morphology in ZDF rat islets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0332437:Morphology [Qualitative Concept]
   742   C0543482:morphology [Spatial Concept]
   742   C0700329:Morphology, NOS [Finding]
   742   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "its reversal by systemic treatment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443290:Reversal [Functional Concept]

Phrase: "with troglitazone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0245514:troglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "also"

Phrase: "observed by Higa et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1441672:Observed [Functional Concept]
Processing 00000000.tx.177: (43). 

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.178: Because ZDF rat islets accumulate triglycerides (43), these changes can be explained by increased ROS production as a result of increased content of free fatty acids in these -cells.  

Phrase: "Because"

Phrase: "ZDF rat islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0034719:Zucker rat [Mammal]

Phrase: "accumulate"

Phrase: "triglycerides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041004:Triglycerides [Biologically Active Substance,Lipid]

Phrase: "(43"

Phrase: ")"

Phrase: ","

Phrase: "these changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "explained by increased ROS production"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0033268:production [Occupational Activity]
   748   C0205217:Increased [Quantitative Concept]
   748   C0205332:Reactive [Qualitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C1705920:Species [Conceptual Entity]

Phrase: "as a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of increased content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "of free fatty acids"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "in these -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.179: Dual role of -cell mitochondria uncoupling. 

Phrase: "Dual role of -cell mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0026237:Mitochondria [Cell Component]

Phrase: "uncoupling."
Processing 00000000.tx.180: TOP ABSTRACT GDIS and adenine nucleotide... 

Phrase: "TOP ABSTRACT GDIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   839   C1719133:Glucose/Insulin [Quantitative Concept]
   827   C1256369:insulin secretion [Cell Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "adenine nucleotide..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.181: Dependence of ROS production... 

Phrase: "Dependence of ROS production..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011546:Dependence [Mental Process]
   753   C0439857:Dependence [Mental or Behavioral Dysfunction]
   753   C2698668:DEPENDENCE [Regulation or Law]
Processing 00000000.tx.182: Manifestations of oxidative... 

Phrase: "Manifestations of oxidative..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   866   C1280464:Manifestation of [Qualitative Concept]
           manifestations
   790   C0205319:manifestations [Functional Concept]
Processing 00000000.tx.183: Dual role of the... 

Phrase: "Dual role of the..."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.184: Dual role of -cell... 

Phrase: "Dual role of -cell..."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.185: Intracellular inhibition of ROS... 

Phrase: "Intracellular inhibition of ROS..."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0034750:Reactive Inhibition [Individual Behavior]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
Processing 00000000.tx.186: Preservation of -cell... 

Phrase: "Preservation of -cell..."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.187: CONCLUSIONS REFERENCES  Another consequence resulting from the GDISROS hypothesis relates to the uncoupling of -cell mitochondria. 

Phrase: "CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusions [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Another consequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "resulting from the GDISROS hypothesis"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0678226:resulting [Functional Concept]
   760   C1512571:Hypothesis [Idea or Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "relates to the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0163712:Relate [Organic Chemical]

Phrase: "uncoupling"

Phrase: "of -cell mitochondria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0026237:Mitochondria [Cell Component]
Processing 00000000.tx.188: Any active or passive transport of cations or anions across the mitochondrial inner membrane will affect . Multiple uncoupling agents could degrade the proton gradient across the mitochondrial inner membrane and decrease the level, causing a corresponding decreased ATP secretion, increased ADP concentration, and diminished ROS production rates. 

Phrase: "Any active"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205177:Active [Functional Concept]

Phrase: "or"

Phrase: "passive transport of cations"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0301624:Passive transport [Molecular Function]
   802   C1159651:cation transport [Molecular Function]
   770   C0005528:Transport, NOS [Cell Function]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "or"

Phrase: "anions across the mitochondrial inner membrane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0003075:Anions [Element, Ion, or Isotope]

Phrase: "will"

Phrase: "affect . Multiple uncoupling agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0041658:Uncoupling Agents [Pharmacologic Substance]
   779   C0450442:Agent [Chemical Viewed Functionally]
   779   C1254351:Agent [Pharmacologic Substance]
   779   C1521826:Agent [Intellectual Product]

Phrase: "could"

Phrase: "degrade"

Phrase: "the proton gradient across the mitochondrial inner membrane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439182:% gradient [Quantitative Concept]
   744   C0812409:Gradient [Quantitative Concept]

Phrase: "and"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the level,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "a corresponding decreased ATP secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]

Phrase: "increased ADP concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "diminished ROS production rates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0033268:production [Occupational Activity]
   766   C0871208:Rate [Activity]
   766   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.189: However, this should be accompanied by a decrease in the ATP-to-ADP ratio and, consequently, by decreased insulin production because plasma membrane KATP channels will be insufficiently closed (see GDIS AND ADENINE NUCLEOTIDES REGULATION). 

Phrase: "However,"

Phrase: "this"

Phrase: "should"

Phrase: "be"

Phrase: "accompanied by a decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "in the ATP-to-ADP ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: ","

Phrase: "consequently,"

Phrase: "by decreased insulin production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033268:production [Occupational Activity]

Phrase: "because"

Phrase: "plasma membrane KATP channels"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0022009:Membrane Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]

Phrase: "will"

Phrase: "be"

Phrase: "insufficiently"

Phrase: "closed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0587267:Closed [Functional Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "GDIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "AND"

Phrase: "ADENINE NUCLEOTIDES REGULATION"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]
   734   C0001413:Adenine Nucleotides [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.190: This dual role of uncoupling can be illustrated by considering the principal -cell uncoupling protein (UCP)2, which catalyzes a regulated proton leak across the mitochondrial inner membrane (Fig. 1) (see Saleh, Wheeler, and Chan [44] for review). 

Phrase: "This dual role of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "uncoupling"

Phrase: "can"

Phrase: "be"

Phrase: "illustrated by considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0750591:considering [Idea or Concept]

Phrase: "the principal -cell uncoupling protein (UCP)2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   884   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "catalyzes"

Phrase: "a regulated proton leak across the mitochondrial inner membrane"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0332234:Leak [Functional Concept]
   742   C1608322:Leak NOS [Finding]
   742   C1881366:LEAK [Phenomenon or Process]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Saleh,"

Phrase: "Wheeler,"

Phrase: "and"

Phrase: "Chan"

Phrase: "[44"

Phrase: "]"

Phrase: "for review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.191: Indeed, islets from UCP2-deficient mice have an increased ATP level and an enhanced glucose-stimulated insulin secretion compared with control animals (45). 

Phrase: "Indeed,"

Phrase: "islets from UCP2-deficient mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   781   C1522528:Mouse Islets [Tissue]

Phrase: "have"

Phrase: "an increased ATP level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "an enhanced glucose-stimulated insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   853   C1719133:Glucose/Insulin [Quantitative Concept]
   840   C1256369:insulin secretion [Cell Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "compared with control animals"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   799   C1511501:Control Animal [Animal]
   770   C0003062:Animals [Animal]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.192: On the other hand, overexpression of UCP2 in isolated pancreatic islets results in decreased ATP content, reduced , and blunted glucose-stimulated insulin secretion (46). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "overexpression of UCP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514559:Overexpression [Genetic Function]

Phrase: "in isolated pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "results in decreased ATP content,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0423896:Content [Mental Process]
   760   C0442797:decreased [Qualitative Concept]
   760   C0456205:Content [Conceptual Entity]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "blunted glucose-stimulated insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   853   C1719133:Glucose/Insulin [Quantitative Concept]
   840   C1256369:insulin secretion [Cell Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.193: However, in line with the suggested dual role of mitochondrial membrane uncoupling, overexpression of UCP2 enhanced the resistance of -cells toward H2O2 toxicity (47). 

Phrase: "However,"

Phrase: "in line with the suggested dual role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035820:Role [Social Behavior]
   827   C1705810:Role [Conceptual Entity]

Phrase: "of mitochondrial membrane"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0596952:Mitochondrial membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "uncoupling"

Phrase: ","

Phrase: "overexpression of UCP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514559:Overexpression [Genetic Function]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "the resistance of -cells toward H2O2 toxicity"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   757   C0007634:THE CELL [Cell]
           Cells
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.194: The inner mitochondrial membrane KATP channel is another mechanism through which could be regulated. 

Phrase: "The inner mitochondrial membrane KATP channel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   888   C0764439:KATP channel, mitochondrial [Amino Acid, Peptide, or Protein,Receptor]
   853   C0022009:Membrane Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0439799:Channel [Spatial Concept]
   804   C1706095:Channel [Conceptual Entity]
   717   C0230840:Inner mitochondrial membrane [Cell Component]

Phrase: "is"

Phrase: "another mechanism through which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "could"

Phrase: "be"

Phrase: "regulated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]
Processing 00000000.tx.195: Enhanced K+ uptake through mitochondrial KATP channels would lead to a lower . This effect could promote a decline in mitochondrial ROS production (48,49). 

Phrase: "Enhanced K+ uptake through mitochondrial KATP channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243144:Uptake [Physiologic Function]
   748   C0347980:% uptake [Quantitative Concept]

Phrase: "would"

Phrase: "lead to a lower ."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0441994:Lower [Spatial Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "could"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "a decline in mitochondrial ROS production"

Phrase: "(48,"

Phrase: "49"

Phrase: ")."
Processing 00000000.tx.196: There is as yet no direct data on the role of mitochondrial KATP channels in pancreatic -cells; 

Phrase: "There"

Phrase: "is as yet"

Phrase: "no direct data on the role of mitochondrial KATP channels"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1546437:No Data [Qualitative Concept]
   757   C1572381:NO DATA [Pharmacologic Substance]
   739   C1511726:Data [Idea or Concept]
   739   C3245479:data [Medical Device]

Phrase: "in pancreatic -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.197: however, one would expect that the openers of mitochondrial KATP will act similarly to UCP2 activation.  

Phrase: "however,"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "would"

Phrase: "expect"

Phrase: "that"

Phrase: "the openers of mitochondrial KATP"

Phrase: "will"

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "similarly to UCP2 activation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1421314:UCP2 [Gene or Genome]
   770   C1879547:Activation [Activity]
Processing 00000000.tx.198: Intracellular inhibition of ROS production can lead to a decrease in GDIS. 

Phrase: "Intracellular inhibition of ROS production"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0034750:Reactive Inhibition [Individual Behavior]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "can"

Phrase: "lead to a decrease"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in GDIS."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.199: TOP ABSTRACT GDIS and adenine nucleotide... 

Phrase: "TOP ABSTRACT GDIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   839   C1719133:Glucose/Insulin [Quantitative Concept]
   827   C1256369:insulin secretion [Cell Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "adenine nucleotide..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.200: Dependence of ROS production... 

Phrase: "Dependence of ROS production..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011546:Dependence [Mental Process]
   753   C0439857:Dependence [Mental or Behavioral Dysfunction]
   753   C2698668:DEPENDENCE [Regulation or Law]
Processing 00000000.tx.201: Manifestations of oxidative... 

Phrase: "Manifestations of oxidative..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   866   C1280464:Manifestation of [Qualitative Concept]
           manifestations
   790   C0205319:manifestations [Functional Concept]
Processing 00000000.tx.202: Dual role of the... 

Phrase: "Dual role of the..."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.203: Dual role of -cell... 

Phrase: "Dual role of -cell..."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.204: Intracellular inhibition of ROS... 

Phrase: "Intracellular inhibition of ROS..."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0034750:Reactive Inhibition [Individual Behavior]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
Processing 00000000.tx.205: Preservation of -cell... 

Phrase: "Preservation of -cell..."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.206: CONCLUSIONS REFERENCES  We have suggested that the initial stages of GDIS can be responsible for increased ROS production in -cells. 

Phrase: "CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusions [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the initial stages of GDIS"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   744   C0205265:Initial [Temporal Concept]
   744   C1279901:Initial [Qualitative Concept]
   744   C1306673:Stages [Qualitative Concept]
   744   C1555582:Initial [Idea or Concept]
   744   C1705685:INITIAL [Functional Concept]
   711 E C0205390:Stage [Temporal Concept]
   711 E C1300072:Stage [Clinical Attribute]

Phrase: "can"

Phrase: "be"

Phrase: "responsible for increased ROS production in -cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1273518:Responsible [Finding]
Processing 00000000.tx.207: Therefore, it is possible that inhibition of these stages can be used by -cells as a defense against oxidative stress. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that inhibition of these stages"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "can"

Phrase: "be"

Phrase: "used by -cells"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   882   C1273517:Used by [Finding]
           used
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1947944:Use [Intellectual Product]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "as a defense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880266:Defense [Conceptual Entity]

Phrase: "against oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.208: There are several examples of such potential mechanisms. 

Phrase: "There"

Phrase: "are"

Phrase: "several examples of such potential mechanisms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1707959:Example [Conceptual Entity]
Processing 00000000.tx.209: For example, studies (50,51) on the mechanism of action of the diabetogenic agent alloxan have suggested that its target, glucokinase, is sensitive to oxidation by ROS. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "(50,"

Phrase: "51"

Phrase: ")"

Phrase: "on the mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "of action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441472:Action [Functional Concept]
  1000   C3266814:Action [Activity]

Phrase: "of the diabetogenic agent alloxan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002151:Alloxan [Biologically Active Substance,Organic Chemical]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "its target,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "glucokinase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415014:GLUCOKINASE [Gene or Genome]

Phrase: "is"

Phrase: "sensitive to oxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332324:Sensitive to [Functional Concept]
           Sensitive
   790   C1550474:sensitive [Idea or Concept]

Phrase: "by ROS."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.210: Generation of ROS in HIT-T15 cells treated with the D-ribose caused a significant reduction in both glucokinase transcription and protein expression, leading to reduced glucokinase activity (52). 

Phrase: "Generation of ROS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "in HIT-T15 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "treated with the"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "D-"

Phrase: "ribose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035549:Ribose [Carbohydrate]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a significant reduction in both glucokinase transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "protein expression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1171362:protein expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "leading to reduced glucokinase activity"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   806   C1150444:glucokinase activity [Molecular Function]
   797   C0086439:Reduced Activity [Sign or Symptom]
   760   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205177:Activity [Functional Concept]
   760   C0332152:Leading [Temporal Concept]
   760   C0392756:Reduced [Qualitative Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1415014:GLUCOKINASE [Gene or Genome]
   760   C1522538:Leading [Functional Concept]
   760   C1561536:*Activity [Idea or Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(52"

Phrase: ")."
Processing 00000000.tx.211: Therefore, increased ROS production in -cells might lead to glucose sensor (glucokinase) inhibition. 

Phrase: "Therefore,"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "ROS production in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "might"

Phrase: "lead to glucose sensor"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0872382:GLUCOSE SENSOR [Medical Device]
   833   C1625163:glucose sensor [Molecular Function]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0183210:Sensor [Medical Device]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1705193:Sensor [Manufactured Object]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(glucokinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415014:GLUCOKINASE [Gene or Genome]

Phrase: ")"

Phrase: "inhibition."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]
Processing 00000000.tx.212: In addition, both H2O2 and high glucose suppress the activity of glyceraldehyde 3-phosphate dehydrogenase, a glycolytic enzyme, in pancreatic -cells that can lead to impaired GDIS (19). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "both H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "high glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:high glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "the activity of glyceraldehyde 3-phosphate dehydrogenase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "a glycolytic enzyme,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   789   C0017952:Glycolysis [Molecular Function]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "in pancreatic -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "can"

Phrase: "lead to impaired GDIS"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   778   C1256369:insulin secretion [Cell Function]
   774   C1719133:Glucose/Insulin [Quantitative Concept]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0221099:Impaired [Functional Concept]
   748   C0684336:Impaired [Pathologic Function]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1701901:Dependent [Qualitative Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3244310:dependent [Functional Concept]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.213: It also seems likely that -cells can increase UCP2 expression to decrease oxidative stress. 

Phrase: "It also"

Phrase: "seems"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "UCP2 expression to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.214: For example, superoxide increases proton conductance in mitochondria from pancreatic -cells, probably via activation of UCP2 (53). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "superoxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038836:Superoxide [Element, Ion, or Isotope]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "proton conductance in mitochondria"

Phrase: "from pancreatic -cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "probably via activation of UCP2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0750492:Probably [Idea or Concept]
   760   C1421314:UCP2 [Gene or Genome]
   760   C1879547:Activation [Activity]

Phrase: "(53"

Phrase: ")."
Processing 00000000.tx.215: Increased glucose induces expression of UCP2 in isolated human islets (54). 

Phrase: "Increased glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:increased glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "expression of UCP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in isolated human islets"

Phrase: "(54"

Phrase: ")."
Processing 00000000.tx.216: Chronic exposure of pancreatic islets to free fatty acids, blunting GDIS, is accompanied by increased synthesis of UCP2 (55). 

Phrase: "Chronic exposure of pancreatic islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205191:chronic [Temporal Concept]
   760   C0274281:Exposure, NOS [Injury or Poisoning]
   760   C0332157:Exposure [Clinical Attribute]

Phrase: "to free fatty acids,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "blunting"

Phrase: "GDIS,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "accompanied by increased synthesis of UCP2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205217:Increased [Quantitative Concept]
   753   C0220781:synthesis [Biologic Function]
   753   C0442805:Increased [Functional Concept]
   753   C1421314:UCP2 [Gene or Genome]
   753   C1883254:Synthesis [Activity]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.217: These mechanisms of protection from oxidative stress would decrease the rate of ATP production and the corresponding ATP-to-ADP ratio, leading to impaired -cell sensitivity to glucose simulation, a characteristic feature of type 2 diabetes.  

Phrase: "These mechanisms of protection"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]

Phrase: "from oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "would"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the rate of ATP production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "the corresponding ATP-to-ADP ratio,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0456603:Ratio [Quantitative Concept]
   804   C1547037:Ratio [Intellectual Product]

Phrase: "leading to impaired -cell sensitivity"
Meta Candidates (Total=20; Excluded=4; Pruned=0; Remaining=16)
   762   C0332324:Sensitive to [Functional Concept]
   760   C0007634:Cell [Cell]
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0221099:Impaired [Functional Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0332152:Leading [Temporal Concept]
   760   C0427965:Sensitivity [Finding]
   760   C0684336:Impaired [Pathologic Function]
   760   C1269647:Cell [Cell]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522538:Leading [Functional Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2349185:Sensitivity [Qualitative Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to glucose simulation,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679083:Simulation [Research Activity]
   789 E C0284447:simulated [Biomedical or Dental Material]

Phrase: "a characteristic feature of type 2 diabetes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1521970:Feature [Qualitative Concept]
   748   C1706388:Feature [Conceptual Entity]
   748   C2346469:Feature [Qualitative Concept]
   748   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.218: Preservation of -cell function and islet mass versus enhancement of GDIS: mutually exclusive goals? 

Phrase: "Preservation of -cell function"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0007613:Cell Function [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1705273:Function [Intellectual Product]
   812   C1948049:Cell [Spatial Concept]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "islet mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "versus"

Phrase: "enhancement of GDIS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   753   C2349975:Enhancement [Activity]

Phrase: ":"

Phrase: "mutually exclusive goals?"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0018017:Goals [Intellectual Product]
   793 E C1571704:Goal [Idea or Concept]
Processing 00000000.tx.219: TOP ABSTRACT GDIS and adenine nucleotide... 

Phrase: "TOP ABSTRACT GDIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   839   C1719133:Glucose/Insulin [Quantitative Concept]
   827   C1256369:insulin secretion [Cell Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "adenine nucleotide..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.220: Dependence of ROS production... 

Phrase: "Dependence of ROS production..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011546:Dependence [Mental Process]
   753   C0439857:Dependence [Mental or Behavioral Dysfunction]
   753   C2698668:DEPENDENCE [Regulation or Law]
Processing 00000000.tx.221: Manifestations of oxidative... 

Phrase: "Manifestations of oxidative..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   866   C1280464:Manifestation of [Qualitative Concept]
           manifestations
   790   C0205319:manifestations [Functional Concept]
Processing 00000000.tx.222: Dual role of the... 

Phrase: "Dual role of the..."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.223: Dual role of -cell... 

Phrase: "Dual role of -cell..."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.224: Intracellular inhibition of ROS... 

Phrase: "Intracellular inhibition of ROS..."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0034750:Reactive Inhibition [Individual Behavior]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
Processing 00000000.tx.225: Preservation of -cell... 

Phrase: "Preservation of -cell..."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.226: CONCLUSIONS REFERENCES  Cellular antioxidant systems exist within cells to neutralize ROS. 

Phrase: "CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusions [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cellular antioxidant systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "exist within cells to"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C2987476:Exist [Conceptual Entity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "neutralize"

Phrase: "ROS."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.227: Oxidative stress can arise only when the endogenous antioxidant network fails to provide a sufficient compensatory response to survival or to restore a cellular function (2,35). 

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "can"

Phrase: "arise"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "when"

Phrase: "the endogenous antioxidant network"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a sufficient compensatory response to survival"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "or"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "restore"

Phrase: "a cellular function"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0007613:Cellular Function [Cell Function]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.228: Resent research has also demonstrated a direct link among the imbalance of oxidative stress, impaired glucose uptake, and antioxidants for both diabetic animal models and in human disease. 

Phrase: "Resent research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "has"

Phrase: "also"

Phrase: "demonstrated"

Phrase: "a direct link among the imbalance of oxidative stress,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1517892:Link [Intellectual Product]
   742   C1704666:Link [Intellectual Product]

Phrase: "impaired glucose uptake,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1159527:glucose uptake [Cell Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "antioxidants for both diabetic animal models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "and in human disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0012634:Disease [Disease or Syndrome]
   770   C0086418:Human [Human]
   770   C1515981:And [Idea or Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.229: This leads to the hypothesis that the imbalance of ROS production and antioxidants is one important factor in the etiology of diabetes (2,56). 

Phrase: "This"

Phrase: "leads to the hypothesis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1512571:Hypothesis [Idea or Concept]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "the imbalance of ROS production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1397014:Imbalance [Sign or Symptom]

Phrase: "and"

Phrase: "antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "is"

Phrase: "one important factor in the etiology of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1521761:Factor [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "56"

Phrase: ")."
Processing 00000000.tx.230: This hypothesis suggests that ROS overproduction in -cells is only part of the process leading to the development of -cell dysfunction. 

Phrase: "This hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that ROS overproduction in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "only part of the process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1292711:Part of [Spatial Concept]
   760   C0449719:Part [Spatial Concept]
   760   C1709471:Part [Quantitative Concept]

Phrase: "leading to the development of -cell dysfunction."
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   774   C0815089:cell development [Cell Function]
   748   C0007634:Cell [Cell]
   748   C0031847:dysfunction [Functional Concept]
   748   C0243107:development [Physiologic Function]
   748   C0277785:Dysfunction, NOS [Qualitative Concept]
   748   C0332152:Leading [Temporal Concept]
   748   C0678723:Development [Organism Function]
   748   C1269647:Cell [Cell]
   748   C1522538:Leading [Functional Concept]
   748   C1527148:Development [Functional Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.231: It seems likely that some additional defect as, for example, decreased antioxidant production, is required for -cell dysfunction and/or apoptosis. 

Phrase: "It"

Phrase: "seems"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "some additional defect as,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1457869:Defect [Functional Concept]
   770   C1861101:DEFECT [Disease or Syndrome]

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "decreased antioxidant production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "required for -cell dysfunction"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0007634:Cell [Cell]
   770   C0031847:dysfunction [Functional Concept]
   770   C0277785:Dysfunction, NOS [Qualitative Concept]
   770   C1269647:Cell [Cell]
   770   C1514873:Required [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   715 E C0231174:Malfunction [Functional Concept]
   715 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and/or"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.232: However, as we have attempted to illustrate, some specific -cell properties make them a weak link in the defense against oxyradicals. 

Phrase: "However,"

Phrase: "as"

Phrase: "we"

Phrase: "have"

Phrase: "attempted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "illustrate"

Phrase: ","

Phrase: "some specific -cell properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0871161:properties [Qualitative Concept]
   827   C1292721:properties [Functional Concept]
   793 E C1882134:Property [Conceptual Entity]
   793 E C2347695:Property [Entity]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "them a weak link in the defense"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1517892:Link [Intellectual Product]
   748   C1704666:Link [Intellectual Product]

Phrase: "against oxyradicals."
Processing 00000000.tx.233: Because the activation of initial stages of GDIS or increased immediately leads to increased insulin secretion, it is not surprising that these stages are targets for therapeutic intervention. 

Phrase: "Because"

Phrase: "the activation of initial stages of GDIS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C2245392:activation of insulin secretion [Cell Function]
   777   C2259154:activation of secretion [Cell Function]
   739   C1879547:Activation [Activity]

Phrase: "or"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "leads to increased insulin secretion,"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   862   C1372360:Increased Insulin Secretion [Organ or Tissue Function]
   806   C0020459:increased insulin [Disease or Syndrome]
   806   C1256369:insulin secretion [Cell Function]
   797   C0861064:increased lead [Finding]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C0181586:leads [Medical Device]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "surprising"

Phrase: "that"

Phrase: "these stages"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1306673:Stages [Qualitative Concept]
   966 E C0205390:Stage [Temporal Concept]
   966 E C1300072:Stage [Clinical Attribute]

Phrase: "are"

Phrase: "targets for therapeutic intervention."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1521840:Target [Functional Concept]
   737   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.234: For example, glucokinase plays a key role in initial GDIS stages by catalyzing the phosphorylation of glucose in -cells. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "glucokinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415014:GLUCOKINASE [Gene or Genome]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a key role in initial GDIS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "stages by catalyzing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205390:Stage [Temporal Concept]
   790   C1300072:Stage [Clinical Attribute]
   790   C1306673:Stage [Qualitative Concept]

Phrase: "the phosphorylation of glucose in -cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.235: A new class of antidiabetic agents, mixed-type glucokinase activators that increased both the affinity for glucose and the Vmax, was shown to stimulate GDIS (8,57). 

Phrase: "A new class of antidiabetic agents,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0456387:Class [Intellectual Product]
   753   C1705943:Class [Classification]

Phrase: "mixed-"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205430:Mixed [Functional Concept]
  1000   C3160715:Mixed [Finding]
   966 E C1421951:MIX [Gene or Genome]
   966 E C1720722:Mix [Qualitative Concept]

Phrase: "type glucokinase activators"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   884   C2246534:glucokinase activator [Molecular Function]

Phrase: "that"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "both the affinity for glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "the Vmax,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710637:Vmax [Phenomenon or Process]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stimulate"

Phrase: "GDIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(8,"

Phrase: "57"

Phrase: ")."
Processing 00000000.tx.236: A reduction in UCP2 activity was also suggested as a mechanism for significant improvement in insulin secretion (58). 

Phrase: "A reduction in UCP2 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C2267000:Reduction Activity [Molecular Function]
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "also"

Phrase: "suggested as a mechanism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]
   737   C1705535:Suggest [Idea or Concept]

Phrase: "for significant improvement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986411:Improvement [Conceptual Entity]

Phrase: "in insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(58"

Phrase: ")."
Processing 00000000.tx.237: We can also suggest that a reduction in KATP activity in the inner mitochondrial membrane should lead to increased insulin secretion rate, as does decreased UCP2 activity. 

Phrase: "We"

Phrase: "can"

Phrase: "also"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a reduction in KATP activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C2267000:Reduction Activity [Molecular Function]
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in the inner mitochondrial membrane"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0230840:Inner mitochondrial membrane [Cell Component]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0205102:Inner [Spatial Concept]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "should"

Phrase: "lead to increased insulin secretion rate,"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   833   C1372360:Increased Insulin Secretion [Organ or Tissue Function]
   790   C0020459:increased insulin [Disease or Syndrome]
   790   C1256369:insulin secretion [Cell Function]
   783   C0861064:increased lead [Finding]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0871208:Rate [Activity]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1521828:Rate [Quantitative Concept]
   753   C1522538:Lead [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "as"

Phrase: "does"

Phrase: "decreased UCP2 activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0086439:Decreased activity [Sign or Symptom]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.238: However, such a therapeutic strategy should be used with caution, since according to our proposal an increase in insulin secretion achieved by these approaches could also considerably increase ROS production, leading to oxidative stress. 

Phrase: "However,"

Phrase: "such"

Phrase: "a therapeutic strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategy [Mental Process]

Phrase: "should"

Phrase: "be"

Phrase: "used with caution,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   988   C1710588:Use with caution [Functional Concept]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "since according to our proposal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0680240:according [Social Behavior]
   760   C1555306:proposal [Idea or Concept]
   760   C1711239:Since [Temporal Concept]
   760   C1948033:Proposal [Intellectual Product]

Phrase: "an increase in insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0020459:INSULIN INCREASE [Disease or Syndrome]
   760   C0442805:Increase [Functional Concept]

Phrase: "achieved by these approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449445:Approaches [Spatial Concept]
   770   C1292724:Approaches [Functional Concept]

Phrase: "could"

Phrase: "also considerably"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "ROS production,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033268:production [Occupational Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "leading to oxidative stress."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]
   770   C0332152:Leading [Temporal Concept]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.239: The concept of "-cell rest" as originally developed, perhaps more for amelioration of type 1 than type 2 diabetes, argued that decreased demand on -cell function can lead to improvements in insulin secretion and -cell viability (2,59,60). 

Phrase: "The concept of ""-cell rest"""
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0007634:Cell [Cell]
   812   C0035253:Rest [Daily or Recreational Activity]
   812   C1269647:Cell [Cell]
   812   C1622890:ResT [Molecular Function]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "originally"

Phrase: "developed"

Phrase: ","

Phrase: "perhaps more for amelioration of type 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0441729:Type 1 [Classification]
   748   C0332307:Type [Qualitative Concept]
   748   C1547052:*Type [Quantitative Concept]

Phrase: "than type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "argued"

Phrase: "that decreased demand on -cell function"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   840   C0007613:Cell Function [Cell Function]
   804   C0007634:Cell [Cell]
   804   C0031843:function [Physiologic Function]
   804   C0542341:Function [Functional Concept]
   804   C0700205:FUNCTION [Classification]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1705273:Function [Intellectual Product]
   804   C1948049:Cell [Spatial Concept]
   733 E C0205245:Functional [Functional Concept]
   733 E C2700217:Functional [Conceptual Entity]

Phrase: "can"

Phrase: "lead to improvements"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]
   756   C2986411:Improvement [Conceptual Entity]

Phrase: "in insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and -"

Phrase: "cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "59,"

Phrase: "60"

Phrase: ")."
Processing 00000000.tx.240: Such agents as diazoxide and calcium channel blockers, which reversibly inhibit insulin secretion, have improved -cell function both in rodent models of diabetes (61,62) and in humans (63). 

Phrase: "Such agents as diazoxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0450442:Agent [Chemical Viewed Functionally]
   737   C1254351:Agent [Pharmacologic Substance]
   737   C1521826:Agent [Intellectual Product]

Phrase: "and"

Phrase: "calcium channel blockers,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0006684:Calcium Channel Blockers [Pharmacologic Substance]
   966 E C2757014:Calcium Channel Blocker [Molecular Function]
   966 E C3536851:Calcium Channel Blocker [Pharmacologic Substance]
   901   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0870261:channel blockers [Pharmacologic Substance]
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]
   827   C2936886:Calcium [Pharmacologic Substance]

Phrase: "which reversibly"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulin secretion,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "have"

Phrase: "improved -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0184511:Improved [Qualitative Concept]
  1000   C0332272:Improved [Qualitative Concept]
  1000   C1561611:Improved [Intellectual Product]

Phrase: "cell function"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0007613:Cell Function [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1705273:Function [Intellectual Product]
   861   C1948049:Cell [Spatial Concept]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "both in rodent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0035804:Rodent [Mammal]
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "models of diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C3161035:Model [Intellectual Product]

Phrase: "(61,"

Phrase: "62"

Phrase: ")"

Phrase: "and in humans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0086418:Humans [Human]
   790   C1515981:And [Idea or Concept]

Phrase: "(63"

Phrase: ")."
Processing 00000000.tx.241: This beneficial effect could be explained by the decreased ROS production during "-cell rest" associated with decreased GDIS activity. 

Phrase: "This beneficial effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "explained by the decreased ROS production"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   800   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   750   C0242184:Oxygen decrease [Pathologic Function]
   744   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0033268:production [Occupational Activity]
   744   C0205216:Decreased [Quantitative Concept]
   744   C0205332:Reactive [Qualitative Concept]
   744   C0392756:Decreased [Qualitative Concept]
   744   C0442797:decreased [Qualitative Concept]
   744   C1705920:Species [Conceptual Entity]
   711 E C0547047:Decrease [Quantitative Concept]

Phrase: "during ""-cell rest"""
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0007634:Cell [Cell]
   861   C0035253:Rest [Daily or Recreational Activity]
   861   C1269647:Cell [Cell]
   861   C1622890:ResT [Molecular Function]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "associated with decreased GDIS activity."
Meta Candidates (Total=28; Excluded=4; Pruned=0; Remaining=24)
   793   C1371675:Decreased Insulin Secretion [Organ or Tissue Function]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0860801:decreased glucose [Finding]
   770   C1256369:insulin secretion [Cell Function]
   767   C0086439:Decreased activity [Sign or Symptom]
   767   C1145751:insulin activity [Molecular Function]
   767 E C1704381:Glucose decreased [Finding]
   767   C1719133:Glucose/Insulin [Quantitative Concept]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]
   744   C0205177:Activity [Functional Concept]
   744   C0205216:Decreased [Quantitative Concept]
   744   C0392756:Decreased [Qualitative Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0442797:decreased [Qualitative Concept]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1561536:*Activity [Idea or Concept]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]
   711 E C0547047:Decrease [Quantitative Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.242: Inhibition of the early stages of GDIS or decreased should also lead to decreased ROS production. 

Phrase: "Inhibition of the early stages of GDIS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C2250323:inhibition of insulin secretion [Cell Function]
   777   C2259158:inhibition of secretion [Cell Function]
   739   C0021467:Inhibition [Mental Process]
   739   C0021469:Inhibition [Molecular Function]
   739   C1628982:% inhibition [Quantitative Concept]
   739   C3463820:Inhibition [Activity]

Phrase: "or"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "should"

Phrase: "also"

Phrase: "lead to decreased ROS production."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   814   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   757   C0242184:Oxygen decrease [Pathologic Function]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0033268:production [Occupational Activity]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0205332:Reactive [Qualitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C1705920:Species [Conceptual Entity]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]
   714 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.243: Any inhibitor of glycolytic flux, the tricarboxylic acid cycle, fatty acid oxidation, or mitochondrial membrane uncoupling could result in decreased ROS production. 

Phrase: "Any inhibitor of glycolytic flux,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "the tricarboxylic acid cycle,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008858:Tricarboxylic Acid Cycle [Molecular Function]
   901   C0040887:tricarboxylic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C1511572:Cycle [Temporal Concept]

Phrase: "fatty acid oxidation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1158366:fatty acid oxidation [Molecular Function]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0030011:Oxidation [Molecular Function]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "or"

Phrase: "mitochondrial membrane"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0596952:Mitochondrial membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "uncoupling"

Phrase: "could"

Phrase: "result in decreased ROS production."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   814   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   757   C0242184:Oxygen decrease [Pathologic Function]
   748   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0033268:production [Occupational Activity]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0205332:Reactive [Qualitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1705920:Species [Conceptual Entity]
   748   C2825142:Result [Finding]
   714 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.244: For example, this could be accomplished by specific inhibitors of -cell glucokinase, by an increase in UCP2 expression, or by openers of mitochondrial KATP channels. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "this"

Phrase: "could"

Phrase: "be"

Phrase: "accomplished by specific inhibitors of -cell glucokinase,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   757   C2246531:glucokinase inhibitor [Molecular Function]
   748   C0007634:Cell [Cell]
   748   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205369:Specific [Qualitative Concept]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   748   C1269647:Cell [Cell]
   748   C1415014:GLUCOKINASE [Gene or Genome]
   748   C1552740:specific [Intellectual Product]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "by an increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "in UCP2 expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or by openers of mitochondrial KATP channels."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0764439:KATP channel, mitochondrial [Amino Acid, Peptide, or Protein,Receptor]
   778   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   748   C0026237:Mitochondrial [Cell Component]
   748   C0521451:Mitochondrial [Functional Concept]
   714   C0439799:Channel [Spatial Concept]
   714   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.245: However, a decreased insulin secretion rate is the necessary price to pay for these approaches to increasing -cell function and survival. 

Phrase: "However,"

Phrase: "a decreased insulin secretion rate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0871208:Rate [Activity]
   812   C1521828:Rate [Quantitative Concept]
   756   C1371675:Decreased Insulin Secretion [Organ or Tissue Function]

Phrase: "is"

Phrase: "the necessary price to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0080045:Price [Quantitative Concept]

Phrase: "pay for these approaches"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449445:Approaches [Spatial Concept]
   770   C0871051:pay [Quantitative Concept]
   770   C1292724:Approaches [Functional Concept]

Phrase: "to increasing -cell function"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   901   C0007613:Cell Function [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1705273:Function [Intellectual Product]
   827   C1948049:Cell [Spatial Concept]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "survival."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]
Processing 00000000.tx.246: For this reason, such methods can predominantly be used when the GDIS mechanism is not the main source of insulin production. 

Phrase: "For this reason,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392360:Reason [Idea or Concept]

Phrase: "such methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "can"

Phrase: "predominantly"

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "when"

Phrase: "the GDIS mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0441712:Mechanism [Functional Concept]
   804   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the main source of insulin production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449416:Source [Finding]
   753   C1705919:Source [Idea or Concept]
Processing 00000000.tx.247: This of course can occur following treatment by plasma membrane KATP channel blockers, such as sulfonylureas and meglitinides, which can compensate for the inadequate closure of these KATP channels at reduced ATP/ADP levels, or simply by insulin therapy. 

Phrase: "This of course"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0750729:Course [Temporal Concept]
   790   C1080058:This [Eukaryote]

Phrase: "can"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "treatment by plasma membrane KATP channel blockers,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "such as sulfonylureas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0038766:SULFONYLUREAS [Organic Chemical,Pharmacologic Substance]
   966 E C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "and"

Phrase: "meglitinides,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0065880:meglitinides [Organic Chemical,Pharmacologic Substance]
  1000   C1579432:Meglitinides [Pharmacologic Substance]

Phrase: "which"

Phrase: "can"

Phrase: "compensate for the inadequate closure of these KATP channels"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   742   C0185003:Closure [Therapeutic or Preventive Procedure]
   742   C0205412:Inadequate [Qualitative Concept]
   742   C0205432:compensate [Qualitative Concept]
   742   C1521802:Closure [Research Activity]
   708   C0439799:Channel [Spatial Concept]
   708   C1706095:Channel [Conceptual Entity]

Phrase: "at reduced ATP/ADP levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "simply by insulin therapy."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0039798:therapy [Functional Concept]
   770   C0087111:Therapy [Therapeutic or Preventive Procedure]
   770   C1363945:Therapy [Finding]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.248: However, plasma membrane KATP channel blockade is accompanied by increased Ca2+ levels in -cells, which can itself increase oxidative stress (see DEPENDENCE OF ROS PRODUCTION IN -CELLS ON THE GDIS MECHANISM). 

Phrase: "However,"

Phrase: "plasma membrane KATP channel blockade"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332206:Blockade [Functional Concept]
   804   C3540676:Blockade [Pharmacologic Substance]

Phrase: "is"

Phrase: "accompanied by increased Ca2+ levels in -cells,"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   748   C0007634:Cells [Cell]
   748   C0205217:Increased [Quantitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C3282337:Cells [Cell]
   714 E C0456079:Level [Classification]
   714 E C1269647:Cell [Cell]
   714 E C1547707:Level [Geographic Area]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "which"

Phrase: "can"

Phrase: "itself"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "DEPENDENCE OF ROS PRODUCTION IN -CELLS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0011546:Dependence [Mental Process]
   744   C0439857:Dependence [Mental or Behavioral Dysfunction]
   744   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "ON THE GDIS MECHANISM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0441712:Mechanism [Functional Concept]
   804   C1706376:Mechanism [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.249: For this reason, the simplest and potentially most beneficial method to decrease oxidative stress in -cells may be that of early use of the above-mentioned GDIS inhibitors, with insulin as necessary. 

Phrase: "For this reason,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392360:Reason [Idea or Concept]

Phrase: "the simplest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205352:Simple [Qualitative Concept]

Phrase: "and"

Phrase: "potentially most beneficial method to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025663:Method [Intellectual Product]
   804   C0449851:Method [Functional Concept]
   804   C0871511:METHOD [Intellectual Product]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "oxidative stress in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "that of early use"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1279919:Early [Temporal Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "of the above-mentioned GDIS inhibitors,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   813   C0021643:insulin inhibitor [Pharmacologic Substance]
   795   C0243077:inhibitors [Chemical Viewed Functionally]
   762 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "with insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "as necessary."
Processing 00000000.tx.250: This approach would decrease both glucose levels and the corresponding ROS production. 

Phrase: "This approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "would"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "both glucose levels"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0428548:glucose levels [Laboratory or Test Result]
   966 E C0337438:glucose level [Laboratory Procedure]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "the corresponding ROS production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0033268:production [Occupational Activity]
   717   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
Processing 00000000.tx.251: Although this approach has not always been used to an advantage (59), recent studies (60,64) have suggested that early insulin treatment in type 2 diabetes indeed preserved endogenous insulin secretion. 

Phrase: "Although"

Phrase: "this approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "has"

Phrase: "not always"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Not [Functional Concept]
   861   C2003902:Always [Temporal Concept]

Phrase: "been"

Phrase: "used to an advantage"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "(59"

Phrase: ")"

Phrase: ","

Phrase: "recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "(60,"

Phrase: "64"

Phrase: ")"

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that early insulin treatment in type 2 diabetes indeed"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   742   C0039798:treatment [Functional Concept]
   742   C0087111:Treatment [Therapeutic or Preventive Procedure]
   742   C1522326:Treatment [Functional Concept]
   742   C1533734:Treatment [Therapeutic or Preventive Procedure]
   742   C1705169:Treatment [Conceptual Entity]
   742   C3538994:TREATMENT [Research Activity]

Phrase: "preserved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033085:Preserved [Laboratory Procedure]

Phrase: "endogenous insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.252: Additional intervention with GDIS inhibitors could improve the "-cell rest" approach to treatment.  

Phrase: "Additional intervention with GDIS inhibitors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0886296:intervention [Health Care Activity]
   744   C1273869:Intervention [Health Care Activity]
   744   C1948041:Intervention [Therapeutic or Preventive Procedure]

Phrase: "could"

Phrase: "improve"

Phrase: "the ""-cell rest"" approach to treatment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449445:Approach [Spatial Concept]
Processing 00000000.tx.253: CONCLUSIONS TOP ABSTRACT GDIS and adenine nucleotide... 

Phrase: "CONCLUSIONS TOP ABSTRACT GDIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   829   C1719133:Glucose/Insulin [Quantitative Concept]
   818   C1256369:insulin secretion [Cell Function]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0036536:secretion [Biologic Function]
   795   C0036537:Secretion [Body Substance]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "adenine nucleotide..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.254: Dependence of ROS production... 

Phrase: "Dependence of ROS production..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011546:Dependence [Mental Process]
   753   C0439857:Dependence [Mental or Behavioral Dysfunction]
   753   C2698668:DEPENDENCE [Regulation or Law]
Processing 00000000.tx.255: Manifestations of oxidative... 

Phrase: "Manifestations of oxidative..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   866   C1280464:Manifestation of [Qualitative Concept]
           manifestations
   790   C0205319:manifestations [Functional Concept]
Processing 00000000.tx.256: Dual role of the... 

Phrase: "Dual role of the..."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.257: Dual role of -cell... 

Phrase: "Dual role of -cell..."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.258: Intracellular inhibition of ROS... 

Phrase: "Intracellular inhibition of ROS..."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0034750:Reactive Inhibition [Individual Behavior]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
Processing 00000000.tx.259: Preservation of -cell... 

Phrase: "Preservation of -cell..."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.260: CONCLUSIONS REFERENCES  We have compared metabolic pathways of GDIS and ROS production and suggest that secretagogues causing increased insulin secretion by the activation of initial steps of the GDIS mechanism can also lead to increased ROS production. 

Phrase: "CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusions [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "have"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "metabolic pathways of GDIS"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C1291081:Metabolic Pathways [Functional Concept]
   774   C1159342:Secretion Pathways [Cell Function]
   757   C2984427:Insulin Pathway [Functional Concept]
   748   C0311400:Metabolic [Functional Concept]
   748   C1524026:Metabolic [Cell Function]
   748   C1704259:Pathways [Molecular Function]
   748   C1705987:Pathways [Conceptual Entity]
   748   C2707259:Metabolic [Clinical Attribute]

Phrase: "and"

Phrase: "ROS production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033268:production [Occupational Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that secretagogues"

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "increased insulin secretion by the activation of initial steps"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   807   C2245392:activation of insulin secretion [Cell Function]
   790   C1372360:Increased Insulin Secretion [Organ or Tissue Function]
   784   C2259154:activation of secretion [Cell Function]
   764   C0020459:increased insulin [Disease or Syndrome]
   764   C1256369:insulin secretion [Cell Function]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]

Phrase: "of the GDIS mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0441712:Mechanism [Functional Concept]
   804   C1706376:Mechanism [Manufactured Object]

Phrase: "can"

Phrase: "also"

Phrase: "lead to increased ROS production."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   774   C0861064:increased lead [Finding]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0033268:production [Occupational Activity]
   748   C0205217:Increased [Quantitative Concept]
   748   C0205332:Reactive [Qualitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C1705920:Species [Conceptual Entity]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.261: This should lead to activation of oxidative stress concomitant with stimulation of the GDIS mechanism. 

Phrase: "This"

Phrase: "should"

Phrase: "lead to activation of oxidative stress"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0038435:Stress [Finding]
   753   C0311404:Oxidative [Functional Concept]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C1879547:Activation [Activity]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "concomitant with stimulation of the GDIS mechanism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0521115:Concomitant [Temporal Concept]
Processing 00000000.tx.262: By this reasoning, the main function of a -cell, i.e., regulated insulin secretion, can be connected with the seeds of its own destruction. 

Phrase: "By this reasoning,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0684328:Reasoning [Mental Process]
  1000   C3244293:reasoning [Intellectual Product]
   966 E C0392360:Reason [Idea or Concept]

Phrase: "the main function of a -cell,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0007613:Cell Function [Cell Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "i.e.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "regulated insulin secretion,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "can"

Phrase: "be"

Phrase: "connected with the seeds of its own destruction."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0036563:Seed [Plant]
   744   C1261381:Destruction [Therapeutic or Preventive Procedure]
   744   C1705192:Seed [Laboratory Procedure]
   744   C1882540:{Seed} [Quantitative Concept]
   744   C1948029:Destruction [Activity]
   744   C2346495:Seed [Conceptual Entity]
   711   C2986575:Connect [Activity]
Processing 00000000.tx.263: This paradoxical feature of pancreatic -cells suggests some specific therapeutic strategies, such as reexamination of the "-cell rest" concept in type 2 diabetes.  

Phrase: "This paradoxical feature of pancreatic -cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1562749:Cell feature [Organism Attribute]
   753   C1521970:Feature [Qualitative Concept]
   753   C1706388:Feature [Conceptual Entity]
   753   C2346469:Feature [Qualitative Concept]
   753   C2348519:Feature [Qualitative Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "some specific therapeutic strategies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0679199:strategies [Mental Process]

Phrase: "such as reexamination"

Phrase: "of the ""-cell rest"" concept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0178566:concept [Idea or Concept]

Phrase: "in type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.264: ACKNOWLEDGMENTS  This work was partially supported by National Institutes of Health Grants DK 44840, DK20595, and DK48494. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "partially"

Phrase: "supported by National Institutes of Health Grants DK 44840,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   818   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   742   C0011318:DK [Geographic Area]
   742   C0018173:Grants [Quantitative Concept]
   742   C0018684:Health [Idea or Concept]
   742   C0021622:Institutes [Organization]
   742   C1521721:Supported [Conceptual Entity]
   742   C3245503:national [Intellectual Product]
   708 E C0183683:Support [Medical Device]
   708 E C1272753:Institute [Idea or Concept]
   708 E C1548284:Grant [Idea or Concept]

Phrase: "DK20595,"

Phrase: "and"

Phrase: "DK48494."
Processing 00000000.tx.265: We thank N. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.266: Tamarina and D. 

Phrase: "Tamarina"

Phrase: "and"

Phrase: "D."
Processing 00000000.tx.267: Jacobson for helpful discussions.  

Phrase: "Jacobson for helpful discussions."
Processing 00000000.tx.268: FOOTNOTES  , membrane potential; 

Phrase: "FOOTNOTES  ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "membrane potential"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0025251:Membrane Potential [Cell Function]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   861   C3245505:Potential [Qualitative Concept]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.269: ETC, electron transport chain; 

Phrase: "ETC,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2244392:electron transport chain [Molecular Function]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   734   C0013846:Electron Transport [Molecular Function]

Phrase: "electron transport chain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2244392:electron transport chain [Molecular Function]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   734   C0013846:Electron Transport [Molecular Function]

Phrase: ";"
Processing 00000000.tx.270: GDIS, glucose-dependent insulin secretion; 

Phrase: "GDIS,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "glucose-dependent insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.271: KATP channel, ATP-sensitive K+ channel; 

Phrase: "KATP channel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439799:Channel [Spatial Concept]
   861   C1706095:Channel [Conceptual Entity]

Phrase: "ATP-sensitive K+ channel"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0332324:Sensitive [Functional Concept]
   812   C0439799:Channel [Spatial Concept]
   812   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1550474:sensitive [Idea or Concept]
   812   C1706095:Channel [Conceptual Entity]
   812   C1708601:K' [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.272: NF, nuclear factor; 

Phrase: "NF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0521447:Nuclear [Spatial Concept]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "nuclear factor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0521447:Nuclear [Spatial Concept]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.273: ROS, reactive oxygen species; 

Phrase: "ROS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "reactive oxygen species"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.274: UCP, uncoupling protein. 

Phrase: "UCP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "uncoupling protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.275: Address correspondence and reprint requests to Louis H. 

Phrase: "Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Louis H."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C0686900:request [Functional Concept]
   770   C1272683:Request [Functional Concept]
   770   C1522634:Request [Intellectual Product]
Processing 00000000.tx.276: Philipson, Department of Medicine, MC 1027, University of Chicago, 5841 S. 

Phrase: "Philipson,"

Phrase: "Department of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "MC 1027,"

Phrase: "University of Chicago,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0008044:Chicago [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "5841 S."
Processing 00000000.tx.277: Maryland Ave., Chicago, IL 60637. 

Phrase: "Maryland Ave.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "IL 60637."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]
Processing 00000000.tx.278: E-mail: l-philipson{at}uchicago.edu Received for publication October 16, 2003 and accepted in revised form March 15, 2004  REFERENCES TOP ABSTRACT GDIS and adenine nucleotide... 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "l-philipson{at}uchicago.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "Received for publication October 16,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2003"

Phrase: "and"

Phrase: "accepted in revised form March 15,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1272684:Accepted [Qualitative Concept]
   753   C1522492:Form [Functional Concept]
   753   C1527075:Revised [Therapeutic or Preventive Procedure]
   753   C1548435:Accepted [Idea or Concept]
   719 E C1548601:Accept [Idea or Concept]

Phrase: "2004"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT GDIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   839   C1719133:Glucose/Insulin [Quantitative Concept]
   827   C1256369:insulin secretion [Cell Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "adenine nucleotide..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.279: Dependence of ROS production... 

Phrase: "Dependence of ROS production..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011546:Dependence [Mental Process]
   753   C0439857:Dependence [Mental or Behavioral Dysfunction]
   753   C2698668:DEPENDENCE [Regulation or Law]
Processing 00000000.tx.280: Manifestations of oxidative... 

Phrase: "Manifestations of oxidative..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   866   C1280464:Manifestation of [Qualitative Concept]
           manifestations
   790   C0205319:manifestations [Functional Concept]
Processing 00000000.tx.281: Dual role of the... 

Phrase: "Dual role of the..."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.282: Dual role of -cell... 

Phrase: "Dual role of -cell..."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.283: Intracellular inhibition of ROS... 

Phrase: "Intracellular inhibition of ROS..."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0034750:Reactive Inhibition [Individual Behavior]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
Processing 00000000.tx.284: Preservation of -cell... 

Phrase: "Preservation of -cell..."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.285: CONCLUSIONS REFERENCES  Hotta M, Yamato E, Miyazaki JI: Oxidative stress and pancreatic -cell destruction in insulin-dependent diabetes mellitus. 

Phrase: "CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusions [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Hotta M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Yamato E,"

Phrase: "Miyazaki JI"

Phrase: ":"

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "pancreatic -cell destruction in insulin-dependent diabetes mellitus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1261381:Destruction [Therapeutic or Preventive Procedure]
   744   C1948029:Destruction [Activity]
Processing 00000000.tx.286: In Antioxidants and Diabetes Management. 

Phrase: "In Antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "and"

Phrase: "Diabetes Management."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0001554:Management [Occupational Activity]
   861   C0376636:management [Health Care Activity]
   861   C1273870:Management [Occupational Activity]
   861   C3273539:Management [Occupation or Discipline]
Processing 00000000.tx.287: Packer L, Rosen P, Tritschler H, King GL, Azzi A, Eds. 

Phrase: "Packer L,"

Phrase: "Rosen P,"

Phrase: "Tritschler H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "King"

Phrase: "GL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018229:GL [Geographic Area]
  1000   C1423073:GL [Gene or Genome]
  1000   C1427674:GL [Gene or Genome]

Phrase: "Azzi A,"

Phrase: "Eds."
Processing 00000000.tx.288: New York, Marcel Dekker,2000 , p.265 274 Evans JL, Goldfine ID, Maddux BA, Grodsky GM: Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. 

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "Marcel Dekker,"

Phrase: "2000 ,"

Phrase: "p.265 274 Evans JL,"

Phrase: "Goldfine ID,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: "Maddux BA,"

Phrase: "Grodsky GM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: ":"

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "stress-activated signaling pathways"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C0037080:Signal Pathways [Molecular Function]
   844   C0037083:signaling pathway [Cell Function]
   844   C0086982:Signaling Pathway [Molecular Function]
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]

Phrase: ":"

Phrase: "a unifying hypothesis of type 2 diabetes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1512571:Hypothesis [Idea or Concept]
Processing 00000000.tx.289: Endocr Rev23 :599 622,2002[Abstract/Free FullText] Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H: Glucose toxicity in -cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. 

Phrase: "Endocr Rev23"

Phrase: ":"

Phrase: "599 622,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Robertson RP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1538326:RP [Gene or Genome]
   861   C3541325:RP [Idea or Concept]

Phrase: "Harmon J,"

Phrase: "Tran PO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442027:PO [Spatial Concept]

Phrase: "Tanaka Y,"

Phrase: "Takahashi H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Glucose toxicity in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "good radicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0302912:radicals [Chemical Viewed Structurally]
   827 E C0439807:Radical [Qualitative Concept]

Phrase: "gone"

Phrase: "bad,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Bad [Qualitative Concept]

Phrase: "and"

Phrase: "the glutathione connection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449379:Connection [Intellectual Product]
Processing 00000000.tx.290: Diabetes52 :581 587,2003[Abstract/Free FullText] Donath MY, Storling J, Maedler K, Mandrup-Poulsen T: Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. 

Phrase: "Diabetes52"

Phrase: ":"

Phrase: "581 587,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Donath"

Phrase: "MY,"

Phrase: "Storling J,"

Phrase: "Maedler K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Mandrup-Poulsen T"

Phrase: ":"

Phrase: "Inflammatory mediators"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   861   C0333348:Inflammatory [Functional Concept]
   827 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "islet beta-cell failure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0231174:Failure [Functional Concept]
   812   C0680095:failure [Individual Behavior]
   708   C0022131:Islet cell [Body Part, Organ, or Organ Component]
   708   C1522529:Islet Cell [Cell]

Phrase: ":"

Phrase: "a link between type 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1517892:Link [Intellectual Product]
   760   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.291: J Mol Med81 :455 470,2003[Medline] Mandrup-Poulsen T: Apoptotic signal transduction pathways in diabetes. 

Phrase: "J Mol Med81"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2346604:J/mol [Quantitative Concept]

Phrase: ":"

Phrase: "455 470,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mandrup-Poulsen T"

Phrase: ":"

Phrase: "Apoptotic signal transduction pathways in diabetes."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0086982:Signal Transduction Pathways [Molecular Function]
   790   C0037083:Signal Transduction [Cell Function]
   783   C0037080:Signal Pathways [Molecular Function]
   753   C1160185:transduction [Organism Function]
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]
   753   C1710082:Signal [Phenomenon or Process]
   731   C0162638:Apoptosis Pathway [Cell Function]
Processing 00000000.tx.292: Biochem Pharmacol66 :1433 1440,2003[Medline] Lortz S, Tiedge M: Sequential inactivation of reactive oxygen species by combined overexpression of SOD isoforms and catalase in insulin-producing cells. 

Phrase: "Biochem Pharmacol66"

Phrase: ":"

Phrase: "1433 1440,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lortz S,"

Phrase: "Tiedge M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Sequential inactivation of reactive oxygen species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "by combined overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514559:Overexpression [Genetic Function]

Phrase: "of SOD isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "catalase in insulin-producing cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1413138:CATALASE [Gene or Genome]
Processing 00000000.tx.293: Free Radic Biol Med34 :683 688,2003[Medline] Deeney JT, Prentki M, Corkey BE: Metabolic control of beta-cell function. 

Phrase: "Free Radic Biol Med34"

Phrase: ":"

Phrase: "683 688,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Deeney JT,"

Phrase: "Prentki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Corkey"

Phrase: "BE"

Phrase: ":"

Phrase: "Metabolic control of beta-cell function."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C1513158:Metabolic Control [Molecular Function]
   783   C2587213:Control function [Functional Concept]
           Control
   753   C0243148:control [Qualitative Concept]
   753   C0311400:Metabolic [Functional Concept]
   753   C1524026:Metabolic [Cell Function]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2707259:Metabolic [Clinical Attribute]
   753   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.294: Semin Cell Dev Biol11 :267 275,2000[Medline] Matschinsky FM: Regulation of pancreatic -cell glucokinase: from basics to therapeutics. 

Phrase: "Semin Cell Dev Biol11"

Phrase: ":"

Phrase: "267 275,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Matschinsky FM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: ":"

Phrase: "Regulation of pancreatic -cell glucokinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: ":"

Phrase: "from basics"

Phrase: "to therapeutics."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039796:Therapeutics [Therapeutic or Preventive Procedure]
  1000   C0723712:therapeutics [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.295: Diabetes51 (Suppl. 3) :S394 S404,2002[Medline] Rutter GA: Nutrient-secretion coupling in the pancreatic islet beta-cell: recent advances. 

Phrase: "Diabetes51"

Phrase: "(Suppl. 3"

Phrase: ")"

Phrase: ":"

Phrase: "S394 S404,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rutter GA"

Phrase: ":"

Phrase: "Nutrient-secretion coupling in the pancreatic islet beta-cell"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1948027:Coupling [Functional Concept]

Phrase: ":"

Phrase: "recent advances."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0725066:Advance [Medical Device]
Processing 00000000.tx.296: Mol Aspects Med22 :247 284,2001[Medline] Fridlyand LE, Tamarina N, Philipson LH: Modeling of Ca2+ flux in pancreatic beta-cells: role of the plasma membrane and intracellular stores. 

Phrase: "Mol Aspects Med22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1420530:MED22 [Gene or Genome]

Phrase: ":"

Phrase: "247 284,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fridlyand LE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439090:LE [Idea or Concept]
   861   C1423767:LE [Gene or Genome]

Phrase: "Tamarina N,"

Phrase: "Philipson LH"

Phrase: ":"

Phrase: "Modeling of Ca2+ flux"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0870071:Modeling [Intellectual Product,Research Activity]
   770   C2348693:Flux [Natural Phenomenon or Process]
   737 E C3161035:Model [Intellectual Product]

Phrase: "in pancreatic beta-cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   827   C0007634:Cells [Cell]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "role of the plasma membrane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "intracellular stores."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1698986:Store [Functional Concept]
Processing 00000000.tx.297: Am J Physiol Endocrinol Metab285 :E138 E154,2003[Abstract/Free FullText] Erecinska M, Bryla J, Michalik M, Meglasson MD, Nelson D: Energy metabolism in islets of Langerhans. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab285"

Phrase: ":"

Phrase: "E138 E154,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Erecinska M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bryla J,"

Phrase: "Michalik M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Meglasson MD,"

Phrase: "Nelson D"

Phrase: ":"

Phrase: "Energy metabolism in islets of Langerhans."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0014272:Energy Metabolism [Physiologic Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]
   753   C0424589:Energy [Finding]
   753   C0542479:Energy [Natural Phenomenon or Process]
   753   C1442080:Energy [Quantitative Concept]
Processing 00000000.tx.298: Biochim Biophys Acta1101 :273 295,1992[Medline] Ronner P, Naumann CM, Friel E: Effects of glucose and amino acids on free ADP in HC9 insulin-secreting cells. 

Phrase: "Biochim Biophys Acta1101"

Phrase: ":"

Phrase: "273 295,"

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ronner P,"

Phrase: "Naumann CM,"

Phrase: "Friel E"

Phrase: ":"

Phrase: "Effects of glucose"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   841   C1158774:glucose effect [Genetic Function]
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "amino acids on free ADP"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   773 E C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acids [Chemical]
   726 E C0202406:Acid [Laboratory Procedure]

Phrase: "in HC9 insulin-secreting cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   923   C0030281:Insulin-Secreting Cells [Cell]
           Insulin Cell
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.299: Diabetes50 :291 300,2001[Abstract/Free FullText] Tsuboi T, da Silva Xavier G, Holz, Jouaville LS, Thomas AP, Rutter GA: Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells. 

Phrase: "Diabetes50"

Phrase: ":"

Phrase: "291 300,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tsuboi T,"

Phrase: "da Silva Xavier G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "Holz,"

Phrase: "Jouaville LS,"

Phrase: "Thomas AP,"

Phrase: "Rutter GA"

Phrase: ":"

Phrase: "Glucagon-like peptide-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0061355:Glucagon-Like Peptide 1 [Amino Acid, Peptide, or Protein]
  1000   C1333664:glucagon-like peptide 1 [Gene or Genome]
   923   C0014361:glucagon like peptide [Amino Acid, Peptide, or Protein,Hormone]
   812   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "mobilizes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185112:mobilize [Therapeutic or Preventive Procedure]
  1000   C0578718:Mobilizes [Finding]

Phrase: "intracellular Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "stimulates"

Phrase: "mitochondrial ATP synthesis in pancreatic MIN6 beta-cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1157223:ATP synthesis [Molecular Function]
   770   C1510700:ATP Synthesis [Functional Concept]
   744   C0220781:synthesis [Biologic Function]
   744   C1883254:Synthesis [Activity]
   731   C2936320:Synthetic Cells [Manufactured Object]
Processing 00000000.tx.300: Biochem J369 :287 299,2003[Medline] Veech LR, Lawson JWR, Cornell NW, Krebs HA: Cytosolic phosphorylation potential. 

Phrase: "Biochem J369"

Phrase: ":"

Phrase: "287 299,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Veech LR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023617:LR [Geographic Area]
   861   C2986899:LR [Idea or Concept]

Phrase: "Lawson JWR,"

Phrase: "Cornell NW,"

Phrase: "Krebs HA"

Phrase: ":"

Phrase: "Cytosolic phosphorylation potential."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   827   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.301: J Biol Chem254 :6538 6547,1979[Abstract] Ghosh A, Ronner P, Cheong E, Khalid P, Matschinsky FM: The role of ATP and free ADP in metabolic coupling during fuel-stimulated insulin release from islet beta-cells in the isolated perfused rat pancreas. 

Phrase: "J Biol Chem254"

Phrase: ":"

Phrase: "6538 6547,"

Phrase: "1979"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ghosh A,"

Phrase: "Ronner P,"

Phrase: "Cheong E,"

Phrase: "Khalid P,"

Phrase: "Matschinsky FM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: ":"

Phrase: "The role of ATP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "free ADP in metabolic coupling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0523452:ADP [Laboratory Procedure]

Phrase: "during fuel-stimulated insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1963578:Release [Therapeutic or Preventive Procedure]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "from islet beta-cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   913   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   896 E C1522529:Islet Cell [Cell]
   867   C0030281:Beta cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "in the isolated perfused rat pancreas."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1882810:Rat Pancreas [Body Part, Organ, or Organ Component]
   812   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   812   C1278931:Pancreas [Body Part, Organ, or Organ Component]
Processing 00000000.tx.302: J Biol Chem266 :22887 22892,1991[Abstract/Free FullText] Kakei M, Kelly RP, Ashcroft SJ, Ashcroft FM: The ATP-sensitivity of K+ channels in rat pancreatic beta-cells is modulated by ADP. 

Phrase: "J Biol Chem266"

Phrase: ":"

Phrase: "22887 22892,"

Phrase: "1991"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kakei M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kelly RP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1538326:RP [Gene or Genome]
   861   C3541325:RP [Idea or Concept]

Phrase: "Ashcroft SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Ashcroft FM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: ":"

Phrase: "The ATP-sensitivity of K+ channels"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C1547341:Channel sensitivity [Idea or Concept]
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]

Phrase: "in rat pancreatic beta-cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   923   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   812   C0007634:Cells [Cell]
   812   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C2004068:Beta [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "modulated by ADP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0443264:Modulated [Spatial Concept]
   790   C0523452:ADP [Laboratory Procedure]
Processing 00000000.tx.303: FEBS Lett208 :63 66,1986[Medline] Hopkins WF, Fatherazi S, Peter-Riesch B, Corkey BE, Cook DL: Two sites for adenine-nucleotide regulation of ATP-sensitive potassium channels in mouse pancreatic beta-cells and HIT cells. 

Phrase: "FEBS Lett208"

Phrase: ":"

Phrase: "63 66,"

Phrase: "1986"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hopkins WF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043021:WF [Geographic Area]

Phrase: "Fatherazi S,"

Phrase: "Peter-Riesch B,"

Phrase: "Corkey"

Phrase: "BE"

Phrase: ","

Phrase: "Cook DL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: ":"

Phrase: "Two sites for adenine-nucleotide regulation of ATP-sensitive potassium channels"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   738   C0205145:Sites [Spatial Concept]
   737   C2945843:Site of [Qualitative Concept]
   704 E C1515974:Site [Body Location or Region]
   704 E C2825164:Site [Spatial Concept]

Phrase: "in mouse pancreatic beta-cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   923   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   906   C1522214:Mouse Beta Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C2004068:Beta [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "HIT cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.304: J Membr Biol129 :287 295,1992[Medline] Bindokas VP, Kuznetsov A, Sreenan S, Polonsky KS, Roe MW, Philipson LH: Visualizing superoxide production in normal and diabetic rat islets of Langerhans. 

Phrase: "J Membr Biol129"

Phrase: ":"

Phrase: "287 295,"

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bindokas VP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883540:{VP} [Quantitative Concept]

Phrase: "Kuznetsov A,"

Phrase: "Sreenan S,"

Phrase: "Polonsky KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Roe MW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]

Phrase: "Philipson LH"

Phrase: ":"

Phrase: "Visualizing superoxide production in normal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "diabetic rat islets of Langerhans."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   862   C0022131:Islets of Langerhans [Body Part, Organ, or Organ Component]
           Langerhans Islets
Processing 00000000.tx.305: J Biol Chem278 :9796 9801,2003[Abstract/Free FullText] Sakai K, Matsumotot K, Nishikawa T, Suefuji M, Nakamura K, Hirashmia Y, Kawashima J, Shirotani T, Ichinose K, Brownlee M, Araki E: Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic beta-cells. 

Phrase: "J Biol Chem278"

Phrase: ":"

Phrase: "9796 9801,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sakai K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Matsumotot K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Nishikawa T,"

Phrase: "Suefuji M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Nakamura K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hirashmia Y,"

Phrase: "Kawashima J,"

Phrase: "Shirotani T,"

Phrase: "Ichinose K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Brownlee M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Araki E"

Phrase: ":"

Phrase: "Mitochondrial reactive oxygen species"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0205332:Reactive [Qualitative Concept]
   812   C1705920:Species [Conceptual Entity]

Phrase: "reduce"

Phrase: "insulin secretion by pancreatic beta-cells."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   809   C1327616:secretion by cell [Cell Function]
           Cell secretion
   790   C1256369:insulin secretion [Cell Function]
   783   C0030296:Pancreatic Secretion [Body Substance]
   783   C0232787:Pancreatic secretion [Organ or Tissue Function]
   767   C0030281:Insulin Cell [Cell]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.306: Biochem Biophys Res Commun300 :216 222,2003[Medline] Skulachev VP: Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductants. 

Phrase: "Biochem Biophys Res Commun300"

Phrase: ":"

Phrase: "216 222,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Skulachev VP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883540:{VP} [Quantitative Concept]

Phrase: ":"

Phrase: "Role of uncoupled"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "non-coupled oxidations in maintenance of safely low levels of oxygen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0030011:oxidations [Molecular Function]

Phrase: "and"

Phrase: "its one-electron reductants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0376446:Reductants [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.307: Q Rev Biophys29 :169 202,1996[Medline] Kadenbach B: Intrinsic and extrinsic uncoupling of oxidative phosphorylation. 

Phrase: "Q Rev Biophys29"

Phrase: ":"

Phrase: "169 202,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kadenbach B"

Phrase: ":"

Phrase: "Intrinsic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205102:Intrinsic [Spatial Concept]
  1000   C0439674:Intrinsic [Functional Concept]

Phrase: "and"

Phrase: "extrinsic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205101:Extrinsic [Spatial Concept]
  1000   C0595947:Extrinsic [Functional Concept]

Phrase: "uncoupling of oxidative phosphorylation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0030013:Oxidative Phosphorylation [Molecular Function]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0311404:Oxidative [Functional Concept]
   770   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.308: Biochim Biophys Acta1604 :77 94,2003[Medline] Turrens JF: Mitochondrial formation of reactive oxygen species. 

Phrase: "Biochim Biophys Acta1604"

Phrase: ":"

Phrase: "77 94,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Turrens JF"

Phrase: ":"

Phrase: "Mitochondrial formation of reactive oxygen species."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]
Processing 00000000.tx.309: J Physiol552 :335 344,2003[Abstract/Free FullText] Patterson GH, Knobel SM, Arkhammar P, Thastrup O, Piston DW: Separation of the glucose-stimulated cytoplasmic and mitochondrial NAD(P)H responses in pancreatic islet beta cells. 

Phrase: "J Physiol552"

Phrase: ":"

Phrase: "335 344,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Patterson GH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033993:GH [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539616:GH [Gene or Genome]

Phrase: "Knobel SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Arkhammar P,"

Phrase: "Thastrup O,"

Phrase: "Piston DW"

Phrase: ":"

Phrase: "Separation of the glucose-stimulated cytoplasmic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0036679:Separation [Pathologic Function]
   753   C0237868:Separation [Social Behavior]
   753   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "and"

Phrase: "mitochondrial NAD(P)H responses in pancreatic islet beta cells."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   739   C0871261:responses [Organism Attribute]
   706 E C1704632:Response [Finding]
   706 E C1706817:Response [Intellectual Product]
   706 E C2911692:Response [Mental Process]
Processing 00000000.tx.310: Proc Natl Acad Sci U S A97 :5203 5207,2000[Abstract/Free FullText] Liu SS: Generating, partitioning, targeting and functioning of superoxide in mitochondria. 

Phrase: "Proc Natl Acad Sci U S A97"

Phrase: ":"

Phrase: "5203 5207,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Liu SS"

Phrase: ":"

Phrase: "Generating,"

Phrase: "partitioning"

Phrase: ","

Phrase: "targeting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeting [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "and"

Phrase: "functioning of superoxide"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0542341:functioning [Functional Concept]
   756 E C0031843:function [Physiologic Function]
   756 E C0700205:FUNCTION [Classification]
   756 E C1705273:Function [Intellectual Product]

Phrase: "in mitochondria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]
Processing 00000000.tx.311: Biosci Rep17 :259 272,1997[Medline] Korshunov SS, Skulachev VP, Starkov AA: High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. 

Phrase: "Biosci Rep17"

Phrase: ":"

Phrase: "259 272,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Korshunov SS,"

Phrase: "Skulachev VP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883540:{VP} [Quantitative Concept]

Phrase: "Starkov AA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: ":"

Phrase: "High protonic potential"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3245505:Potential [Qualitative Concept]

Phrase: "actuates"

Phrase: "a mechanism of production of reactive oxygen species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "in mitochondria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]
Processing 00000000.tx.312: FEBS Lett416 :15 18,1997[Medline] Starkov AA, Polster BM, Fiskum G: Regulation of hydrogen peroxide production by brain mitochondria by calcium and Bax. 

Phrase: "FEBS Lett416"

Phrase: ":"

Phrase: "15 18,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Starkov AA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "Polster BM,"

Phrase: "Fiskum G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "Regulation of hydrogen peroxide production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "by brain mitochondria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0026237:Mitochondria [Cell Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "by calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0006726:Calcium [Inorganic Chemical]
  1000   C2936886:Calcium [Pharmacologic Substance]

Phrase: "and"

Phrase: "Bax."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]
Processing 00000000.tx.313: J Neurochem83 :220 228,2002[Medline] Demin OV, Westerhoff HV, Kholodenko BN: Mathematical modelling of superoxide generation with the bc1 complex of mitochondria. 

Phrase: "J Neurochem83"

Phrase: ":"

Phrase: "220 228,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Demin OV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0445574:ov [Intellectual Product]

Phrase: "Westerhoff HV,"

Phrase: "Kholodenko BN"

Phrase: ":"

Phrase: "Mathematical modelling of superoxide generation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0876936:mathematical modeling [Intellectual Product]
   760   C0870071:Modeling [Intellectual Product,Research Activity]

Phrase: "with the bc1 complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "of mitochondria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]
Processing 00000000.tx.314: Biochemistry (Mosc)63 :755 772,1998 Nioka S, Argov Z, Dobson GP, Forster RE, Subramanian HV, Veech RL, Chance B: Substrate regulation of mitochondrial oxidative phosphorylation in hypercapnic rabbit muscle. 

Phrase: "Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "(Mosc"

Phrase: ")"

Phrase: "63"

Phrase: ":"

Phrase: "755 772,"

Phrase: "1998 Nioka S,"

Phrase: "Argov Z,"

Phrase: "Dobson GP,"

Phrase: "Forster RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Subramanian HV,"

Phrase: "Veech RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Chance B"

Phrase: ":"

Phrase: "Substrate regulation of mitochondrial oxidative phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C1817350:regulation of oxidative phosphorylation [Molecular Function]
   820   C1158897:regulation of phosphorylation [Cell Function]
   783   C1518760:Oxidative Regulation [Molecular Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "in hypercapnic rabbit muscle."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026845:Muscle [Tissue]
   755 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.315: J Appl Physiol72 :521 528,1992[Abstract/Free FullText] Jeneson JA, Wiseman RW, Westerhoff HV, Kushmerick MJ: The signal transduction function for oxidative phosphorylation is at least second order in ADP. 

Phrase: "J Appl Physiol72"

Phrase: ":"

Phrase: "521 528,"

Phrase: "1992"

Phrase: "[Abstract/Free FullText"

Phrase: "] Jeneson JA,"

Phrase: "Wiseman RW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035978:RW [Geographic Area]
   861   C2700310:RW [Fish]

Phrase: "Westerhoff HV,"

Phrase: "Kushmerick MJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: ":"

Phrase: "The signal transduction function for oxidative phosphorylation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0030013:Oxidative phosphorylation, function [Molecular Function]
   804   C0037083:Signal transduction, function [Cell Function]
   774   C0031715:Phosphorylation, function [Molecular Function]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "is at least second order"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0205436:Second [Quantitative Concept]
   760   C0457385:Second [Temporal Concept]
   760   C0565930:/second [Quantitative Concept]
   760   C1561503:second [Idea or Concept]
   760   C1705175:Order [Intellectual Product]
   760   C1705176:Order [Qualitative Concept]
   760   C1705177:Order [Classification]
   760   C1705178:Order [Activity]
   760   C1705190:Second [Qualitative Concept]
   760   C1882348:Order [Qualitative Concept]

Phrase: "in ADP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]
Processing 00000000.tx.316: J Biol Chem271 :27995 27998,1996[Abstract/Free FullText] Mader A: Glycolysis and oxidative phosphorylation as a function of cytosolic phosphorylation state and power output of the muscle cell. 

Phrase: "J Biol Chem271"

Phrase: ":"

Phrase: "27995 27998,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mader A"

Phrase: ":"

Phrase: "Glycolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017952:Glycolysis [Molecular Function]

Phrase: "and"

Phrase: "oxidative phosphorylation as a function of cytosolic phosphorylation state"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   784   C0030013:Oxidative phosphorylation, function [Molecular Function]
           Oxidative Phosphorylation
   762   C0031715:Phosphorylation, function [Molecular Function]
           Phosphorylation
   742   C0311404:Oxidative [Functional Concept]
   742   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "power output of the muscle cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0445194:Power output [Natural Phenomenon or Process]
   783   C0427052:Muscle power [Finding]
   753   C0032863:Power [Human-caused Phenomenon or Process]
   753   C1709366:Output [Conceptual Entity]
Processing 00000000.tx.317: Eur J Appl Physiol88 :317 338,2003[Medline] Koshkin V, Wang X, Scherer PE, Chan CB, Wheeler MB: Mitochondrial functional state in clonal pancreatic beta-cells exposed to free fatty acids. 

Phrase: "Eur J Appl Physiol88"

Phrase: ":"

Phrase: "317 338,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Koshkin V,"

Phrase: "Wang X,"

Phrase: "Scherer PE,"

Phrase: "Chan CB,"

Phrase: "Wheeler MB"

Phrase: ":"

Phrase: "Mitochondrial functional state in clonal pancreatic beta-cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0205245:Functional [Functional Concept]
   744   C0542341:Functional [Functional Concept]
   744   C1301808:State [Geographic Area]
   744   C1442792:State [Functional Concept]
   744   C2700217:Functional [Conceptual Entity]
   744   C3148680:State [Geographic Area]

Phrase: "exposed to free fatty acids."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   862   C0015688:Free Fatty Acids [Lipid]
   828 E C2698488:Free Fatty Acid [Laboratory Procedure]
   806   C0015684:Fatty Acids [Lipid]
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0001128:Acids [Chemical]
   760   C0332296:free [Functional Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
   726 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.318: J Biol Chem278 :19709 19715,2003[Abstract/Free FullText] Tiedge M, Lortz S, Drinkgern J, Lenzen S: Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. 

Phrase: "J Biol Chem278"

Phrase: ":"

Phrase: "19709 19715,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tiedge M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lortz S,"

Phrase: "Drinkgern J,"

Phrase: "Lenzen S"

Phrase: ":"

Phrase: "Relation between antioxidant enzyme gene expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0080103:Relation [Family Group]
   753   C0869014:relation [Social Behavior]

Phrase: "and"

Phrase: "antioxidative defense status of insulin-producing cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449438:Status [Qualitative Concept]
Processing 00000000.tx.319: Diabetes46 :1733 1742,1997[Abstract] Fleury C, Mignotte B, Vayssiere JL: Mitochondrial reactive oxygen species in cell death signaling. 

Phrase: "Diabetes46"

Phrase: ":"

Phrase: "1733 1742,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Fleury C,"

Phrase: "Mignotte B,"

Phrase: "Vayssiere JL"

Phrase: ":"

Phrase: "Mitochondrial reactive oxygen species in cell death signaling."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   835   C1516341:Cell Death Signaling [Molecular Function]
   822   C0037083:Cell Signaling [Cell Function]
           Signaling
   793   C3537152:signaling [Biologic Function]
Processing 00000000.tx.320: Biochimie84 :131 141,2002[Medline] Evans JL, Goldfine ID, Maddux BA, Grodsky GM: Are oxidative stress-activated signaling pathways mediators of insulin resistance and -cell dysfunction? 

Phrase: "Biochimie84"

Phrase: ":"

Phrase: "131 141,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Evans JL,"

Phrase: "Goldfine ID,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: "Maddux BA,"

Phrase: "Grodsky GM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: ":"

Phrase: "Are"

Phrase: "oxidative stress-activated signaling pathways mediators of insulin resistance"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   708 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and -"

Phrase: "cell dysfunction?"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.321: Diabetes52 :1 8,2003[Abstract/Free FullText] Skulachev VP: Programmed death phenomena: from organelle to organism. 

Phrase: "Diabetes52"

Phrase: ":"

Phrase: "1 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Skulachev VP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883540:{VP} [Quantitative Concept]

Phrase: ":"

Phrase: "Programmed death phenomena"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1882365:Phenomena [Phenomenon or Process]

Phrase: ":"

Phrase: "from organelle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029219:Organelle [Cell Component]

Phrase: "to organism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029235:Organism [Organism]
Processing 00000000.tx.322: Ann N Y Acad Sci959 :214 237,2002[Abstract/Free FullText] Cardozo AK, Heimberg H, Heremans Y, Leeman R, Kutlu B, Kruhoffer M, Orntoft T, Eizirik DL: A comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat pancreatic beta-cells. 

Phrase: "Ann N Y Acad Sci959"

Phrase: ":"

Phrase: "214 237,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cardozo AK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]

Phrase: "Heimberg H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Heremans Y,"

Phrase: "Leeman R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kutlu B,"

Phrase: "Kruhoffer M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Orntoft T,"

Phrase: "Eizirik DL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: ":"

Phrase: "A comprehensive analysis of cytokine-induced"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "nuclear factor-kappa B-dependent genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0017337:Genes [Gene or Genome]
   734   C0079904:Nuclear Factor kappa B [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "in primary rat pancreatic beta-cells."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   884   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   804   C0007634:Cells [Cell]
   804   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   804   C0330390:Beta [Plant]
   804   C0439096:Beta [Intellectual Product]
   804   C2004068:Beta [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.323: J Biol Chem276 :48879 48886,2001[Abstract/Free FullText] Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. 

Phrase: "J Biol Chem276"

Phrase: ":"

Phrase: "48879 48886,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nishikawa T,"

Phrase: "Edelstein D,"

Phrase: "Du XL,"

Phrase: "Yamagishi S,"

Phrase: "Matsumura T,"

Phrase: "Kaneda Y,"

Phrase: "Yorek MA,"

Phrase: "Beebe D,"

Phrase: "Oates PJ,"

Phrase: "Hammes HP,"

Phrase: "Giardino I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Brownlee M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Normalizing mitochondrial superoxide production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033268:production [Occupational Activity]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "three pathways of hyperglycaemic damage."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704259:Pathways [Molecular Function]
   760   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.324: Nature404 :787 790,2000[Medline] Maestre I, Jordan J, Calvo S, Reig JA, Cena V, Soria B, Prentki M, Roche E: Mitochondrial dysfunction is involved in apoptosis induced by serum withdrawal and fatty acids in the beta-cell line INS-1. 

Phrase: "Nature404"

Phrase: ":"

Phrase: "787 790,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Maestre I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Jordan J,"

Phrase: "Calvo S,"

Phrase: "Reig JA,"

Phrase: "Cena V,"

Phrase: "Soria B,"

Phrase: "Prentki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Roche E"

Phrase: ":"

Phrase: "Mitochondrial dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "is"

Phrase: "involved in apoptosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0162638:Apoptosis [Cell Function]
   790   C1314939:Involved [Functional Concept]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "induced by serum withdrawal"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205263:Induced [Functional Concept]
   770   C0229671:Serum [Body Substance]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]
   770   C2349954:Withdrawal [Activity]
   770   C2825032:Withdrawal [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "fatty acids in the beta-cell line"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   778   C0015684:Fatty Acids [Lipid]
   748   C0001128:Acids [Chemical]
   714 E C0202406:Acid [Laboratory Procedure]

Phrase: "INS-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.325: Endocrinology144 :335 345,2003[Abstract/Free FullText] Nielsen K, Karlsen AE, Deckert M, Madsen OD, Serup P, Mandrup-Poulsen T, Nerup J: -Cell maturation leads to in vitro sensitivity to cytotoxins. 

Phrase: "Endocrinology144"

Phrase: ":"

Phrase: "335 345,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nielsen K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Karlsen AE,"

Phrase: "Deckert M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Madsen OD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0029421:OD [Disease or Syndrome]
   861   C0439164:OD [Quantitative Concept]
   861   C1512019:OD [Intellectual Product]

Phrase: "Serup P,"

Phrase: "Mandrup-Poulsen T,"

Phrase: "Nerup J"

Phrase: ": -"

Phrase: "Cell maturation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1516349:Cell Maturation [Cell Function]
   861   C0678723:Maturation [Organism Function]
   861   C0870861:maturation [Phenomenon or Process]
   861   C1254042:Maturation [Physiologic Function]

Phrase: "leads to in vitro sensitivity"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]
   762   C0332324:Sensitive to [Functional Concept]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0181586:leads [Medical Device]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522538:Lead [Functional Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C2349185:Sensitivity [Qualitative Concept]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to cytotoxins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010868:Cytotoxins [Biologically Active Substance,Hazardous or Poisonous Substance]
Processing 00000000.tx.326: Diabetes48 :2324 2332,1999[Abstract] Piro S, Anello M, Di Pietro C, Lizzio MN, Patane G, Rabuazzo AM, Vigneri R, Purrello M, Purrello F: Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. 

Phrase: "Diabetes48"

Phrase: ":"

Phrase: "2324 2332,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Piro S,"

Phrase: "Anello M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Di Pietro C,"

Phrase: "Lizzio MN,"

Phrase: "Patane G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Rabuazzo"

Phrase: "AM"

Phrase: ","

Phrase: "Vigneri R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Purrello M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Purrello F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: ":"

Phrase: "Chronic exposure to free fatty acids"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332157:Exposure to [Clinical Attribute]
           Exposure
   753   C0205191:chronic [Temporal Concept]
   753   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "or"

Phrase: "high glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:high glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis in rat pancreatic islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162638:Apoptosis [Cell Function]

Phrase: ":"

Phrase: "possible role of oxidative stress."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.327: Metabolism51 :1340 1347,2002[Medline] Rutter GA: Insulin secretion: fatty acid signalling via serpentine receptors. 

Phrase: "Metabolism51"

Phrase: ":"

Phrase: "1340 1347,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rutter GA"

Phrase: ":"

Phrase: "Insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "fatty acid signalling via serpentine receptors."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C3537152:signalling [Biologic Function]
   719 E C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.328: Curr Biol13 :R403 R405,2003[Medline] Carlsson C, Borg LA, Welsh N: Sodium palmitate induces partial mitochondrial uncoupling and reactive oxygen species in rat pancreatic islets in vitro. 

Phrase: "Curr Biol13"

Phrase: ":"

Phrase: "R403 R405,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Carlsson C,"

Phrase: "Borg LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Welsh N"

Phrase: ":"

Phrase: "Sodium palmitate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0142904:Sodium Palmitate [Biomedical or Dental Material,Lipid]
   861   C0030233:palmitate [Lipid]
   861   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "partial mitochondrial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "uncoupling"

Phrase: "and"

Phrase: "reactive oxygen species in rat pancreatic islets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0205332:Reactive [Qualitative Concept]
   748   C1705920:Species [Conceptual Entity]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.329: Endocrinology140 :3422 3428,1999[Abstract/Free FullText] Higa M, Zhou YT, Ravazzola M, Baetens D, Orci L, Unger RH: Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats. 

Phrase: "Endocrinology140"

Phrase: ":"

Phrase: "3422 3428,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Higa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Zhou YT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412122:YT [Gene or Genome]

Phrase: "Ravazzola M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Baetens D,"

Phrase: "Orci L,"

Phrase: "Unger RH"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: ":"

Phrase: "Troglitazone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0245514:troglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "mitochondrial alterations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0544926:Mitochondrial alteration [Cell or Molecular Dysfunction]
   827   C1515926:Alteration [Idea or Concept]

Phrase: "beta cell destruction,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1261381:Destruction [Therapeutic or Preventive Procedure]
   827   C1948029:Destruction [Activity]
   734   C0030281:Beta cell [Cell]

Phrase: "and"

Phrase: "diabetes in obese prediabetic rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.330: Proc Natl Acad Sci U S A96 :11513 11518,1999[Abstract/Free FullText] Saleh MC, Wheeler MB, Chan CB: Uncoupling protein-2: evidence for its function as a metabolic regulator. 

Phrase: "Proc Natl Acad Sci U S A96"

Phrase: ":"

Phrase: "11513 11518,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Saleh MC,"

Phrase: "Wheeler MB,"

Phrase: "Chan CB"

Phrase: ":"

Phrase: "Uncoupling protein-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "evidence for its function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "as a metabolic regulator."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0182953:REGULATOR [Medical Device]
   861   C1704734:Regulator [Medical Device]
   861   C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.331: Diabetologia45 :174 187,2002[Medline] Zhang CY, Baffy G, Perret P, Krauss S, Peroni O, Grujic D, Hagen T, Vidal-Puig AJ, Boss O, Kim YB, Zheng XX, Wheeler MB, Shulman GI, Chan CB, Lowell BB: Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. 

Phrase: "Diabetologia45"

Phrase: ":"

Phrase: "174 187,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zhang CY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010622:CY [Geographic Area]
   861   C0332298:CY [Functional Concept]

Phrase: "Baffy G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Perret P,"

Phrase: "Krauss S,"

Phrase: "Peroni O,"

Phrase: "Grujic D,"

Phrase: "Hagen T,"

Phrase: "Vidal-Puig AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0230613:AJ [Cell Component]

Phrase: "Boss O,"

Phrase: "Kim YB,"

Phrase: "Zheng XX,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450371:XX [Organism Attribute]

Phrase: "Wheeler MB,"

Phrase: "Shulman GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "Chan CB,"

Phrase: "Lowell BB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: ":"

Phrase: "Uncoupling protein-2 negatively"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "regulates"

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "is"

Phrase: "a major link between obesity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1517892:Link [Intellectual Product]
   760   C1704666:Link [Intellectual Product]

Phrase: "beta cell dysfunction,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1969875:Beta-cell dysfunction [Finding]
   827   C0031847:dysfunction [Functional Concept]
   827   C0277785:Dysfunction, NOS [Qualitative Concept]
   771 E C0231174:Malfunction [Functional Concept]
   771 E C1881681:MALFUNCTION [Phenomenon or Process]
   734   C0030281:Beta cell [Cell]

Phrase: "and"

Phrase: "type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.332: Cell105 :745 755,2001[Medline] Chan CB, De Leo D, Joseph JW, McQuaid TS, Ha XF, Xu F, Tsushima RG, Pennefather PS, Salapatek AM, Wheeler MB: Increased uncoupling protein-2 levels in -cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action. 

Phrase: "Cell105"

Phrase: ":"

Phrase: "745 755,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chan CB,"

Phrase: "De Leo D,"

Phrase: "Joseph JW,"

Phrase: "McQuaid TS,"

Phrase: "Ha XF,"

Phrase: "Xu F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Tsushima RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Pennefather PS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "Salapatek"

Phrase: "AM"

Phrase: ","

Phrase: "Wheeler MB"

Phrase: ":"

Phrase: "Increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "uncoupling protein-2 levels in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "associated with impaired glucose-stimulated insulin secretion"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1256369:insulin secretion [Cell Function]
   774   C1719133:Glucose/Insulin [Quantitative Concept]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0221099:Impaired [Functional Concept]
   748   C0684336:Impaired [Pathologic Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1948023:Stimulated [Natural Phenomenon or Process]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: ":"

Phrase: "mechanism of action."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031327:mechanism of action [Physiologic Function]
  1000   C1524059:mechanism of action [Functional Concept]
   790   C0441712:Mechanism [Functional Concept]
   790   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.333: Diabetes50 :1302 1310,2001[Abstract/Free FullText] Li LX, Skorpen F, Egeberg K, Jorgensen IH, Grill V: Uncoupling protein-2 participates in cellular defense against oxidative stress in clonal beta-cells. 

Phrase: "Diabetes50"

Phrase: ":"

Phrase: "1302 1310,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Li LX,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441916:LX [Finding]
   861   C0560137:lx [Quantitative Concept]

Phrase: "Skorpen F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Egeberg K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Jorgensen IH,"

Phrase: "Grill V"

Phrase: ":"

Phrase: "Uncoupling protein-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "participates in cellular defense"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007634:Cellular [Cell]
   770   C0178539:Cellular [Functional Concept]
   770   C1880266:Defense [Conceptual Entity]

Phrase: "against oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "in clonal beta-cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   877   C0009013:Clone Cells [Cell]
   867   C0030281:Beta cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.334: Biochem Biophys Res Commun282 :273 277,2001[Medline] Garlid KD, Paucek P: The mitochondrial potassium cycle. 

Phrase: "Biochem Biophys Res Commun282"

Phrase: ":"

Phrase: "273 277,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Garlid KD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026691:KD [Disease or Syndrome]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]

Phrase: "Paucek P"

Phrase: ":"

Phrase: "The mitochondrial potassium cycle."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]
Processing 00000000.tx.335: IUBMB Life52 :153 158,2001[Medline] Ferranti R, da Silva MM, Kowaltowski AJ: Mitochondrial ATP-sensitive K+ channel opening decreases reactive oxygen species generation. 

Phrase: "IUBMB Life52"

Phrase: ":"

Phrase: "153 158,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ferranti R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "da Silva MM,"

Phrase: "Kowaltowski AJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: ":"

Phrase: "Mitochondrial ATP-sensitive K+ channel opening"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0175566:Opening [Spatial Concept]
   799   C1882151:Opening [Spatial Concept]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "reactive oxygen species generation."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0079411:Generation [Temporal Concept]
   812   C3146294:Generation [Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   719 E C1414672:Genesis [Gene or Genome]
   719 E C2984892:Genesis [Gene or Genome]
Processing 00000000.tx.336: FEBS Lett536 :51 55,2003[Medline] Tiedge M, Krug U, Lenzen S: Modulation of human glucokinase intrinsic activity by SH reagents mirrors post-translational regulation of enzyme activity. 

Phrase: "FEBS Lett536"

Phrase: ":"

Phrase: "51 55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tiedge M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Krug U,"

Phrase: "Lenzen S"

Phrase: ":"

Phrase: "Modulation of human glucokinase intrinsic activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443264:Modulation [Spatial Concept]

Phrase: "by SH reagents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038738:SH-Reagents [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "mirrors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181868:Mirror [Manufactured Object]
  1000   C1706183:Mirror [Manufactured Object]

Phrase: "post-translational regulation of enzyme activity."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C1327623:regulation of enzyme activity [Molecular Function]
   833   C1514251:Post-Translational Regulation [Molecular Function]
   797   C1157519:regulation of translation [Cell Function]
   790   C3537096:Translational Regulation [Genetic Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.337: Biochim Biophys Acta1337 :175 190,1997[Medline] Tiedge M, Richter T, Lenzen S: Importance of cysteine residues for the stability and catalytic activity of human pancreatic beta cell glucokinase. 

Phrase: "Biochim Biophys Acta1337"

Phrase: ":"

Phrase: "175 190,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tiedge M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Richter T,"

Phrase: "Lenzen S"

Phrase: ":"

Phrase: "Importance of cysteine residues"

Phrase: "for the stability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205360:Stability [Qualitative Concept]
  1000   C2347098:Stability [Qualitative Concept]
   928 E C1547311:Stable [Intellectual Product]

Phrase: "and"

Phrase: "catalytic activity of human pancreatic beta cell glucokinase."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0243102:catalytic activity [Molecular Function]
   770   C1264638:Catalytic activity [Functional Concept]
   770   C1547012:*Catalytic Activity [Quantitative Concept]
   767   C0020115:Human Activity [Activity]
   767   C1150444:glucokinase activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.338: Arch Biochem Biophys375 :251 260,2000[Medline] Kajimoto Y, Matsuoka T, Kaneto H, Watada H, Fujitani Y, Kishimoto M, Sakamoto K, Matsuhisa M, Kawamori R, Yamasaki Y, Hori M: Induction of glycation suppresses glucokinase gene expression in HIT-T15 cells. 

Phrase: "Arch Biochem Biophys375"

Phrase: ":"

Phrase: "251 260,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kajimoto Y,"

Phrase: "Matsuoka T,"

Phrase: "Kaneto H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Watada H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Fujitani Y,"

Phrase: "Kishimoto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sakamoto K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Matsuhisa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kawamori R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Yamasaki Y,"

Phrase: "Hori M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Induction of glycation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205263:Induction [Functional Concept]
   790   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "glucokinase gene expression in HIT-T15 cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0017262:Gene Expression [Genetic Function]
   757   C1861886:CELL Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.339: Diabetologia42 :1417 1424,1999[Medline] Echtay KS, Roussel D, St-Pierre J, Jekabsons MB, Cadenas S, Stuart JA, Harper JA, Roebuck SJ, Morrison A, Pickering S, Clapham JC, Brand MD: Superoxide activates mitochondrial uncoupling proteins. 

Phrase: "Diabetologia42"

Phrase: ":"

Phrase: "1417 1424,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Echtay KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Roussel D,"

Phrase: "St-Pierre J,"

Phrase: "Jekabsons MB,"

Phrase: "Cadenas S,"

Phrase: "Stuart JA,"

Phrase: "Harper JA,"

Phrase: "Roebuck SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Morrison A,"

Phrase: "Pickering S,"

Phrase: "Clapham JC,"

Phrase: "Brand MD"

Phrase: ":"

Phrase: "Superoxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038836:Superoxide [Element, Ion, or Isotope]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "mitochondrial uncoupling proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0066604:mitochondrial uncoupling protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   913   C0949610:Mitochondrial Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.340: Nature415 :96 99,2002[Medline] Brown JE, Thomas S, Digby JE, Dunmore SJ: Glucose induces and leptin decreases expression of uncoupling protein-2 mRNA in human islets. 

Phrase: "Nature415"

Phrase: ":"

Phrase: "96 99,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Brown JE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: "Thomas S,"

Phrase: "Digby JE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: "Dunmore SJ"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: ":"

Phrase: "Glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "and"

Phrase: "leptin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0299583:Leptin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1416825:LEPTIN [Gene or Genome]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "expression of uncoupling protein-2 mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1171362:expression protein [Genetic Function]
   783   C1515670:mRNA Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in human islets."
Processing 00000000.tx.341: FEBS Lett513 :189 192,2002[Medline] Medvedev AV, Robidoux J, Bai X, Cao W, Floering LM, Daniel KW, Collins S: Regulation of the uncoupling protein-2 gene in INS-1 beta-cells by oleic acid. 

Phrase: "FEBS Lett513"

Phrase: ":"

Phrase: "189 192,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Medvedev AV,"

Phrase: "Robidoux J,"

Phrase: "Bai X,"

Phrase: "Cao W,"

Phrase: "Floering LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Daniel KW,"

Phrase: "Collins S"

Phrase: ":"

Phrase: "Regulation of the uncoupling protein-2 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0017263:Gene Regulation [Genetic Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "in"

Phrase: "INS-1 beta-cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   867   C0030281:Beta cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "by oleic acid."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.342: J Biol Chem277 :42639 42644,2002[Abstract/Free FullText] Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L: The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. 

Phrase: "J Biol Chem277"

Phrase: ":"

Phrase: "42639 42644,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Rosen P,"

Phrase: "Nawroth PP,"

Phrase: "King"

Phrase: "G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Moller W,"

Phrase: "Tritschler HJ,"

Phrase: "Packer L"

Phrase: ":"

Phrase: "The role of oxidative stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "progression of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0242656:progression [Pathologic Function]
   790   C0449258:Progression [Functional Concept]

Phrase: "and"

Phrase: "its complications"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009566:Complications [Pathologic Function]
  1000   C1171258:complications [Pathologic Function]
   966 E C2362589:Complication [Idea or Concept]
   916 E C0231242:Complicated [Functional Concept]

Phrase: ":"

Phrase: "a summary of a Congress Series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1552616:summary [Intellectual Product]
   753   C1706244:Summary [Intellectual Product]

Phrase: "sponsored by UNESCO-MCBN,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0041677:UNESCO [Organization]
   737   C1711305:Sponsor [Human]
   737   C2347796:SPONSOR [Organization]

Phrase: "the American Diabetes Association"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1705019:American Diabetes Association [Professional Society]
   827   C0004083:Association [Mental Process]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0439849:Association [Qualitative Concept]
   827   C0596070:American [Population Group]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "the German Diabetes Society."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037455:society [Organization]
Processing 00000000.tx.343: Diabetes Metab Res Rev17 :189 212,2001[Medline] Grimsby J, Sarabu R, Corbett WL, Haynes NE, Bizzarro FT, Coffey JW, Guertin KR, Hilliard DW, Kester RF, Mahaney PE, Marcus L, Qi L, Spence CL, Tengi J, Magnuson MA, Chu CA, Dvorozniak MT, Matschinsky FM, Grippo JF: Allosteric activators of glucokinase: potential role in diabetes therapy. 

Phrase: "Diabetes Metab Res Rev17"

Phrase: ":"

Phrase: "189 212,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Grimsby J,"

Phrase: "Sarabu R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Corbett WL,"

Phrase: "Haynes NE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538705:NE [Gene or Genome]

Phrase: "Bizzarro FT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881534:ft. [Functional Concept]

Phrase: "Coffey JW,"

Phrase: "Guertin KR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022773:KR [Geographic Area]

Phrase: "Hilliard DW,"

Phrase: "Kester RF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035448:RF [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0201660:RF [Laboratory Procedure]
   861   C0748398:RF [Finding]

Phrase: "Mahaney PE,"

Phrase: "Marcus L,"

Phrase: "Qi L,"

Phrase: "Spence CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Tengi J,"

Phrase: "Magnuson MA,"

Phrase: "Chu CA,"

Phrase: "Dvorozniak MT,"

Phrase: "Matschinsky FM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: "Grippo JF"

Phrase: ":"

Phrase: "Allosteric activators of glucokinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   802   C2246534:glucokinase activator [Molecular Function]

Phrase: ":"

Phrase: "potential role in diabetes therapy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.344: Science301 :370 373,2003[Abstract/Free FullText] Polonsky KS, Semenkovich CF: The pancreatic beta cell heats up: UCP2 and insulin secretion in diabetes. 

Phrase: "Science301"

Phrase: ":"

Phrase: "370 373,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Polonsky KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Semenkovich CF"

Phrase: ":"

Phrase: "The pancreatic beta cell heats up"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0018837:Heat [Natural Phenomenon or Process]

Phrase: ":"

Phrase: "UCP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421314:UCP2 [Gene or Genome]

Phrase: "and"

Phrase: "insulin secretion in diabetes."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1256369:insulin secretion [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.345: Cell105 :705 707,2001[Medline] Palmer JP: Beta cell rest and recovery: does it bring patients with latent autoimmune diabetes in adults to euglycemia? 

Phrase: "Cell105"

Phrase: ":"

Phrase: "705 707,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Palmer JP"

Phrase: ":"

Phrase: "Beta cell rest"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0035253:Rest [Daily or Recreational Activity]
   827   C1622890:ResT [Molecular Function]
   734   C0030281:Beta cell [Cell]

Phrase: "and"

Phrase: "recovery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237820:Recovery [Activity]
  1000   C1555688:recovery [Idea or Concept]
  1000   C2004454:Recovery [Organism Function]

Phrase: ":"

Phrase: "does"

Phrase: "it"

Phrase: "bring"

Phrase: "patients with latent autoimmune diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "in adults"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001675:Adults [Age Group]
   966 E C1706450:Adult [Human]

Phrase: "to euglycemia?"
Processing 00000000.tx.346: Ann N Y Acad Sci958 :89 98,2002[Abstract/Free FullText] Alvarsson M, Sundkvist G, Lager I, Henricsson M, Berntorp K, Fernqvist-Forbes E, Steen L, Westermark G, Westermark P, Orn T, Grill V: Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients. 

Phrase: "Ann N Y Acad Sci958"

Phrase: ":"

Phrase: "89 98,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Alvarsson M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sundkvist G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Lager I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Henricsson M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Berntorp K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Fernqvist-Forbes E,"

Phrase: "Steen L,"

Phrase: "Westermark G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Westermark P,"

Phrase: "Orn T,"

Phrase: "Grill V"

Phrase: ":"

Phrase: "Beneficial effects of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "versus"

Phrase: "sulphonylurea on insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   770   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "and"

Phrase: "metabolic control in recently diagnosed type 2 diabetic patients."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C1513158:Metabolic Control [Molecular Function]
   762   C1707504:Control Type [Research Activity]
   762   C1879930:Control Type [Intellectual Product]
   762   C2986481:Metabolic Type [Functional Concept]
   742   C0243148:control [Qualitative Concept]
   742   C0311400:Metabolic [Functional Concept]
   742   C1524026:Metabolic [Cell Function]
   742   C1550141:Control [Substance]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C2707259:Metabolic [Clinical Attribute]
   742   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.347: Diabetes Care26 :2231 2237,2003[Abstract/Free FullText] Alemzadeh R, Slonim AE, Zdanowicz MM, Maturo J: Modification of insulin resistance by diazoxide in obese Zucker rats. 

Phrase: "Diabetes Care26"

Phrase: ":"

Phrase: "2231 2237,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Alemzadeh R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Slonim AE,"

Phrase: "Zdanowicz MM,"

Phrase: "Maturo J"

Phrase: ":"

Phrase: "Modification of insulin resistance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392747:Modification [Functional Concept]
   770   C1554963:modification [Qualitative Concept]

Phrase: "by diazoxide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012022:Diazoxide [Organic Chemical,Pharmacologic Substance]
   944 E C0699324:Hyperstat [Organic Chemical,Pharmacologic Substance]

Phrase: "in obese Zucker rats."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]
Processing 00000000.tx.348: Endocrinology133 :705 712,1993[Abstract] Aizawa T, Taguchi N, Sato Y, Nakabayashi T, Kobuchi H, Hidaka H, Nagasawa T, Ishihara F, Itoh N, Hashizume K: Prophylaxis of genetically determined diabetes by diazoxide: a study in a rat model of naturally occurring obese diabetes. 

Phrase: "Endocrinology133"

Phrase: ":"

Phrase: "705 712,"

Phrase: "1993"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Aizawa T,"

Phrase: "Taguchi N,"

Phrase: "Sato Y,"

Phrase: "Nakabayashi T,"

Phrase: "Kobuchi H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hidaka H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Nagasawa T,"

Phrase: "Ishihara F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Itoh N,"

Phrase: "Hashizume K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ":"

Phrase: "Prophylaxis of genetically determined diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033107:prophylaxis [Intellectual Product]
   760   C0199176:Prophylaxis [Therapeutic or Preventive Procedure]

Phrase: "by diazoxide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012022:Diazoxide [Organic Chemical,Pharmacologic Substance]
   944 E C0699324:Hyperstat [Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "a study in a rat model of naturally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0557651:Study [Manufactured Object]
   744   C2603343:Study [Research Activity]

Phrase: "occurring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1709305:Occur [Activity]
   966   C2745955:OCCUR [Temporal Concept]

Phrase: "obese diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.349: J Pharmacol Exp Ther275 :194 199,1995[Abstract] Alemzadeh R, Langley G, Upchurch L, Smith P, Slonim AE: Beneficial effect of diazoxide in obese hyperinsulinemic adults. 

Phrase: "J Pharmacol Exp Ther275"

Phrase: ":"

Phrase: "194 199,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Alemzadeh R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Langley G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Upchurch L,"

Phrase: "Smith P,"

Phrase: "Slonim AE"

Phrase: ":"

Phrase: "Beneficial effect of diazoxide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "in obese hyperinsulinemic adults."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0001675:Adults [Age Group]
   793 E C1706450:Adult [Human]
Processing 00000000.tx.350: J Clin Endocrinol Metab83 :1911 1915,1998[Abstract/Free FullText] Westphal SA, Palumbo PJ: Insulin and oral hypoglycemic agents should not be used in combination in the treatment of type 2 diabetes. 

Phrase: "J Clin Endocrinol Metab83"

Phrase: ":"

Phrase: "1911 1915,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Westphal SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Palumbo PJ"

Phrase: ":"

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "oral hypoglycemic agents"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0359086:HYPOGLYCEMIC AGENTS, ORAL [Pharmacologic Substance]
           Oral hypoglycaemic
   901   C0020616:Hypoglycemic Agents [Pharmacologic Substance]
           Hypoglycaemic
   827   C0442027:Oral [Spatial Concept]
   793   C0450442:Agent [Chemical Viewed Functionally]
   793   C1254351:Agent [Pharmacologic Substance]
   793   C1521826:Agent [Intellectual Product]

Phrase: "should"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "used in combination"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0205195:Combination [Qualitative Concept]
   790   C1273517:used [Finding]
   790   C1947911:Combination [Physical Object]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "in the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "of type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.351: Arch Intern Med163 :1783 1785,2003[Free FullText]

Phrase: "Arch Intern Med163"

Phrase: ":"

Phrase: "1783 1785,"

Phrase: "2003"

Phrase: "[Free FullText"

Phrase: "]"

